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Abstract 
During apoptosis, caspase cleavage of ROCK1 removes an auto-inhibitory region 
yielding a constitutively active kinase fragment. This results in phosphorylation 
of downstream targets that promote contractile force generation leading to cell 
shrinkage, membrane blebbing and nuclear disintegration. To address 
fundamental questions regarding the purpose of ROCK1 cleavage and consequent 
apoptotic morphological features, a novel mouse model was generated that 
carries a single amino acid substitution in the caspase cleavage site (D1113A) 
that converts ROCK1 to a caspase-resistant non-cleavable (ROCK1nc) form. When 
apoptosis was induced in ROCK1nc cells, morphological features were 
significantly impaired, although the biochemical apoptotic program itself was 
unaffected. 
To understand the biological role of apoptotic morphological features in the 
maintenance of tissue homeostasis, acute liver damage was induced in mice with 
the liver-selective genotoxic compound diethylnitrosamine (DEN). Following DEN 
treatment, there were increased TUNEL-positive apoptotic cells and increased 
neutrophil infiltration in ROCK1nc mice. Histologically, ROCK1nc livers were 
more damaged, paralleled by higher serum alanine transaminase levels. We 
hypothesized that uncleared apoptotic debris undergoing secondary necrosis may 
release damage associated molecular patterns (DAMPs) that may aggravate liver 
damage by recruiting neutrophils to the liver. Indeed, inhibiting the cytokine 
activities of HMGB1 reduced neutrophil infiltration as well as liver damage in 
ROCK1nc mice. Furthermore, to determine whether defects in tissue damage 
responses in ROCK1nc mice would affect tumour development, the ROCK1nc 
mutation was introduced into two different cancer models, specifically the DEN-
induced hepatocellular carcinoma and Eµ-myc lymphoma mouse models. 
Defective caspase cleavage of ROCK1 promoted increased infiltration of CD8+ T-
cells in ROCK1nc liver tumours and had a protective effect against tumour 
development in both tumour models. Taken together, our results indicate that 
apoptotic morphological features suppress inflammation which helps to maintain 
tissue homeostasis but enables tumourigenesis.  
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1 Introduction 
[Text extracted from JULIAN, L. & OLSON, M. F. 2014. Rho-associated coiled-coil containing 
kinases (ROCK): structure, regulation, and functions. Small GTPases, 5, e29846 (Julian and 
Olson, 2014) and JULIAN, L. & OLSON, M. F. 2015. Apoptotic membrane dynamics in health and 
disease  Cell Health and Cytoskeleton, 7, 133-142 (Julian and Olson, 2015) ] 
1.1 Rho Associated Coiled-Coil Kinases 
Rho associated coiled-coil kinases (ROCK) are serine/threonine kinases which 
were originally identified as prominent downstream effectors of the Rho GTPases 
(Leung et al., 1995, Matsui et al., 1996, Leung et al., 1996, Nakagawa et al., 
1996, Ishizaki et al., 1996). ROCK proteins primarily regulate and modulate the 
cytoskeleton by promoting the stabilization and bundling of actin filaments and 
the subsequent generation of actin-myosin contractility via phosphorylation of 
downstream targets. ROCK proteins have been extensively studied over the years 
and have been found to be indispensable for many cellular processes that are 
dependent on the actin-myosin cytoskeleton including, but not limited to: cell 
contraction, migration, adhesion, apoptosis, survival and proliferation. In this 
section, I will focus on the structure, regulation, downstream substrates and 
functions of ROCK. 
Two mammalian ROCK homologs have been identified, ROCK1 (also known as 
ROKβ, Rho-kinase β, ROCK I or p160ROCK) and ROCK2 (also known as ROKα, Rho 
kinase and ROCK II). In humans, the two isoforms ROCK1 and ROCK2 both contain 
33 exons and are located on chromosome 18 (18q11.1) and 2 (2p24), 
respectively. The ROCK1 open reading frame encodes 1354 amino acids, whereas 
ROCK2 encodes 1388 amino acids. A pseudogene derived by partial duplication 
and inversion of ROCK1, called Little ROCK, is located on chromosome 18p11.32 
of vascular smooth muscle cell lines and organs rich in vascular smooth muscle 
cells (Montefusco et al., 2010). ROCK2 has a reported splice variant termed 
ROCK2m, preferentially expressed in skeletal muscle, which is characterized by 
the inclusion of an extra exon between exon 27 and exon 28 (Pelosi et al., 2007).  
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 Structure 1.1.1
The two ROCK homologues share 64% identity in their primary amino acid 
sequences, with the highest homology (92%) within the kinase domains and the 
coiled-coil domains being the most diverse (55%) (Nakagawa et al., 1996). The 
kinase domains of ROCK are closely related to many homologous domains in this 
family, including myotonic dystrophy kinase (DMPK), myotonic dystrophy kinase 
related-Cdc42 related kinases (MRCK) α and β, and citron Rho-interacting kinase 
(CRIK). To date, the crystal structures of the kinase domains from ROCK1 (Jacobs 
et al., 2006), ROCK2 (Yamaguchi et al., 2006), MRCKα MRCKβ (Heikkila et al., 
2011) and DMPK (Elkins et al., 2009) have been determined, which has 
highlighted the high degree of tertiary as well as primary similarity. The ROCK 
kinase domains are located in the amino-terminal region, followed by a central 
~600 amino acid long amphipathic α-helix forming a coiled-coil region (Samuel 
and Olson, 2010). At the carboxyl-terminal region, there is a split pleckstrin 
homology (PH) domain, which is bisected by an internal cysteine-rich zinc finger-
like motif domain (CRD) (Figure 1-1). The two separate PH portions assemble 
together to form a typical PH domain that is attached by two short linkers to a 
separate CRD (Wen et al., 2008). Distinct from most other kinase proteins, the 
amino-terminal and carboxyl-terminal extensions of the ROCK kinase domains 
are essential for its catalytic activity (Leung et al., 1996, Jacobs et al., 2006, 
Yamaguchi et al., 2006). 
Crystal structure studies have provided deeper insight into the different domains 
of the protein. The canonical Rho binding domain (RBD) forms a parallel coiled-
coil dimer as revealed by crystal structure determinations and binds exclusively 
to the switch I and switch II regions of GTP-bound active RhoA and RhoC (Shimizu 
et al., 2003, Dvorsky et al., 2004). Two additional Rho-interacting domains were 
identified that can tightly interact with RhoA and which may cooperatively 
contribute to binding (Blumenstein and Ahmadian, 2004). Recent crystal 
structure studies on the coiled-coil domain of ROCK1 revealed a unique sequence 
feature that creates an irregularity in the domain and possible conformational 
flexibility (Tu et al., 2011).  
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Figure 1-1 Molecular organization of ROCK isoforms 
Diagram shows a schematic representation of ROCK1 and ROCK2 protein domains. The 
kinase domain is situated at the N terminus followed by a coiled-coil region with Rho-
binding domain (RBD) in the middle and a pleckstrin homology (PH) domain with an 
internal cysteine-rich region (CRD) at the C-terminus. Protein domains and their indicated 
positions were taken from the National Center for Biotechnology Information. Figure 
adapted from (Julian and Olson, 2014) 
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ROCK has two dimerization domains: the ~70 residue amino terminal 
dimerization region and the coiled-coil helical regions (Jacobs et al., 2006, 
Yamaguchi et al., 2006). Dimerization is essential for its kinase activity and 
regulation (Dvorsky et al., 2004, Jacobs et al., 2006, Yamaguchi et al., 2006, 
Garg et al., 2008). Charged residues in the coiled-coil region might function as a 
hinge that allows the N terminal kinase domains to interact with C-terminal 
inhibitory regions. Structural determination of full-length ROCK protein crystals 
will ultimately reveal how the various domains interact and the mechanism of 
auto-inhibition. 
 Regulation 1.1.2
Although ROCK1 and ROCK2 have highly related functional domains and 
significant amino acid identity, they are regulated both by common means as 
well as mechanisms unique to ROCK1 or ROCK2.  
1.1.2.1 Conventional Activation 
The carboxyl-terminal region of ROCK which contains the Rho binding domain 
and the pleckstrin homology domain acts as an auto-inhibitory region of the 
kinase domain, since deletion of this portion results in constitutive activation of 
either kinase in vitro and in vivo (Amano et al., 1999, Ishizaki et al., 1997) 
(Figure 1-2). Inhibition may occur either because the active site of the kinase 
domain is blocked by interaction with portions of the carboxyl terminal region or 
due to stabilization of a catalytically incompetent conformation (Jacobs et al., 
2006). The Ras superfamily includes the Rho-GTPase proteins RhoA and RhoC, 
which are the most well characterized ROCK regulators. Several lines of 
evidence show that interaction of activated, GTP-bound Rho proteins with the 
RBD elevate the kinase specific activity of ROCK by inducing conformational 
changes that disrupt the negative regulatory interactions between the kinase 
domain and the auto-inhibitory carboxyl terminal region(Leung et al., 1996, 
Ishizaki et al., 1996, Nakagawa et al., 1996). However, structural studies of the 
holoenzyme, either in isolation or associated with active Rho proteins have not 
been reported to confirm this model. 
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However, during apoptosis, ROCK1 is activated by cleavage and removal of the 
auto-inhibitory domain by caspases (Coleman et al., 2001, Sebbagh et al., 2001). 
Similarly, ROCK2 can be activated by Granzyme B-mediated cleavage, which also 
leads to concomitant caspase activation and ROCK1 activation (Sebbagh et al., 
2005) (Figure 1-2). In a non-apoptotic scenario in endothelial cells, thrombin was 
reported to activate caspase 2 and increase ROCK2 expression, resulting in 
increased levels of caspase 2-mediated proteolytic cleavage and consequent 
activation of ROCK2 (Sapet et al., 2006). Several other mechanisms of ROCK 
regulation have also been described over the years including stimulation of ROCK 
activity by lipids messengers like arachidonic acid and sphingophosphocholine 
(Feng et al., 1999, Shirao et al., 2002).  
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Figure 1-2 Conventional modes of ROCK activation 
Diagram shows schematic representation of modes of ROCK activation. In the inactive 
state, the carboxyl terminal of ROCK acts as an auto-inhibitory region. Binding of active 
RhoA to the Rho binding domain (RBD) disrupts the negative regulation, thus rendering 
the kinase active. ROCK protein can also be activated in a Rho-independent manner by 
removal of the inhibitory carboxyl terminal of ROCK1 and ROCK2 by caspase 3 and 
granzyme B mediated cleavage, respectively. Figure adapted from (Julian and Olson, 
2014).  
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1.1.2.2 Phosphorylation 
Crystal structure analyses revealed that the unphosphorylated ROCK1 kinase 
domain had a catalytically competent conformation without phosphorylation or 
conformational input from RhoA binding to the RBD (Jacobs et al., 2006). Unlike 
other AGC family kinases that require activation loop phosphorylation 
(Schackmann et al., 2011), the ROCK kinase domains do not appear to require 
phosphorylation for activity. However, additional kinases may regulate ROCK 
signalling by phosphorylating other regions. For example, Polo-like kinase-1 
works synergistically with RhoA to maximally activate ROCK2 by phosphorylating 
at any one of four conserved sites Thr-967, Ser-1099, Ser-1133 and Ser- 1374 
(Lowery et al., 2007). Phosphorylation of ROCK2 on Tyr-722 inhibits activity by 
decreasing RhoA binding (Sinning et al., 2011), while Shp-2 mediated 
dephosphorylation increases RhoA responsiveness (Lee and Chang, 2008). Auto-
phosphorylation by ROCK2 on S1366 (Rautou et al., 2011) and by ROCK1 on S1333 
(Chuang et al., 2013) is a reflection of the kinase activation, although these sites 
do not regulate catalytic activity. However, phosphorylation on these sites might 
contribute to protein subcellular localization (Ishiuchi and Takeichi, 2011). Large 
scale phosphoproteomics studies have identified numerous phosphorylations on 
human ROCK1 (45 sites reported on www.phosphosite.org) and ROCK2 (43 sites), 
although the majority of them have not been confirmed by independent means. 
The frequency of some observed phosphorylations (e.g. ROCK1 Tyr-913 and Ser-
1341, or ROCK2 Ser-1379) suggests that they have physiological significance, 
which will likely be determined in the future. 
1.1.2.3 Negative Regulation 
Although Rho proteins generally activate ROCK, other GTP-binding proteins have 
been found to negatively regulate ROCK signalling. Gem was shown to interact 
with ROCK1 in the coiled-coil region adjacent to the RBD, thereby inhibiting 
phosphorylation of MLC and the MYPT1 subunit of MLC phosphatase (Ward et al., 
2002). Rad1, another small GTP-binding protein was also reported to mimic Gem 
in inhibiting actin-myosin contractility by blocking ROCK2, resulting in reduced 
cell rounding and neurite retraction (Ward et al., 2002). In contrast to the highly 
related RhoA, B and C proteins that can stimulate stress fibre formation through 
ROCK, RhoE decreases stress fibre formation (Guasch et al., 1998, Nobes et al., 
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1998) by binding to the amino-terminal region of ROCK1, but not ROCK2, thus 
physically interfering with ROCK1 kinase activity (Riento et al., 2003, Riento and 
Ridley, 2003, Riento et al., 2005). Interestingly, protein kinase PDK1 
competitively binds to a similar region of ROCK1 as RhoE, thereby antagonizing 
the negative regulation of ROCK1 by Rho E (Pinner and Sahai, 2008). Recently, 
Coronin1B was identified as an attenuator of ROCK2 signalling by directly binding 
to the PH domain (Rana and Worthylake, 2012). Identification of additional 
interactions with similar ROCK regulators may highlight mechanisms that 
modulate ROCK activity locally without global effects on this signalling pathway. 
 Expression and Localization  1.1.3
Initial studies revealed a uniform expression of ROCKs during embryogenesis and 
in adult tissues (Leung et al., 1996, Nakagawa et al., 1996). Analysis of ROCK1 
and ROCK2 expressed sequence tag distribution using the Tissue-specific Gene 
Expression and Regulation (TiGER) database (Liu et al., 2008b) revealed that 
their distribution patterns were similar and that there were few specific 
organ/tissues with expression levels that were dramatically higher than another 
(Julian and Olson, 2014). Notably, there was significant ROCK1 expression in the 
thymus and blood, with little to no ROCK2 expression detected. 
Several studies examined the subcellular localization of the two ROCK isoforms. 
Early studies on ROCK2 localization reported a predominantly cytosolic 
distribution (Leung et al., 1995, Matsui et al., 1996). Overexpression of an active 
RhoA mutant resulted in the recruitment of ROCK2 to both internal and 
peripheral cell membranes, where it was observed to be largely associated with 
actin microfilaments (Vandenabeele et al., 2010, Leung et al., 1995). Further 
studies on ROCK2 subcellular distribution revealed accumulation at the cleavage 
furrow, implicating its role in the formation of contractile ring during cytokinesis 
(Kosako et al., 1999, Inada et al., 1999). In addition, ROCK2 has been reported 
to localize in the nucleus of growing cells (Tanaka et al., 2006), stress fibres 
(Katoh et al., 2001, Kawabata et al., 2004), filamentous vimentin network in 
serum-starved cells (Sin et al., 1998) as well as to the centrosomes (Ma et al., 
2006). Interestingly, Shroom, a key player in apical cell constriction in 
neurulation, binds to ROCK2 and regulates its distribution to apical cell junctions 
to achieve a localized activation (Flynn and Helfman, 2010, Ehrenschwender et 
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al., 2010). Subcellular localization of ROCK1 has not been as well characterized, 
but some studies point to ROCK1 association with the plasma membrane (Glyn et 
al., 2003, Stroeken et al., 2006) and centrosomes (Chevrier et al., 2002). In rat 
embryonic fibroblasts, ROCK1 and ROCK2 had distinct distribution pattern with 
ROCK1 concentrated in the perinuclear regions and sometimes associated with 
stress fibres whereas ROCK2 was characteristically distributed at the cell 
membrane ruffles along with perinuclear distribution (Yoneda et al., 2005). 
 Downstream Targets 1.1.4
Activated ROCK proteins phosphorylate a number of downstream targets 
involved in different biological processes, and given the high similarity in their 
kinase domains, it is likely that the two isoform would phosphorylate numerous 
common substrates. From the several studies aimed at identifying ROCK 
substrates, a consensus amino acid motif for phosphorylation in most cases was 
found to be R/KXXS/T or R/KXS/T (R- Arginine, K- Lysine, S- Serine, T- 
Threonine, X- any amino acid), although some non-canonical sites have also been 
identified by peptide phosphorylation screening (Kang et al., 2007).  
One of the primary roles defined for ROCK is the regulation of actin-myosin 
cytoskeletal organization. Phosphorylated myosin II regulatory light chains (MLC) 
promote actin-myosin contractility by activating myosin ATPase, thus enabling 
its interaction with F-actin to generate a contractile force (Vicente-Manzanares 
et al., 2009). ROCKs can phosphorylate MLC at Ser-19 and Thr-18 and this occurs 
at the same sites that are phosphorylated by MLC kinase (Amano et al., 1996). 
However, depletion of Ca2+ to block activation of MLC kinase (MLCK) resulted in 
decreased MLC phosphorylation in response to G-protein activation in airway 
smooth muscle cells, indicating that ROCK may largely contribute to elevating 
MLC phosphorylation indirectly by inhibiting dephosphorylation (Iizuka et al., 
1999, Sward et al., 2000). MLC dephosphorylation is mediated by a phosphatase 
complex (PP1M) that is composed of a PP1cδ catalytic subunit, the myosin 
binding subunit MYPT1 that modulates the targeting of myosin to the 
phosphatase, and a small regulatory subunit M20 (Hartshorne and Hirano, 1999). 
Phosphorylation of MYPT1 by ROCK on Thr-695 and Thr-850 leads to the 
inhibition of MLC dephosphorylation by dissociating myosin from the 
phosphatase, thereby allowing for increased net MLC phosphorylation and 
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subsequent activation of myosin ATPase (Kimura et al., 1996, Feng et al., 1999a, 
Kawano et al., 1999, Velasco et al., 2002). Moreover, MLC phosphorylation to 
induce stress fibre and focal adhesion assembly is spatially regulated by MLCK, 
MRCK and ROCK, where ROCK is involved in the formation of stress fibres in the 
centre of fibroblasts, while MLCK and MRCK function at the periphery 
(Totsukawa et al., 2000, Ando et al., 2013). In addition, ROCK kinases also 
regulate actin filament dynamics by phosphorylating LIM kinases 1 and 2 (Scott 
and Olson, 2007) on activation loop Thr-508 (Ohashi et al., 2000) and Thr-505 
(Katoh et al., 2001, Sumi et al., 2001) respectively. Activated LIM kinases 
phosphorylate and inactivate the actin severing protein cofilin, resulting in a net 
increase in the number of actin filaments within cells (Arber et al., 1998, Adams 
et al., 1996). Collectively, ROCK activation leads to a concerted series of events 
that promote actin-myosin mediated contractile force generation and 
consequent morphological changes. 
 ROCK Functions  1.1.5
At the time when the two isoforms of ROCK were identified, nearly 20 years ago, 
they were proposed to be regulators of the actin cytoskeleton. Since then the 
role of ROCKs has been studied comprehensively in many different contexts. 
Some of the major functions will be discussed here. But, its role in apoptosis will 
be addressed in the next section.  
1.1.5.1 Actin Organization 
Formation of stress fibres and focal adhesion complexes by MLC phosphorylation 
was one of the first functions identified for ROCK (Amano et al., 1997). Stress 
fibres are contractile apparatus in cells that are composed of bundles of F-actin 
and myosin II which are especially prominent in cultured cells, but have also 
been shown to be manifested in cells in vivo (Sugimoto et al., 1991, Murakami 
and Ishikawa, 1991). These actin-myosin fibres are linked to discrete points on 
the inner plasma membrane called focal adhesions, where dynamic protein 
complexes that contribute to cell adhesion to the extracellular matrix are 
localized (Schiller et al., 2013). Expression of constitutively active ROCK 
consistently induced the formation of stress fibres and focal adhesions, whereas 
kinase dead and the N terminal truncated ROCK mutants induced disassembly of 
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stress fibres and focal adhesion complexes, accompanied by cell spreading 
(Leung et al., 1996, Amano et al., 1997, Ishizaki et al., 1997). Although both 
ROCK isoforms appear to contribute to focal adhesion formation and 
microfilament bundling, siRNA knockdown experiments have revealed some 
differences in their functions. In fibroblasts, ROCK1 and ROCK2 play distinct roles 
in the subcellular sites of MLC phosphorylation and in the assembly of fibronectin 
matrices at the cell surface during actin cytoskeleton mediated extracellular 
matrix assembly (Yoneda et al., 2005, Yoneda et al., 2007). Knockdown of ROCK1 
in keratinocytes blocked focal adhesion maturation, which decreased cell 
adhesion to fibronectin, while ROCK2 knockdown reduced turnover, leading to 
the formation of large focal adhesions with increased stability that promoted 
fibronectin adhesion (Surma et al., 2011, Hohenberger et al., 2011). Using mouse 
embryo fibroblasts (MEFs) deleted for ROCK1 or ROCK2, it was observed that 
ROCK1 regulates peripheral actin-myosin ring formation through MLC 
phosphorylation and ROCK2 stabilizes the cytoskeleton through cofilin 
phosphorylation following treatment with the chemotherapeutic drug 
doxorubicin (Shi et al., 2013). These results indicate that ROCK1 and ROCK2 may 
have different functions in cells, likely due to differences in the way that there 
are regulated and subtle differences in localization that result from non-
overlapping patterns of lipid and/or protein binding. 
Although ROCK signalling can recapitulate the effects of Rho activation, this may 
not hold true in all instances and may require additional Rho effector proteins to 
work cooperatively with ROCK. This has been well demonstrated in the context 
of stress fibre assembly where ROCK induced stress fibres are thicker than those 
induced by RhoA (Leung et al., 1996, Amano et al., 1997, Ishizaki et al., 1997). 
Rho activates one of its effectors mDia1 (mammalian homologue of Drosophila 
Diaphanous 1), which interacts with profilin, thus transforming the condensed 
stress fibres to thinner actin fibres, which remains disorganized in the absence of 
ROCK activity (Watanabe et al., 1999). These studies indicate the necessity for 
mDia to act in concert with ROCKs following Rho activation in stress fibre 
assembly. 
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1.1.5.2 Cell Migration 
One of the crucial events that enable cellular motion is actin-myosin-mediated 
contraction that allows anterograde motion of the cell and rear cell retraction. 
Given the importance of ROCK in the regulation of actin cytoskeleton dynamics, 
it is not surprising that this enzyme has been implicated in cell migration. There 
are two predominant modes of single cell migration, that have been described as 
mesenchymal and amoeboid, which are interconvertible in tumour cells 
depending on the microenvironment. An elongated, spindle like morphology that 
requires the activation of small GTPase Rac as well as presence of protease 
activity characterizes the mesenchymal migration mode. In amoeboid migration, 
cells exhibit a rounded morphology as well as formation of bleb like protrusions 
that deforms the collagen thus allowing them to squeeze through extracellular 
matrix without the need for proteolysis (Wolf et al., 2003, Wilkinson et al., 2005, 
Wyckoff et al., 2006). ROCK signalling is a requirement for amoeboid migration 
as it generates actin-myosin contractility and protrusion of blebs in all 
directions. Interestingly, low adhesion cells like lymphocytes and neutrophils 
appear to take on the amoeboid mode, thus conferring them a high degree of 
mobility even in the absence of proteolysis which is well suited for their function 
(Friedl and Wolf, 2003). On the other hand, mesenchymal invasion seems to have 
limited dependence on ROCK, as the ROCK inhibitor Y-27632 can inhibit invasion 
of several amoeboid cell lines in 3D matrices but not mesenchymal invasion 
(Sahai and Marshall, 2003). In accordance, expression of an active ROCK resulted 
in rounded morphology with several membrane blebs (Sahai and Marshall, 2003). 
A recent study reported that FilGAP, a Rac GTPase activating protein, acts 
downstream of ROCK during amoeboid migration and can also regulate 
mesenchymal to amoeboid transition by inactivating Rac (Saito et al., 2012). As 
mentioned above, tumour cells display a high degree of plasticity as inhibition of 
ROCK converts their morphology from amoeboid to transitional (Sanz-Moreno et 
al., 2008). On the other hand, inhibition of Rac or in the presence of protease 
inhibitors, there is transition from proteolysis dependent mesenchymal mode to 
amoeboid (Sahai and Marshall, 2003, Wolf et al., 2003, Sanz-Moreno et al., 
2008). These studies can have a deep impact on the development of anti-
metastatic drug therapies. 
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1.1.5.3 Cell Proliferation and Cytokinesis 
Numerous studies have highlighted the importance of ROCK in the regulation of 
cell proliferation, which may be due to a role in mediating cytoskeletal tension 
or may be mediated by cytoskeleton-independent pathways. In accordance with 
this, ROCK inhibitors have been shown to have anti-proliferative effects in some 
cell types including airway and prostatic smooth muscle cells and cardiac 
myocytes (Takeda et al., 2006, Zhao and Rivkees, 2003, Yahiaoui et al., 2006). 
Conversely, active ROCK can induce proliferation in some cell types including 
fibroblasts, in which modulation of the levels of specific cell cycle regulators 
appears to play an important role (Croft and Olson, 2006). The influence of ROCK 
activity on the levels of cell cycle regulatory proteins also has been implicated in 
the proliferation of corneal epithelial cells (Chen et al., 2008) and gastric cells 
(Zhang et al., 2009). 
Although ROCK activity may promote proliferation in some cells types, in other 
contexts ROCK appears to have anti-proliferative functions. For example, 
inhibition of ROCK activity in human keratinocytes resulted in increased 
proliferation and decreased terminal differentiation, while conditional ROCK2 
activation had the opposite effects, suggesting a role for ROCK in the regulation 
of keratinocyte fate (McMullan et al., 2003). 
During cytokinesis, cells undergo dramatic reorganization of the cytoskeleton and 
are divided in two daughters through the actions of the actin-myosin rich 
contractile ring. Shortly after the identification of ROCK kinases, it was observed 
that dominant negative ROCK2 inhibited cleavage furrow formation in Xenopus 
embryos and in mammalian cells, resulting in multinucleation (Yasui et al., 
1998). Further studies revealed the accumulation of ROCK2 at the cleavage 
furrow during cytokinesis, where it was an important contributor to MLC 
phosphorylation (Kosako et al., 1999, Kosako et al., 2000). However, although 
ROCK2 inhibition did not completely arrest cytokinesis, it did result in prolonged 
cleavage furrow ingression, suggesting that ROCK2 makes indispensable 
contributions to the normal progression of cytokinesis (Kosako et al., 2000). 
Interestingly, ROCK kinases do not appear to be responsible for the 
phosphorylation of ezrin/radixin/moesin (ERM) proteins localized at the cleavage 
furrow, suggesting that there must be other cleavage furrow kinases that may 
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play complementary and/or redundant roles in cytokinesis (Kosako et al., 2000, 
Yokoyama et al., 2005). Taken together, ROCK may have a general positive role 
as a promoter of cell proliferation in many cell types, with some exceptions in 
specialized contexts. 
1.1.5.4 Embryonic Development 
ROCK1 and ROCK2 have been reported to have overlapping expression patterns 
in developing embryos and are highly enriched in the cardiac mesoderm, lateral 
plate mesoderm, and the neural plate in chick and mouse embryos where they 
play vital roles in various embryonic morphogenetic events, including cell 
migration, differentiation and axis formation (Shi et al., 2011). Earlier 
experiments that sought to elucidate the roles of ROCK signalling in 
development have been performed with small molecule inhibitors that block 
both kinases with equal potency (Wei et al., 2001); therefore these studies do 
not provide any information on the specific functions of each ROCK protein. 
Genetic deletion of ROCK1 or ROCK2 in mice made it possible to dissect the roles 
of these proteins in development (Table 1-1). A consistent abnormality in ROCK1 
and ROCK2 knockout mice on a C57BL/6N strain background was failure of 
closure of eyelids and ventral body wall giving rise to eyes open at birth and 
omphalocele phenotypes (Shimizu et al., 2005, Thumkeo et al., 2005). 
Formation of organized actin-myosin cables in the eyelid epithelial sheets and 
the actin-myosin-mediated closure of umbilical rings were impaired in both 
knockout models (Shimizu et al., 2005, Thumkeo et al., 2005). Despite the two 
isoforms having highly conserved kinase domains, they apparently cannot 
compensate for each other in these tissues. ROCK1 and ROCK2 double 
heterozygous mice also displayed the same phenotype, albeit at a lower 
frequency, suggesting that the observed phenotypes are the result of insufficient 
gene dosage with both isoforms cooperatively regulating the movement of 
epithelial sheets for eyelid and ventral body wall closure (Thumkeo et al., 2005). 
Yet, ROCK1 or ROCK2 knockout mice and double heterozygous mice that survived 
continued to develop normally, and were fertile and apparently healthy, 
suggesting that ROCK1 and ROCK2 are particularly important during development 
when cell movement is required for the formation of tissues and organs (Shimizu 
et al., 2005, Thumkeo et al., 2005). 
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Interestingly, ROCK2 deletion on a mixed genetic background of C57BL/6N and 
129/SvJ strains exhibited placental dysfunction, intrauterine growth retardation 
and 90% embryonic death in utero (Thumkeo et al., 2003). On the same 
C57BL/6N strain background, the survival rate of ROCK2 knockouts was less than 
was observed for ROCK1 deletion, due to an additional defect in the placental 
labyrinth layer (Thumkeo et al., 2005). Similarly, differences in strain 
background also had an effect in ROCK1 knockouts, as the eyelids open at birth 
and omphalocele phenotypes were not observed in mice with mixed C57BL/6N 
and 129/SvJ or FVB backgrounds (Zhang et al., 2006). These studies indicate that 
strain differences, and by inference additional genetic modifiers that have yet to 
be identified, affect the manifestation of these phenotypes in ROCK1 or ROCK2 
deleted mice. The lack of phenotypes in other tissues suggests that both 
homologues can functionally compensate for each other during development or 
that there is a lower requirement for total ROCK protein.  
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Genotype Strain 
Genetic 
Modification 
Lethality, 
Developmental 
Phenotype 
Phenotype 
of 
Survivors 
Refs 
ROCK1-/- 
C57BL/6 
Deletion of 
exon 3 and 4 
Perinatal (~90%) 
EOB and omphalocele 
Fertile and 
healthy, 
50% had 
eye lesions 
(Shimizu 
et al., 
2005) 
C57BL/6 
Deletion of 
exon 1b 
In utero or perinatal 
(~95%) 
EOB and omphalocele 
Not 
recorded 
Rikitake 
et al, 
2005 
FVB 
Disruption of 
exon 5 
Embryonic (~60%) 
Not recorded 
Fertile and 
healthy 
Zhang et 
al, 2006 
ROCK2-/- 
C57BL/6
-
129/SvJ 
Deletion of 
most of exon 
3 
Embryonic (~92%), 
Perinatal (~95%) 
Placental 
dysfunction, 
intrauterine growth 
retardation 
Runted, 
fertile 
Thumkeo 
et al, 
2003 
C57BL/6 
Deletion of 
most of exon 
3 
Embryonic (~88%), 
Perinatal (>99%) 
Placental 
dysfunction, EOB and 
omphalocele 
Not 
recorded 
Thumkeo 
et al, 
2005 
CD-1 
Deletion of 
most of exon 
3 
None 
Impaired 
motor 
function 
Duffy et 
al, 2009 
ROCK1+/- C57BL/6 
Deletion of 
exon 1b 
None 
Fertile and 
healthy 
Rikitake 
et al, 
2005 
ROCK1+/- FVB 
Disruption of 
exon 5 
Embryonic (~30%) 
Not recorded 
Fertile and 
healthy 
Zhang et 
al, 2006 
ROCK1+/-
ROCK2+/- 
C57BL/6 
Deletion of 
exon 3 and 4 
(ROCK1); 
most of exon 
3 (ROCK2) 
Perinatal (~30%) 
EOB and omphalocele 
Fertile and 
healthy 
Thumkeo 
et al, 
2005 
Table 1-1: Genetic mouse models of ROCK knockout  
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 Current Status of ROCK Inhibitors 1.1.6
Existing information about many of the cellular functions of ROCKs was aided by 
the availability of several commercial inhibitors. Most of these inhibitors work by 
competing with the ATP for binding to their catalytic site. The implication of the 
ROCK isoforms in several pathological conditions (Julian and Olson, 2014) has 
promoted the therapeutic use of these inhibitors in various animal and human 
disease models, a major one being cardiovascular diseases.  
Among the different inhibitors, Y-27632 (Uehata et al., 1997) and fasudil (Asano 
et al., 1987) have been extensively used for experiments. Y-27632 belongs to the 
pyridine class of chemicals and is a non- selective inhibitor of both ROCK1 and 
ROCK2. Fasudil (HA-1077), belonging to the isoquinoline group, although being a 
moderate inhibitor of ROCK, is the only one that has been approved for clinical 
use in Japan since 1995 for the treatment of cerebral vasospasm and ischemia 
(Olson, 2008). Various clinical studies have been undertaken to test the efficacy 
of fasudil, for example in pulmonary arterial hypertension (Ishikura et al., 2006), 
atherosclerosis (Nohria et al., 2006) and aortic stiffness (Noma et al., 2007). 
Other inhibitors which are commonly used include Y-32885 (Uehata et al., 1997), 
hydroxyfasudil (HA-1100) (Arai et al., 1993), and H-1152 (Ikenoya et al., 2002). 
In addition to fasudil, more inhibitors are gaining access to clinical trials (phase 
2) including Y-39983 for glaucoma (Tokushige et al., 2007), BA-210 for spinal 
cord injury (Lord-Fontaine et al., 2008)and SAR407899 for erectile dysfunction 
(Lohn et al., 2009). Despite the development of so many inhibitors, none of 
them is absolutely ROCK specific. Most of these inhibitors also inhibit protein 
kinase C-related kinase (PRK) as well as ribosomal S6 kinase (RSK), cyclic AMP 
dependent protein kinase (PKA) and mitogen and stress activated protein kinase 
(MSK1) (Bain et al., 2007). Whether the effect of ROCK inhibitors in clinical trials 
is a result of inhibition of additional kinases is not known and hence evidence 
gleaned from ROCK inhibitor studies have to be interpretted with caution. 
Recently, the focus has been shifted to identifying and developing isoform-
specific ROCK inhibitors (Boerma et al., 2008). Since these are still in their 
infancy, mouse models with conditional or tissue specific deletion of ROCK1 
and/or ROCK2 still remain crucial for understanding the biological functions of 
ROCKs.  
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1.2 ROCK1 in Apoptotic Membrane Blebbing 
The role of ROCK isoforms as key regulators of the actin myosin cytoskeleton has 
been appreciated over many years. Despite the advances in the field of cell 
death, not much was known about the mediators driving the morphological 
features of dying cells until the late nineties. Seminal reports implicating the 
ROCK isoforms in the modulation of actin myosin activity, thus driving the 
formation of dynamic membrane protrusions called blebs during cell death 
became the key to unravelling the biological significance of these events. In this 
section, I will present a brief overview about apoptosis and its features before 
delving into the role of ROCK during the execution phase of apoptosis. 
 Apoptosis or Programmed Cell Death 1.2.1
Multicellular organisms need to get rid of excess, unwanted or damaged cells 
through a dedicated molecular programme called ‘apoptosis’. The term 
‘apoptosis’ was first conceived in 1972 by Kerr, Wyllie and Currie to describe a 
distinct form of programmed cell death (Kerr et al., 1972). Our understanding of 
the molecular components governing this program, stem largely from genetic 
studies on the nematode C. elegans, mostly from the 1980s and 1990s (Horvitz, 
1999). Subsequent characterization led to the identification of three apoptotic 
pathways, namely extrinsic or death receptor pathway, intrinsic or 
mitochondrial pathway, and perforin or granzyme pathway. Proteases known as 
cysteine-dependent aspartate specific proteases or caspases, which can cleave 
proteins at aspartic acid residues, were identified as central components of the 
apoptotic program (Cerretti et al., 1992, Nicholson et al., 1995, Alnemri et al., 
1996). These proteases are ubiquitously expressed as inactive precursors that 
are activated during apoptosis. Caspases involved in apoptosis may be divided 
into initiator or effector caspases. Intracellular and extracellular apoptotic 
stimuli received via one of the three pathways activate the initiator caspases 2, 
8, 9 and 10, which in turn signal via a caspase activation cascade to propagate 
the death stimulus by activating the downstream effector caspases 3, 6, and 7 
(Cohen, 1997). Activated effector caspases orchestrate the destruction of 
diverse cellular structures by selectively cleaving target proteins to elicit the 
morphological and biochemical features associated with apoptosis, which will be 
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dealt in detail below. Here, I will briefly describe how apoptosis plays a key and 
central role from development to adult life in multicellular organisms. 
1.2.1.1 Apoptosis during Developmental Processes 
Embryonic development is governed by tight orchestration between cell division 
and cell death. The role of programmed cell death during development was 
elucidated using C. elegans, D. melanogaster and the mouse as model systems.  
A striking and obvious function of apoptosis in vertebrate development is digit 
formation, since impaired apoptosis leads to ineffective removal of cells 
between developing digits resulting in retention of interdigital webbing (Milligan 
et al., 1995, Lindsten et al., 2000). Apoptosis during embryonic development is 
also involved in the conversion of solid structures into hollow tubes thereby 
giving tissues and organs their form and structure. For example, during 
gastrulation, the conversion of solid embryonic ectoderm into hollow closed 
tubes of columnar epithelial cells is made possible by apoptosis of inner 
ectodermal cells (Coucouvanis and Martin, 1995, Coucouvanis et al., 1995). 
Apoptosis is also involved in cardiac morphogenesis as it is essential in the 
development of the four chambered heart (Abdelwahid et al., 2002). Apart from 
sculpting, another role of apoptosis is the deletion of transient structures that 
are no longer essential, for example the Mullerian duct in males and the 
Wolffian duct in females are eliminated during development (Jacobson et al., 
1997). In addition, mechanical force generated by apoptotic cells has recently 
been shown to be vital for generating tension in developing D. melanogaster 
tissues to induce epithelial folding, thus establishing proper topography (Monier 
et al., 2015). 
In other circumstances, cell death mechanisms are also involved in the 
elimination of superfluous and potentially dangerous cells during development.  
For example, the immune system uses apoptosis to eliminate developing 
lymphocytes lacking functional antigen receptors thus eliminating self-reactive 
cells that could lead to autoimmunity (Opferman and Korsmeyer, 2003, 
Opferman et al., 2003). The role of apoptosis in nervous system development 
has also been widely recognized, where superfluous neurons and neurons that 
fail to establish functional synaptic connections are eliminated (Nijhawan et al., 
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2000). These observations clearly demonstrate a decisive role of apoptosis in 
normal embryonic development. 
1.2.1.2 Apoptosis Maintains Tissue Homeostasis 
In addition to its roles in development, apoptosis is also crucial for the 
maintenance of tissue homeostasis throughout adult life. Cell turnover in adult 
tissues is highly variable across tissue types, and heavily relies on the apoptotic 
machinery to remove damaged and superfluous cells. In adults, cell death also 
plays a key role in tissue remodelling, such as mammary gland involution (Lund 
et al., 1996) and follicular atresia of the postovulatory follicle (Tilly et al., 
1991). Along with the tightly controlled apoptotic program, highly efficient 
phagocytic mechanisms ensure prompt removal of apoptotic debris, thereby 
reducing the potential for apoptotic cells to lose their membrane integrity and 
become necrotic (secondary necrosis), resulting in inflammation (Franz et al., 
2006). In contrast to the immunologically silent apoptotic process, necrosis may 
stimulate inflammatory responses that could be harmful to neighbouring cells in 
the tissue. Despite the large number of cells dying by apoptosis in adult tissues, 
only a small number of apoptotic cells can be detected even in tissues with high 
cell turnover such as the thymus (Platt et al., 2000). This is likely to be because 
the apoptotic cells are rapidly recognized and engulfed by professional 
phagocytes or adjacent neighbouring cells. Defects in clearance mechanisms 
have been linked to inflammation and autoimmunity reflecting the importance 
and efficiency of apoptotic cell clearance under normal circumstances (Nagata 
et al., 2010). 
 Cellular Features during Apoptosis 1.2.2
During apoptosis, cells undergo a series of alterations that help in distinguishing 
them from their healthy counterparts and eventually aid in their efficient 
recognition and removal. These cellular alterations are broadly divided into two; 
biochemical and morphological. 
1.2.2.1 Biochemical Features 
Apoptotic cells undergo several biochemical modifications, of which 
externalization of phosphatidylserine is the most well-known. Plasma 
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membranes in eukaryotic cells feature an asymmetric distribution of lipids 
between the inner and outer leaflets, with phosphatidylcholine (PC) and 
sphingomyelin (SM) predominantly present on the outer leaflet, whereas 
phosphatidylserine (PS), phosphatidylinositol (PI) and phosphatidylethanolamine 
(PE) are confined to the cytoplasmic face of membranes (Leventis and Grinstein, 
2010). The maintenance of lipid asymmetry under homeostatic conditions is 
under the control of transporters called flippases and floppases (Contreras et 
al., 2010). A third type of enzyme known as scramblases, contributes to the loss 
of lipid asymmetry and increased PS extracellular exposure when activated 
(Bevers and Williamson, 2010). 
Loss of membrane asymmetry and PS externalization on the outer leaflet of the 
plasma membrane are common features of apoptotic cells, independent of the 
form of apoptotic stimulus (Fadok et al., 1992b). During apoptosis, scramblase 
XK-related protein 8 (Xkr8) gets activated by caspase cleavage, and mediates PS 
externalization in a Ca2+ independent manner (Suzuki et al., 2013). Recent 
studies identified adenosine triphosphate type 11C (ATP11C) and cell division 
cycle protein 50A (CDC50A) as being involved in apoptotic PS exposure (Segawa 
et al., 2014). ATP11C, a flippase responsible for redirecting PS from the outer to 
the inner leaflet, is inactivated by caspase mediated cleavage (Segawa et al., 
2014). CDC50A is required for localization of ATP11C to the plasma membrane, 
and knockout of CDC50A results in constitutive PS exposure (Segawa et al., 
2014). These data strongly indicate that during apoptosis, caspase mediated 
activation of Xkr8 and caspase mediated inactivation of ATP11C work in a 
coordinated fashion to permit PS exposure. However, PS exposure is not 
restricted to apoptotic cells alone, but may also be seen on activated platelets 
(Lentz, 2003). Transmembrane Protein 16F (TMEM16F), which has a Ca2+-
dependent phospholipid scramblase activity, was identified as a mediator of PS 
externalization in activated platelets (Suzuki et al., 2010, Yang et al., 2012). 
Studies confirmed that PS externalization was not just an indicator of loss of 
membrane asymmetry during apoptosis, but has an important active function to 
play in the clearance of apoptotic cells by acting as a recognition signal for 
phagocytic cells (Fadok et al., 1992a, Fadok et al., 1992b). Apart from PS 
externalization, other biochemical features include DNA fragmentation, 
  40 
 
degradation of cytoskeletal and nuclear proteins, and extensive protein cross-
linking. 
1.2.2.2 Morphological Features 
Apart from these biochemical changes that occur in apoptotic cells, several 
dramatic morphological alterations are also key events when cells die by 
apoptosis (Kerr et al., 1972). Broadly termed as the execution phase of 
apoptosis, these structural modifications include cell shrinkage, chromatin 
condensation, nuclear fragmentation, and formation of dynamic plasma 
membrane protrusions called blebs that eventually detach, culminating in 
fragmentation into apoptotic bodies. Blebs are formed when cell membrane 
delaminate from cortical cytoskeletal structures (Figure 1-3). Two phases of 
plasma membrane blebbing were reported in apoptotic cells, with the first 
phase occurring concomitant with cell detachment (Lane et al., 2005). Several 
non-adherent cell lines fail to display this first phase of blebbing, suggesting a 
role for the initial phase in maintaining detachment from substrate and/or 
neighbouring cells (Lane et al., 2005). The second phase observed in both 
adherent and non-adherent cells, results in the formation of blebs that contain 
chromatin and other cellular contents (Lane et al., 2005). These membrane 
protrusions and apoptotic bodies serve as concentration sites for phagocytic 
markers allowing efficient detection and engulfment by patrolling phagocytes 
and/or neighbouring cells (Korb and Ahearn, 1997, Ogden et al., 2001). 
Caspases play major roles both in the commitment phase and in the execution 
phase of apoptosis through their cleavage of numerous protein substrates. 
Adherent cells retract from neighbouring cells and from extracellular substrates 
via caspase cleavage of β-catenin, a critical regulator of adherens junctions 
(Brancolini et al., 1997) and focal adhesion proteins like tensin (Kook et al., 
2003). Caspase-mediated cleavage and weakening of nuclear structural lamin 
proteins, as well as contractile force generated by the actin myosin 
cytoskeleton, results in nuclear fragmentation and redistribution of chromatin to 
the blebs and apoptotic bodies (Croft et al., 2005). Packaging of intracellular 
contents into membrane bound apoptotic bodies is believed to be crucial in 
avoiding unwanted inflammatory responses by preventing the release of 
potential self-antigens into the surrounding milieu. 
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Figure 1-3 Life cycle of a bleb 
Life cycle of a bleb can be subdivided into steps: nucleation, expansion and retraction. 
Blebs are produced when cell membrane delaminates from the cortical cytoskeleton. 
Pressure generated by actomyosin contraction and flow of cytoplasm expands the newly 
formed blebs. Proteins recruited into blebs contribute to contractility and subsequent bleb 
retraction. Figure adapted from (Julian and Olson, 2015). 
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 ROCK1 and Apoptotic Blebbing 1.2.3
Although blebbing may be observed during several cellular processes including 
cytokinesis, migration and spreading, arguably its most totemic manifestation is 
during the execution phase of apoptosis (Fadok et al., 1992b). Despite being one 
of the hallmark features of apoptosis, little was known about the mechanistic 
drivers underlying this phenomenon until the 1990s. Various studies showed that 
reorganization of cytoskeletal structures drives the formation of membrane 
blebs and apoptotic bodies (Mills et al., 1998). Disruption of filamentous actin 
inhibited the formation of apoptotic bodies without affecting DNA 
fragmentation, indicating a requirement for polymerized actin during the later 
stages of apoptosis (Cotter et al., 1992). One early study implicating myosin 
contraction in bleb formation showed that microinjecting an active form of 
myosin light chain kinase (MLCK) resulted in active surface blebbing during 
mitosis (Fishkind et al., 1991). Subsequently, it was shown that blebbing cells 
had increased levels of myosin II regulatory light chain phosphorylation and that 
inhibition of MLCK activity decreased blebbing (Mills et al., 1998). Actin-myosin 
contractile force generation results from the phosphorylation of the regulatory 
myosin light chains, which promotes myosin binding to filamentous actin, 
coupling of actin-myosin filaments to linker proteins at the plasma membrane, 
and ATP-dependent actin-myosin filament contraction (Somlyo and Somlyo, 
1994, Somlyo and Somlyo, 2003). Inhibition of myosin contractility with the 
myosin II ATPase blocker blebbistatin, reduced apoptotic blebbing (Orlando et 
al., 2006). 
Apoptotic membrane blebbing was found to be dependent on ROCK activity and 
independent of the function of its upstream regulator, RhoA (Coleman et al., 
2001, Sebbagh et al., 2001). During apoptosis, activated caspases cleave ROCK1 
after a DETD (amino acids 1110-1113) sequence, thus removing the auto-
inhibitory C terminal region and generating a truncated kinase fragment with 
increased intrinsic activity. The ROCK kinase fragment generated can 
phosphorylate downstream targets including MLC, leading to actin-myosin 
contractile force generation, cell contractility, and consequent membrane 
blebbing and apoptotic body formation. The significance of ROCK1 for apoptotic 
blebbing has been shown in other cell types, including cardiac myocytes, 
lymphoma cells and non-small cell lung carcinoma cells (Parent et al., 2005, 
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Chang et al., 2006, Zihni et al., 2007). Of notable importance was the 
relocalization of fragmented DNA into blebs and apoptotic bodies upon caspase 
activated ROCK1 cleavage (Coleman et al., 2001). In addition to these 
morphological responses, ROCK1 activity was also required for nuclear envelope 
tearing and disintegration (Croft et al., 2005). During the early stages of rapid 
membrane blebbing and apoptotic body release, there may be leakage of 
damage associated molecular pattern (DAMP) proteins, such as nucleosomal 
histones, highlighting a possible role for blebbing cells and apoptotic bodies to 
alert the immune cells for efficient phagocytic uptake prior to secondary 
necrosis (Wickman et al., 2013). 
However, during cell death induced by natural killer cells, Granzyme B cleaves 
ROCK2 at a homologous position to the caspase-cleavage site on ROCK1, leading 
to constitutive ROCK2 activation that is sufficient to promote caspase-
independent membrane blebbing (Sebbagh et al., 2001). However, given that 
Granzyme B also activates caspases leading to ROCK1 activation, the only 
apparent situation in which ROCK2 would be activated without concomitant 
ROCK1 activation in apoptotic cells is in cells that selectively express ROCK2 
with little to no ROCK1 expression. 
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1.3 Blebbing and Apoptotic Cell Clearance 
 The Decisive Phase of Apoptosis: Efferocytosis 1.3.1
Clearance of apoptotic cells, also known as ‘efferocytosis’ is the ultimate, and 
arguably the most important step of programmed cell death. Elegant genetic 
studies in the nematode C. elegans suggested a tight coordination between cell 
death and clearance pathways resulting in removal of apoptotic cells before they 
were fully dead (Reddien et al., 2001, Hoeppner et al., 2001). Swift removal and 
degradation of apoptotic corpses is crucial for immune tolerance and for the 
maintenance of tissue homeostasis. Several significant studies over the years 
have improved our understanding of this complex and evolutionarily conserved 
process. Multicellular organisms are bestowed with specialized cells called 
‘phagocytes’ such as macrophages and immature dendritic cells, resident in 
most tissues and dedicated to the engulfment and prompt removal of apoptotic 
cells. However in some tissues, neighbouring epithelial and mesenchymal cells 
are designed to function as ‘nonprofessional’ phagocytes and engulf nearby 
apoptotic cells (Wood et al., 2000, Nandrot et al., 2004, Monks et al., 2008). 
These professional and non-professional phagocytes efficiently remove enormous 
numbers of unwanted, excess and damaged cells prior to the loss of their plasma 
membrane integrity. Rapid engulfment would prevent leakage of potentially 
damaging intracellular contents into the extracellular milieu, thereby mitigating 
damage. 
To date, a wide range of apoptotic cell derived ligands, phagocytic receptors 
and ligand-receptor bridging molecules involved in corpse removal have been 
identified. In order to simplify the complex clearance mechanism, the process is 
broadly divided into several steps, specifically the recruitment of phagocytes to 
the site of apoptotic cells through ‘find me’ signals, the recognition by 
phagocytes through ‘eat me’ signals displayed by apoptotic cells, and finally the 
ingestion of apoptotic corpses and post engulfment consequences. As discussed 
previously, apoptotic cells undergo several distinct morphological changes to 
facilitate their recognition and clearance. How these typical morphological 
features may interplay with the different steps of clearance mechanism to 
expedite the ‘safe’ removal of apoptotic cells in an immunologically quiescent 
manner will be discussed here. 
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1.3.1.1 Recruitment Phase: ‘Find me’ signals  
Locating dying cells prior to the loss of their plasma membrane integrity and the 
ensuing irrevocable damage is a crucial step for efficient phagocytosis. A 
growing list of ‘find me’ signals released by dying cells to attract phagocytes has 
been reported over the last decade. These include lysophosphatidylcholine 
(LPC), sphingosine-1-phosphate (S1P), chemokine CX3CL1 (Fractalkine FKN) and 
nucleotides ATP and UTP (Lauber et al., 2003, Gude et al., 2008, Truman et al., 
2008, Elliott et al., 2009). LPC and S1P are lipid signals secreted by apoptotic 
cells and recognized by G-protein coupled receptors G2A and S1P-R, respectively 
on phagocytes (Peter et al., 2008, Rosen and Goetzl, 2005). Although these lipid 
ligands have been shown to stimulate macrophage chemotaxis to the proximity 
of apoptotic cells, their role in an in vivo context is yet to be established 
(Lauber et al., 2003, Gude et al., 2008). The chemokine CX3CL1 was shown to 
attract macrophages to apoptotic B cells in germinal centres but knocking out its 
macrophage receptor CX3CR1 failed to exhibit an increased persistence of 
apoptotic cells or accumulation of secondary necrotic cells, suggesting that the 
chemokine was only responsible for recruiting the macrophages but was not 
required for clearance (Truman et al., 2008). Small amounts of nucleotides ATP 
and UTP are also released as chemotactic signals by apoptotic cells through the 
pannexin 1 (PANX1) channels and they mediate phagocyte recruitment via P2γ2 
receptors (Elliott et al., 2009, Chekeni et al., 2010). Disruption of this ligand 
receptor interaction resulted in accumulation of apoptotic cells in the thymus 
suggesting a clear relationship between ‘find me’ signals and efficient clearance 
(Elliott et al., 2009). Release of multiple signals from apoptotic cells to mediate 
phagocyte attraction suggests plausible molecular redundancy to ensure fast and 
proficient removal of apoptotic debris. 
The range of these ‘find me’ signals may be quite short (Elliott et al., 2009), but 
this may suffice for tissues which are granted the luxury of having their very own 
resident phagocytes, possibly in close proximity to a dying cell. However, 
attracting distant tissue phagocytes or phagocytes from the circulation may be 
challenging for these short range signals. Our recent studies showed that limited 
membrane permeabilization occurs in blebs and apoptotic bodies which allows 
the release of damage associated molecular pattern proteins (DAMPs) during 
early apoptosis (Wickman et al., 2013). DAMPs are intracellular contents that 
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when released by dying or dead cells can interact with immune cells through Toll 
like receptors (TLRs) and activate them (Chen and Nunez, 2010). One could 
speculate that these membrane delimited fragments that are produced during 
cell death would enable long distance dispatching of ‘find me’ signals (Gregory 
and Pound, 2010). 
1.3.1.2 Recognition Phase: ‘Eat me’ Signals 
For phagocytes to distinguish a dying cell from its healthy viable counterparts, a 
number of surface markers adorn the apoptotic cell. These ‘eat me’ signals not 
only serve as recognition molecules, but also aid in establishing a physical 
contact between the phagocyte and the apoptotic cell. Of notable importance is 
the exposure of otherwise confined inner membrane lipid phosphatidylserine 
(PS) (Fadok et al., 1992b) as discussed in the previous sections. Over the years, 
many membrane receptors responsible for PS recognition has been identified 
including BAI1, Stabilin 2 and members of the T cell immunoglobulin domain 
(TIM) protein family (Park et al., 2007, Park et al., 2008a, Kobayashi et al., 
2007, Miyanishi et al., 2007). In addition to these bona fide receptors that bind 
to PS directly, several bridging molecules that engage with phagocytic receptors 
and PS simultaneously have been identified. Milk fat globulin EGF factor 8 (MFG-
E8)  is a bridging molecule secreted by macrophages that binds to PS on 
apoptotic cells and mediates uptake by engaging with αvβ3 integrins on 
phagocytes (Hanayama et al., 2002). Other bridging molecules including protein 
S and GAS6 that can also bind to PS and in turn be recognized by phagocytic cell 
surface receptors such as the Tyro3-Axl-Mer family of receptors (Anderson et al., 
2003, Ishimoto et al., 2000). The need for multiple recognition mechanisms for 
just one ‘eat me’ signal is possibly a testament of the importance for the 
efficient clearance of apoptotic debris. 
However, externalized PS has also been detected on some viable cells (Lentz, 
2003) suggesting that additional signals are necessary to trigger phagocytosis. In 
addition it was also proposed that the exposure of PS must be above a certain 
sensitivity threshold to initiate the engulfment phase (Borisenko et al., 2003). 
This proposal was challenged recently by studies showing that both viable and 
apoptotic cells exposing PS can be engulfed by macrophages (Segawa et al., 
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2014). This suggested the need for other ‘eat me’ signals to act in concert with 
PS to aid efficient phagocytosis. Other ‘eat me’ signals identified includes 
Calreticulin and Annexin I (Gardai et al., 2005) (Arur et al., 2003). Calreticulin is 
translocated from the endoplasmic reticulum to the plasma membrane during 
apoptosis and acts together with PS and drives optimal efferocytosis (Gardai et 
al, 2005). Exposed calreticulin is detected by LDL-receptor related protein (LRP) 
on phagocytes, which stimulates the final engulfment phase (Gardai et al., 
2005). Annexin I is another intracellular protein that is externalized during cell 
death and identified to co-localize with PS and facilitates phagocytic uptake of 
the apoptotic cell (Arur et al., 2003, Blume et al., 2009). 
The role of apoptotic blebbing in the clearance of dying cells could also be 
envisioned during the recognition phase of efferocytosis. Apoptotic blebs may be 
able to serve as focal points for the aggregation of ‘eat me’ signals including PS. 
For example, complement C1q specifically and directly binds to apoptotic blebs 
on apoptotic keratinocytes, endothelial cells and peripheral blood mononuclear 
cells and expedites engulfment by phagocytes by engaging with their C1q 
receptors (Korb and Ahearn, 1997, Navratil et al., 2001). Concentration of ‘eat 
me’ signals on blebs may orchestrate rapid and efficient efferocytosis (Wickman 
et al., 2012). 
1.3.1.3 Engulfment Phase 
Molecular tethering between the phagocyte and the ‘eat me’ signal initiates a 
signalling cascade within the phagocytes that drives cytoskeletal reorganization 
to enable engulfment of apoptotic corpses. Deeper insights into the engulfment 
machinery came from numerous genetic studies on C.elegans, D.melanogaster 
and mammalian models. Two Rac dependent engulfment pathways, which are 
evolutionarily conserved, were identified. The first pathway involved proteins 
including Dock180, CrkII and ELMO (Wu and Horvitz, 1998, Reddien and Horvitz, 
2000, Gumienny et al., 2001). Upon receiving cues from the receptor-ligand 
interaction, ELMO functionally co-operates with Dock180 and CrkII, which finally 
leads to Rac1 activation (Gumienny et al., 2001). The second conserved 
signalling pathway involves engagement of LRP receptors on phagocytes by 
ligands like calreticulin causes direct interaction with adaptor protein GULP, 
resulting in downstream Rac activation (Su et al., 2002). Similarly, Stabilin 2 
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receptor which binds to PS can also interact with GULP to initiate uptake of PS 
bound apoptotic cells (Park et al., 2008b). This culminates in cytoskeletal 
rearrangements in phagocytes, thus facilitating internalization of apoptotic 
debris. The ingested apoptotic corpse is then processed via the phagolysosomal 
pathway (Kinchen and Ravichandran, 2010). 
The functional significance of blebbing and apoptotic body formation has not 
been defined yet, but it has been hypothesized that fragmentation of an 
apoptotic cell into ‘bite- sized’ apoptotic bodies may have a beneficial effect in 
phagocytosis (Fadeel, 2004). In vitro studies suggest that ROCK1 mediated 
fragmentation of apoptotic cells is important for phagocytosis (Orlando et al., 
2006). However, it remains to be seen if this holds true in an in vivo context 
across all cell types, because it is possible that smaller cells like the immune 
cells may not require fragmentation to be easily engulfed.  
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 Microenvironmental Effects of Apoptotic Cell Clearance 1.3.2
While the effect of apoptotic cells on phagocytes that come in direct contact 
with them have been extensively studied, recent years have seen an escalating 
interest in understanding the effect of apoptotic cell clearance on their 
microenvironment. Conditioning the microenvironment mostly occurs through 
the release of physiological mediators by apoptotic cells and the participating 
phagocytes. 
Apart from the physical clearance of dying cells that prevents the release of 
toxic intracellular contents into the surrounding milieu, perhaps the most 
celebrated effect of efferocytosis is the suppression of an inflammatory response 
thus facilitating an ‘immunologically silent’ clearance of apoptotic cells. Various 
studies have shown that apoptotic cells not only discourage the production of 
pro-inflammatory cytokines like TNFα, IL-1β, IL-8 and IL-12 by the phagocytes 
but also stimulate them to produce anti-inflammatory mediators such as TGF 
and  IL-10 (Voll et al., 1997, Fadok et al., 1998, McDonald et al., 1999). 
Intuitively, the first step in achieving this feat is recruiting the right kind of 
phagocyte. In concert with the classical ‘find me’ signals, ‘keep out’ signals like 
lactoferrin, which inhibits granulocyte (pro-inflammatory) recruitment, are also 
released from apoptotic cells (Bournazou et al., 2009, Bournazou et al., 2010). 
In addition to inhibiting granulocyte migration, lactoferrin also inhibits pro-
inflammatory mediators and promotes the production of anti-inflammatory 
mediators (Crouch et al., 1992, Togawa et al., 2002). It is interesting to note 
that anti-inflammatory mediators can also increase the capacity of phagocytes 
to engulf apoptotic material (Chung et al., 2006). However, the widely accepted 
notion of apoptotic cell death being immunologically silent has been challenged 
before by studies showing that apoptotic cells can stimulate the production of 
pro-inflammatory mediators (Lucas et al., 2003, Kurosaka et al., 2003). This may 
be due to fact that in some cases the apoptotic cells are progressing to 
secondary necrosis thus resulting in a shift from ‘silent’ to an inflammatory 
state. It is also possible that pro-inflammatory cytokine release precedes anti-
inflammatory mediator release (Lucas et al., 2003). This complex interplay and 
balancing act between the apoptotic cells and phagocytes creates a 
microenvironment conducive for maintaining tissue homeostasis. 
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Cellular responses to apoptotic cells and their clearance are not limited to the 
responding phagocytes. As mentioned earlier, neighbouring epithelial and 
mesenchymal cells can also act as non-professional phagocytes to dispose 
apoptotic debris. In fact, eliminating macrophages in the mouse embryo resulted 
in the phagocytosis duty being taken up by neighbouring mesenchymal cell 
(Wood et al., 2000). This not only underscores the apparent redundancy in 
apoptotic cell clearance but also highlights a type of microenvironmental 
conditioning. In addition to this, apoptotic cells can also directly produce factors 
or stimulate neighbouring cells to produce factors that promote proliferation and 
angiogenesis, thus aiding in the repair process (Knies et al., 1998, Morimoto et 
al., 2001, Golpon et al., 2004, Hristov et al., 2004). Thus it is conclusive that 
apoptotic cell clearance has the potential to induce major effects on cells in the 
near vicinity as well as at long distance. 
 Consequences of Defective Apoptotic Cell Clearance 1.3.3
Considering the fact that apoptotic cell clearance machinery in multicellular 
organisms is complex and highly efficient, it is not surprising that any defects in 
this process can have pathological consequences. Uncleared dead cells can have 
significant implications on the immune system and the neighbouring cells. Here, 
I will highlight some of the main pathologies linked to defective apoptotic cell 
clearance (Table 1-2). The link between apoptotic clearance defects and cancer 
will be discussed in the forthcoming section. 
1.3.3.1 Autoimmunity 
Apoptotic clearance defects have been associated with autoimmune disorders 
like systemic lupus erythematosus for a long time (Herrmann et al., 1998, 
Baumann et al., 2002, Perniok et al., 1998). Persisting dead cells may become 
necrotic, thus releasing their intracellular contents, which would provoke 
autoantibody production against the intracellular antigens and DNA. Patients 
with systemic lupus erythematosus (SLE), a chronic autoimmune disorder 
affecting multiple organs, have autoantibodies in the sera that are specific for 
nuclear components (Rumore and Steinman, 1990). There is also an increase in 
the level of circulating apoptotic cells, and in some SLE patients macrophages 
exhibit reduced ability to engulf apoptotic cells (Herrmann et al., 1998, Perniok 
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et al., 1998, Baumann et al., 2002). Several genetic models bearing defects in 
different components of the clearance pathway have suggested a strong link 
between apoptotic cell clearance defects and autoimmunity (Table 1-2). 
Nevertheless, it should be noted that defective clearance does not always result 
in an autoimmune phenotype as evidenced by studies in CD14 knockout mice and 
mannose binding lectin deficient mice (Devitt et al., 2004, Stuart et al., 2005). 
Whether the uncleared apoptotic cells in these mice retain the ability to induce 
an immunomodulatory environment to curtail autoimmunity still remains to be 
answered. Also, the existence of panoply of apoptotic signals, receptors and 
bridging ligands suggests a high level of redundancy proposing a possible 
explanation for this discrepancy. 
1.3.3.2 Atherosclerosis 
Atherosclerosis is a life threatening disease, which involves chronic inflammation 
of the vascular wall. Monocytes and macrophages play a crucial role in the 
formation of atherosclerotic plaques and a documented characteristic of such 
plaques is the accumulation of cell debris during progression towards advanced 
stages (Tabas, 2010). At the onset of plaque formation, macrophages take up 
lipids, and these lipid-laden macrophages eventually die and get engulfed by 
surrounding macrophages. However, as the plaque lesion expands, there is 
increased cell death and reduced engulfment of apoptotic macrophages. These 
uncleared apoptotic cells ultimately become necrotic, causing plaque rupture 
thus leading to thrombosis (Tabas, 2010). Intuitively, the persistence of 
apoptotic cells was linked to plaque progression. Indeed, defects in some 
components of the clearance pathway caused acceleration of atherogenesis in 
atherosclerotic mouse models like LDLR-/- and ApoE-/- (Table 1-2). These 
genetic studies highlighted the importance of clearance of dead cells from 
atherosclerotic lesions to curb its progression to advanced stages. Contrary to 
this, Gas6 deficiency on an atherosclerotic background has a favourable outcome 
in that it formed stable plaques with smaller necrotic cores suggesting the 
likelihood of other physiological functions for these ligand-receptors interactions 
apart from engulfment itself (Lutgens et al., 2008). 
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1.3.3.3 Respiratory Diseases 
Persistence of apoptotic cells has been observed in a number of human lung 
diseases including cystic fibrosis, chronic obstructive pulmonary disease, asthma 
and acute lung injury (Yun et al., 2008). Although these pathologies have not 
been directly linked to defects in components of the clearance pathways, 
alveolar macrophages from patients show decreased ability to phagocytose 
apoptotic cells (Hodge et al., 2007, Vandivier et al., 2009). In fact, potentially 
harmful environment like cigarette smoke can hamper the phagocytic ability of 
alveolar macrophages (Kirkham et al., 2004, Hodge et al., 2007). Although 
chronic inflammation in the lung seems to be associated with uncleared dead 
cells, additional investigations are essential to understand whether defects in 
the clearance mechanism can influence pathogenesis of these lung diseases. 
1.3.3.4 Neurological Diseases 
In the brain, microglia serves as primary phagocytes that respond to apoptotic 
cells. Several chronic neurodegenerative disorders like Parkinson’s (Mochizuki et 
al., 1996), Alzheimer’s (Su et al., 1994) and Huntington’s disease (Thomas et al., 
1995) exhibit uncleared apoptotic cells in the brain. Mice deficient in fractalkine 
receptor, CX3CR1 in the brain microglia resulted in increased accumulation of 
apoptotic neurons thus suggesting an important role for ‘find me’ cues from 
dying neurons (Cardona et al., 2006). Additionally, reduced levels of bridging 
molecule MFG-E8 was reported in patients with Alzheimer’s disease (Boddaert et 
al., 2007). 
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Model Function Phenotype References 
MFG-E8-/- Bridging ligand 
Autoantibodies, 
Splenomegaly, 
Glomerulonephritis 
(Hanayama et al., 
2004) 
αv-/-(conditional 
knockout) 
Phagocyte 
receptor 
Autoantibodies, 
Ulcerative colitis 
(Lacy-Hulbert et al., 
2007) 
C1q-/- Bridging ligand 
Autoantibodies, 
Glomerulonephritis (Botto et al., 1998) 
merkd (functional 
knockout) 
Receptor for 
Gas6 
Autoantibodies,  
Mild renal pathology (Cohen et al., 2002) 
TIM-4-/- Receptor for 
PS 
Autoantibodies (Rodriguez-Manzanet 
et al., 2010) 
TG-/- (LDLR-/-) Crosslinking 
enzyme 
Increased 
atherosclerotic 
lesions 
(Boisvert et al., 
2006) 
merkd (ApoE-/-) Receptor for Gas6 
Increased plaque 
necrosis (Thorp et al., 2008) 
GAS6-/-(ApoE-/-) Bridging ligand 
Stable 
atherosclerotic 
lesions 
(Lutgens et al., 2008) 
Table 1-2: Genetic mouse models with apoptotic cell clearance defects and 
associated phenotypes 
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1.4 Role of Apoptotic Blebbing in Tumourigenesis 
The preceding section had focussed on the complex mechanism of apoptotic cell 
clearance and how the interplay between apoptotic cells and phagocytes 
manipulates the microenvironment in an immunological context to maintain 
tissue homeostasis. In situations where this highly efficient efferocytosis 
mechanism is disrupted, the apoptotic debris can challenge the otherwise 
normally ensuing immunological tolerance. High levels of cell death can occur 
within the tumour microenvironment. Whether efficient apoptotic cell clearance 
has a beneficial or detrimental effect in neoplastic progression has been a topic 
of debate over many years. Given the fact that efferocytosis has a significant 
impact on the immune microenvironment as discussed in the previous section, it 
seems logical to explore the role of immune system in cancer development and 
progression. In this section, I will discuss how the immune system sculpts the 
tumour microenvironment, and finally will consider the consequences of 
apoptotic cell clearance in a cancer context. 
 Cancer and Inflammation 1.4.1
A link between the cancer development and chronic inflammation has been 
appreciated since the 19th century. There is considerable evidence which points 
towards an association between inflammation and a predisposition for cancer 
development (Grivennikov et al., 2010). Chronic inflammatory conditions 
including hepatitis, bronchitis and gastritis precede tumour development. About 
18 % of the global cancer burden is attributed to chronic inflammation caused by 
infectious agents (Parkin, 2006). Classic examples include increased risk of 
cervical and hepatocellular cancer with human papilloma virus or hepatitis virus 
infection, respectively. Not only do viral infections contribute to cancer, 
infections caused by bacteria Helicobacter pylori can result in gastric cancer, 
and parasitic infection with Schistosomiasis can cause bladder cancer (Balkwill 
and Mantovani, 2001). In other cases, conditions associated with chronic 
irritation and inflammation such as long term exposure to silica, asbestos and 
cigarette smoke also predispose individuals to cancer (Coussens and Werb, 
2002). Figure 1-4 shows the various stages at which inflammation can contribute 
to tumourigenesis.  
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Figure 1-4 Multifaceted role of inflammation in cancer 
Inflammation can contribute to tumour initiation, promotion and metastasis. Reactive 
oxygen species (ROS) produced by inflammatory cells can cause tumour-initiating 
mutations. Inflammatory cells also secrete cytokines that supports survival, proliferation 
and angiogenesis during tumour promotion. Tumour cells produce chemokines that attract 
more inflammatory cells. Eventually, inflammation can also contribute to metastasis by 
producing mediators that increases vascular permeability. ECM = extracellular matrix; 
EMT= epithelial to mesenchymal transition. Figure adapted from (Grivennikov et al., 
2010).  
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 Immunosurveillance of Tumours 1.4.2
Although a causal relationship between inflammation and cancer is widely 
accepted, it is necessary to consider a protective effect of inflammation against 
tumourigenesis. In multicellular organisms, an inflammatory response 
orchestrates defence against microbial infections as well as mediates tissue 
repair and regeneration. By protecting the host against microbes, indirectly the 
host is also protected from pathogen-induced tumours. By the rapid elimination 
of pathogens, the immune system ensures resolution of inflammation thus 
preventing the establishment of an inflammatory microenvironment. The 
immune system can also specifically target and eliminate tumour cells, and this 
is called cancer immunosurveillance. 
In 1909, Paul Ehrlich made the prescient hypothesis that the immune system can 
protect the host from cancer development (Ehrlich, 1909). This concept was 
formally introduced in 1957 by Burnet and Thomas as cancer immunosurveillance 
(Burnet, 1957). Although early experiments failed to establish this hypothesis 
possibly due to limitations in the mouse models available, by the 1990s, several 
studies reinstated support for this concept (Dunn et al., 2004). Removal of 
specific components of the immune system in mouse models resulted in 
increased tumour incidence and broader tumour spectra suggesting that the 
immune system can serve as an extrinsic tumour suppressor (Swann and Smyth, 
2007). Furthermore, mice immunized with tumours were protected against 
subsequent challenge by the same tumours, thus suggesting the existence of 
tumour antigens, which is considered important for cancer immunosurveillance 
(Old and Boyse, 1966, Klein, 1966). In humans with immunodeficiencies or in 
patients undergoing immunosuppressive therapy, there was an increased 
incidence of malignancies (Gatti and Good, 1971, Penn and Starzl, 1970). These 
studies strongly supported a beneficial role for the immune system in curbing 
the development of cancer. 
 Immunoediting: A Refined Model for Cancer 1.4.3
Immunosurveillance 
Despite the protection offered by immunosurveillance, tumours still develop in 
the presence of a functioning immune system. To explain this discrepancy, the 
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concept of immunoediting was introduced in 2002, which offers a better 
explanation concerning the role of immune system in tumour development (Dunn 
et al., 2002). The concept of immunoediting is divided into three phases namely 
elimination, equilibrium and escape (Figure 1-5). 
1.4.3.1 Elimination 
The elimination phase is based on the original concept of immunosurveillance, in 
which the innate and adaptive immune systems work in concert to detect and 
destroy cancer cells to limit tumour development. Although still not 
comprehensive, the mechanism by which immune cells are summoned to a 
neoplastic site is thought to be through the release of danger signals like HMGB1 
by the damaged tumour cells (Sims et al., 2010). The immune cells can 
distinguish the tumour from normal cells by the presence of tumour specific 
antigens. A number of tumour antigens have been identified in humans including 
mutational antigens (aberrant p53), differentiation antigens (melanocyte 
differentiation antigen), viral antigens, overexpressed antigens (HER2) and 
Cancer-Testis (CT) antigens (Boon and van der Bruggen, 1996, Old and Chen, 
1998, Rosenberg, 1999). Of course, if a tumour is successfully eradicated during 
this phase, the immunoediting process has been completed. With the next two 
phases, the discrepancy in the immunosurveillance model was addressed. 
1.4.3.2 Equilibrium 
The tumour cells that manage to survive the elimination phase may then enter 
the equilibrium phase and are maintained in a functional state of dormancy. The 
survivors would be variants of the tumour cells with several genetic and 
epigenetic changes thus giving them increased resistance to immune attack 
(Mittal et al., 2014). Although the molecular mechanisms for this phase remain 
poorly understood, indications of the existence of an equilibrium phase came 
from experiments showing that immunocompetent mice treated with low dose 
carcinogen harboured tumour cells for an extended period of time (Koebel et 
al., 2007, Teng et al., 2012). Experiments to provide conclusive evidence for the 
existence of this phase are awaited. 
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Figure 1-5 Three phases of cancer immunoediting 
During the ‘elimination’ phase, the innate and adaptive immune systems work in concert 
to detect and destroy cancer cells. Immune cells are summoned by the release of danger 
signals (red dots) like HMGB1 by the damaged tumour cells. Immune cells distinguish 
tumour cells by the presence of tumour antigens (black stars) and destroy them. However, 
some tumour variants manage to survive the ‘elimination’ phase to then enter the 
‘equilibrium’ phase. In this phase, tumour remains dormant since its growth is prevented 
by immunologic mechanisms. Tumour cell variants may escape the dormant stage 
possibly as a consequence of constant immune selection pressure. These cells soon 
enter the ‘escape’ phase, where their growth is no longer blocked by immune system. 
Figure adapted from (Schreiber et al., 2011). 
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1.4.3.3 Escape 
During this phase, tumour cell variants selected during the equilibrium phase 
escape the dormant stage and commence expansion to form detectable tumours. 
Reduced recognition by immune cells, increased resistance to the cytotoxic 
effects of the immune system or both, are properties that have been attributed 
to tumour cells escaping the equilibrium phase. Tumour cells eventually may 
impede the establishment of anti-tumour immune response through 
immunosuppressive cytokines like TGF-β and IL-10 or through regulatory T cells 
(Khong and Restifo, 2002, Sakaguchi, 2002). Another way of escaping the 
immune sentinels is by losing expression of tumour specific antigens thus 
allowing tumour cells to hide from the immune system (Marincola et al., 2000).  
Additional mechanisms of escape may exist, which will help in sculpting the 
immunogenicity of a tumour to favour its progression. 
 Apoptotic Cell Clearance and Tumourigenesis 1.4.4
Given the double role of inflammation in cancer, it would be interesting to 
discover the role of apoptotic blebbing and apoptotic cell clearance in the 
development and progression of cancer. As discussed above regarding chronic 
inflammation driving tumourigenesis, it is easy to envisage a beneficial role for 
apoptotic cell clearance in limiting tumourigenesis by maintaining an 
immunosuppressive environment. However, considering the possibility of 
protection offered by the immune cells against tumours, it is possible that the 
immunosuppressive effect of apoptotic cell clearance could have an unwanted 
effect of suppressing anti-tumour immune responses. 
Several studies have hinted at a plausible scenario in which efficient apoptotic 
cell clearance might have an untoward effect on neoplastic progression. 
Inhibiting PS mediated recognition of apoptotic cells by masking the receptors 
with Annexin V resulted in increased immunogenicity of lymphoma cells 
(Bondanza et al., 2004). Additionally, blocking PS mediated uptake of apoptotic 
cells using monoclonal antibodies also enhanced anti-tumour effects in mice 
(Ran et al., 2005, He et al., 2009). Blocking the bridging ligand MFG-E8 was also 
shown to retard the growth of tumours (Jinushi et al., 2008, Jinushi et al., 
2009). Still, one needs to be careful while implicating efferocytosis in tumour 
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development, as it is a complex mechanism primarily designed to maintain tissue 
homeostasis. In fact ‘find me’ signals like ATP released by apoptotic cells can 
activate dendritic cells to mount an anti-tumour immune response (Ghiringhelli 
et al., 2009). However, apoptotic blebbing defects in the context of cancer have 
not been explored. It is possible that the type of immune sentinels that respond 
to apoptotic cells with defective blebbing as well as the differential expression 
of immune mediators in the tumour microenvironment might eventually dictate 
the direction in which the balance is tipped, namely tumour promoting or anti-
tumour immunity. 
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2 Materials and Methods 
2.1 Materials 
  Antibodies 2.1.1
Table 2-1 List of primary antibodies 
 
Antigen (Clone) Species Supplier Catalogue Number 
BrdU (B44) Mouse BD Bioscience 347580 
C1q (9A7) Mouse Abcam ab71089 
CD3 (SP7) Rabbit  Vector VP-RM01 
CD95 (Jo2) Mouse BD Bioscience 554254 
F4/80 (CI:A3-1) Rat Abcam ab6640 
Foxp3 (FJK-16s) Rat eBioscience 14-5773-80 
HMGB1 Rabbit Abcam ab18256 
Ki-67 (MIB-1) Mouse Dako M7240 
MLC Rabbit Cell Signalling 3672 
PARP (C2-10) Mouse BD Bioscience 556362 
pMLC Rabbit Cell Signalling 3674 
ROCK1 (46/ROCK-1) Mouse BD Transduction 611136 
S100A9 (M-19) Goat Santa Cruz sc-8115 
Tubulin-α (B-7) Mouse Santa Cruz sc5286 
NFKBIA (6A920) Mouse Abnova MAB0057 
pNFKBIA (39A1413) Mouse Abnova MAB0056 
 
Table 2-2 List of secondary antibodies 
 
Antibody Supplier Catalogue Number 
Alexa Fluor 594 goat anti- mouse Invitrogen A11032 
Alexa Fluor 594 goat anti- rabbit Invitrogen A11037 
Alexa Fluor 488 goat anti- mouse Invitrogen A11029 
Alexa Fluor 488 goat anti- rabbit Invitrogen A11034 
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  Buffers and solutions 2.1.2
Table 2-3 List of buffers and solutions 
 
Buffer/Solution Recipe 
Citrate Buffer    
(pH 6) 
10 mM Sodium citrate, 0.05 % Tween 20 
FACS Buffer PBS with 5% FBS 
Loading Buffer (6x) 3ml 1M Tris, pH 6.8, 1.47 g SDS, 0.85 g DTT, 7.35 ml of 
Glycerol, 14.2 ml dH2O and bromophenol blue (few grains) 
PBS 170 mM NaCl, 3.3 mM KCl, 1.8 mM Na2HPO4, 10.6 mM 
H2PO4 
PBS-T PBS, 0.1 % Triton x-100 
Phosphate Buffer 
(0.1 M; pH 7.2) 
36 ml of Na2HPO4.2H2O (17.8 g in 500 ml), 14 ml of 
Na2HPO4.H20, 50 ml dH2O (13.6 g in 500 ml) 
SDS Lysis Buffer 50mM Tris, 1% SDS, pH 7.5 
Sodium Cacodylate 
(0.1 M; pH 7.4) 
4.28 g Sodium Cacodylate, 25 g Calcium chloride, 2.5 ml 
0.2 N hydrochloric acid, make up to 200 ml with dH2O 
TBS 20mM Tris-HCL pH 7.5, 136 mM NaCl 
TBS-T 20mM Tris-HCL pH 7.5, 136 mM NaCl, 0.1% Tween 20 
Tris-EDTA Buffer 10 mM Tris base, 1 mM EDTA, 0.05 % Tween 20 
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  Kits 2.1.3
Table 2-4 List of kits 
 
Kit Supplier Catalogue Number 
FITC Annexin V Apoptosis Detection Kit BD Pharmingen 556547 
Mouse Cytokine/ Chemokine Magnetic 
Bead Panel Kit (96-well plate assay) 
Milliplex MCYTOMAG-70K 
In situ Cell Death Detection Kit, 
Fluorescein 
Roche 11 684 795 910 
ImmPRESS Anti-Goat Kit Vector MP-7405 
ImmPRESS Anti-Rat Kit Vector MP-7444 
M.O.M Immunodetection Kit Vector PK-2200 
Vectastain ABC kit (Anti- Rat) Vector PK-6104 
TNFα ELISA Kit R & D System MTA00B 
Caspase-Glo 3/7 Assay  Promega G8091 
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  Reagents and chemicals 2.1.4
Table 2-5 List of reagents and chemicals 
 
Reagent/ Chemical Supplier Catalogue No. 
12-O-Tetradecanoylphorbol 13-acetate (TPA) Sigma P1585 
2- Mercaptoethanol Sigma M3148 
3,3’-Diaminobenzidine Tetrahydrochloride Dako  K3467 
ABT-199 Selleckchem S8048 
Accutase Solution Sigma A6964 
Bafilomycin A1 Sigma  B1793 
Bicinchoninic Acid Sigma B9643 
Blebbistatin Sigma  
Bovine Serum Albumin Thermo 23209 
C1q Protein Abcam ab96363 
Cell Proliferation Labelling Reagent  GE Healthcare RPN201 
Collagen I Corning 354249 
Copper Sulphate Sigma C2284 
Cycloheximide Sigma C4859 
Diethylnitrosamine Sigma N0258 
Dimethyl Sulfoxide Sigma D2650 
Donor Bovine Serum Gibco 16030-074 
Dulbecco’s Modified Eagle Medium (No glutamine) Gibco  21969-035 
Dulbecco’s Modified Eagle Medium (No pyruvate)  Gibco  41965-039 
EnVision+ System-HRP Labelled Polymer (Mouse) Dako K4001 
EnVision+ System-HRP Labelled Polymer (Rabbit) Dako  K4002 
F-12 Gibco 21765-029 
Fetal Bovine Serum Gibco 10270 
Ficoll-Paque Plus GE Healthcare 17-1440-02 
Glutaraldehyde Sigma G5882 
Glycyrrhizin Sigma 50531 
Haematoxylin Z CellPath RBA-4201-00A 
Hydrogen Peroxide (30% w/v) Fisher  10687022 
Liver Digest Media Gibco 17703034 
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Liver Perfusion Media Gibco 17701038 
LY-294002 Cell Signalling 9901 
Matrigel Corning 354234 
L-Glutamine (200 mM)  Gibco 25030-032 
MEM Non-Essential Amino Acids  Gibco 11140-035 
NuPAGE 4-12% Bis-Tris Gel Life Technologies NP0321BOX 
NuPAGE MES SDS Running Buffer (20x) Life Technologies NP0002 
NuPAGE MOPS SDS Running Buffer (20x) Life Technologies NP0001 
NuPAGE Transfer Buffer (20x) Life Technologies NP0006-1 
Paraformaldehyde (16%) EMS 15710 
Penicillin Streptomycin Gibco 15140-122 
Percoll Sigma P1644 
Peroxidase Block Dako S2023 
Ponceau S solution  Sigma P7170 
Prestained Protein Ladder Thermo SM0671 
Primary Antibody Diluent Dako S2022 
Proteinase K Dako S2032 
Recombinant Mouse TNFα R & D Systems 410-MT-050 
RPMI 1640 Gibco 31870-025 
RPMI 1640 (no phenol red) Gibco 32404-014 
Triton X-100 Thermo 28314 
Trypsin-EDTA (0.05%) Gibco 25300-054 
Tween-20 Sigma P1379 
Vectashield DAPI (hard set) Vector  H-1500 
Vybrant DiO Cell Labelling Solution Molecular Probes V-22886 
William’s E Media  Gibco 22551-022 
Y-27632 R & D Systems 1254 
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2.2  Methods 
  Animals 2.2.1
2.2.1.1 Mouse Models 
ROCK1nc mice were generated at the Beatson Institute (Chapter 3). 129-
Trp53tm1Tyj/J and 129/Sv were obtained from Charles River, UK. Eµ-myc mice 
and Tyr-Cre mice were kindly provided by Dr. Karen Blyth and Prof. Laura 
Machesky, respectively.  
2.2.1.2 Maintenance and Breeding  
All animal work was carried out in accordance with UK Home Office regulations 
in line with Animals (Scientific Procedures) Act 1986 and the European Directive 
2010/63/EU. Mice were bred and maintained at the Beatson Institute Animal 
Facility. Ear notching and general maintenance (food, water and housing) was 
carried out by the Biological Services Unit at the Beatson Institute. Experimental 
cohorts and breeding stocks were routinely checked for health concerns. Animals 
were humanely culled using Schedule 1 techniques as stipulated in our project 
licence. 
2.2.1.3 Animal Genotyping 
For routine genotyping, all animals were ear notched at weaning and samples 
sent to Transnetyx (Cordova, TN, US) genotyping service for analysis. 
2.2.1.4 Preparation and administration of substances  
2.2.1.4.1 Diethylnitrosamine for acute studies 
To prepare Diethylnitrosamine (DEN) for administering into mice, 100 ml of 
sterile PBS was injected into the bottle containing 1 g of DEN to give a final 
concentration of 10 mg/ml. The procedure was performed in the fume hood. For 
short-term studies assessing DEN-induced hepatic injury, mice were treated with 
a single dose of DEN at 100 mg/kg body weight by intraperitoneal injection and 
culled at 24, 48, 72 and 96 hours after DEN administration. 
2.2.1.4.2 Diethylnitrosamine for tumour studies 
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For long-term studies of liver tumour development and survival, 14-day old mice 
were treated with a single dose (40 µl/ 400 µg) of DEN by intraperitoneal 
injection. 
2.2.1.4.3 Glycyrrhizin and Diethylnitrosamine 
To prepare Glycyrrhizin (GLZ), sterile PBS was used to dissolve GLZ to a final 
concentration of 5 mg/ml. The solution was filtered using a 70 µm filter prior to 
administration by intraperitoneal injection. For Glycyrrhizin (GLZ) and DEN 
combination treatment, 6 doses of 200 mg/kg each of GLZ were given along with 
a single dose of DEN (100 mg/kg). Briefly, two doses of GLZ were given before 
DEN treatment and following DEN treatment, GLZ was injected twice daily for 
two more days. The following day, mice were sacrificed. 
2.2.1.4.4 BrdU 
Mice were injected intraperitoneally with 250 µl of BrdU two hours prior to 
sacrifice. 
2.2.1.5 Tissue collection and fixation 
Animals were euthanized by a Schedule 1 method using carbon dioxide 
inhalation, weights were recorded and blood collected for haematology or 
biochemistry analysis. Necropsy was performed immediately to prevent tissue 
autolysis. Tissues collected were fixed for at least 24 hours by immersing in 10% 
neutral buffered formalin. For acute liver studies, left lobe of the liver was 
routinely used for histological analysis and fixed in 10% neutral buffered 
formalin. Small pieces from the median lobe were frozen using dry ice or 
collected in RNALater for RNA analysis. The caudate lobe was frozen using dry 
ice for making cryosections. 
For tumour studies, mice were examined for visible lesions in all organs. For 
DEN-induced hepatocellular carcinoma studies, liver weights were recorded and 
the number of tumours counted. Tumour foci were measured using digitised 
vernier callipers. Lungs were also collected to analyse metastatic lesions. All 
lymphoid organs including the thymus, spleen and lymph nodes were harvested 
and weights recorded from Eµ-myc mice. Tissue were either fixed in 10% neutral 
buffered formalin for histological analysis or maintained in PBS until analysis. 
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For p53-deficient mice, tumours were harvested and in addition heart, lungs 
thymus, spleen, pancreas, liver, kidneys, reproductive organs and brain were 
also collected routinely for histological evaluation. Fixed tissues were then 
processed, paraffin embedded and sectioned by the Histology Service at the 
Beatson Institute. 
2.2.1.6 Clinical Pathology 
2.2.1.6.1 Haematology 
Mice were euthanized by carbon dioxide inhalation and blood samples were 
collected via cardiac puncture in potassium-EDTA tubes. Samples were 
immediately sent to Clinical Pathology Lab at University of Glasgow Veterinary 
School for complete haematology analysis. 
2.2.1.6.2 Biochemistry: Liver Function Test 
Mice were euthanized by carbon dioxide inhalation and blood samples were 
collected via cardiac puncture in 1.5 ml eppendorf tubes. The blood was allowed 
to clot at room temperature for at least 30 minutes and then centrifuged at 1500 
rcf for 15 minutes at 4° C. The resulting supernatant (serum) was transferred to 
a fresh tube for analysis. If the serum was not analysed immediately, it was 
aliquoted and stored at -20° C until ready for analysis. Liver function tests were 
kindly performed by the Clinical Pathology Lab at the Veterinary School 
(University of Glasgow), where serum concentrations of ALT, total bilirubin, 
alkaline phosphatase, total protein, albumin and globulin were determined using 
an automated analyser. 
  Histology 2.2.2
Paraffin-embedded tissue sections of 4 μm thickness were cut and routinely 
stained with haematoxylin and eosin (H&E) by the Beatson Histology Service. 
Other standard stains performed by the Histology Service include Sirius Red, 
Perls Prussian Blue and Periodic Acid-Schiff. Blank paraffin sections were cut at 
4 µm thickness and stored at 4° C until ready for use. Frozen liver tissue was 
embedded in OCT and cut at 12 µm thickness and mounted on super-frost slides. 
Cryosections were stored at -80°C until ready to be used. 
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2.2.2.1 Immunohistochemistry on FFPE Sections 
Immunohistochemistry (IHC) was routinely performed on 4 µm thick formalin-
fixed paraffin-embedded (FFPE) sections. IHC for F4/80, S100A9, CD3, Ki-67 and 
BrdU was performed by the histology service. Primary antibody dilutions are 
given in Table 2-6. For secondary antibody staining, either ImmPRESS kits or 
Envision Reagents were used by the histology service. 
All other IHC stainings were performed by me. Briefly, sections were 
deparaffinised in xylene (3 washes of 5 minutes each) and rehydrated through 
decreasing concentrations of ethanol (2 washes for 3 minutes each in 100% 
ethanol, 1 wash for 3 minutes in 70% ethanol). Slides were then washed in 
distilled water (dH2O). To unmask antigens, slides were boiled at 98° C in a 
water bath for the specified time in antigen retrieval buffer. The buffer used 
varied with the antibody in use (Table 2-6). If Proteinase K was used as the 
retrieval agent, then the slides where incubated at room temperature for the 
specified time (Table 2-6). Slides were left to cool down to room temperature 
for at least 30 minutes and then rinsed in distilled water. Endogenous peroxidase 
activity was quenched by incubating sections in 3 % H2O2 in PBS for 10 minutes. 
After slides were rinsed once in distilled water and once in TBST, the sections 
were blocked using blocking solution containing 5% serum (depending on the 
species in which the secondary antibody was raised) in TBST for 30 minutes at 
room temperature. Primary antibody diluted in blocking solution was added to 
the slides and kept in a humidified chamber for the specified time. Primary 
antibody dilutions and incubation times is mentioned in (Table 2-6). Slides were 
rinsed three times in TBST to remove excess/unbound primary antibody. HRP-
labelled secondary antibody was added to the slides and incubated at room 
temperature for a stipulated time period at room temperature (Table 2-7). 
Slides were rinsed again three times in TBST before staining with 3, 3’-
diaminobenzidine tetrahydrochloride (DAB), as chromogen. Sections were 
incubated with DAB solution until brown colour develops and the slides were 
immediately transferred to TBST to stop the reaction. 
For counterstaining, slides were rinsed in distilled water and then stained with 
haematoxylin for 1 minute. After rinsing in distilled water, the slides were then 
transferred to Scots tap water for 1 minute or until blue colour develops to the 
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desired intensity. Slides were rinsed in distilled water and the sections were 
dehydrated using increasing concentrations of ethanol (1 wash for 3 minutes in 
70% ethanol, 2 washes for 3 minutes each in 100% ethanol). Slides were then 
cleared by three washes in xylene for 3-minutes each, before mounting with 
DPX. In all staining experiments, omitting the primary antibody on one slide 
served as the negative control. Sections were analysed using bright field 
microscope (Olympus BX51) and representative images were obtained at 
different magnifications. 
Table 2-6 Primary antibodies with dilutions, incubation conditions and antigen retrieval 
methods for IHC  
 
Antigen Dilution; Conditions Antigen Retrieval 
Solution 
Retrieval Method 
BrdU 1:200;35 min, RT Citrate buffer pH 6 WB; 98°C; 25 min 
CD3 1:75; 35 min, RT Citrate buffer pH 6 WB; 98°C; 25 min 
F4/80 1:400; 35 min; RT Proteinase K 10 min at RT 
Foxp3 1:50; O/N; 4°C Tris-EDTA buffer pH 9 WB; 98°C; 20 min 
HMGB1 1:100; O/N; 4°C Citrate buffer pH 6 WB; 98°C; 20 min 
Ki-67 1:100; 35 min; RT Tris-EDTA buffer pH8 WB; 98°C; 25 min 
S100A9 1:1000; 35 min; RT Citrate buffer pH 6 WB; 98°C; 25 min  
 
Table 2-7 Secondary antibodies with dilutions and incubation conditions for IHC 
 
Secondary antibody Product Dilution; Conditions 
Anti-Rabbit K4002; Dako  No dilution; 45 min, RT 
Anti-Rat PK-6104; Vectastain Kit 1:66; 30 min, RT 
Anti-Mouse PK-2200; M.O.M Kit 1:250; 10 min, RT 
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2.2.2.2 Immunofluorescence on Frozen Sections 
Immunofluorescent staining on cryosections was performed on 12 µm thick 
cryosections of liver. Tissue sections were fixed by immersing the slides in pre-
cooled acetone (-20°C) for 10 minutes. Slides were removed from fixative and 
acetone was allowed to evaporate from the tissue sections for 20 minutes. After 
slides were rinsed in PBS, cryosections were blocked in blocking buffer (5 % 
serum in PBS) for 1 hour at room temperature. Primary antibodies diluted in 
blocking buffer (1:100) was added to the slides and kept in a humidified 
chamber for 2 hours at room temperature. Slides were rinsed twice in PBS 
before adding secondary antibodies (1:500 in blocking buffer) and incubated for 
1 hour at room temperature. Slides were then rinsed three times in PBS before 
mounting with Vectashield DAPI (hard set). Cryosections were analysed using 
fluorescence microscope (Olympus BX51) and images were obtained at 20x 
magnification. 
2.2.2.3 TUNEL Staining 
TUNEL staining was performed using the In situ cell death detection kit. 
Formalin fixed paraffin embedded tissue sections were deparaffinised and 
rehydrated. The sections were then incubated in Proteinase K solution for 15 
minutes at room temperature. TUNEL reaction mixture was prepared according 
to manufacturer’s instructions by mixing 50 µl of Enzyme solution and 450 µl of 
Label solution. The slides were rinsed twice in PBS and 50-100 µl (depending on 
the size of the section) of TUNEL reaction mixture was added to the sections. 
Label solution alone was added to the negative control slide. The slides were 
incubated in a humidified chamber for 60 minutes at 37°C in the dark. Slides 
were then rinsed three times in PBS before mounting with Vectashield DAPI 
(hard set). Sections were analysed using fluorescence microscope (Olympus 
BX51) and images were obtained at 20x magnification. 
2.2.2.4 Quantification of Staining 
Quantification of staining was performed using ImageJ software (version 1.41). 3 
to 5 representative images were captured using Olympus BX51 and cell counter 
plugin was utilized for analysis of TUNEL, F4/80, S100A9, BrdU, CD3, HMGB1, 
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Foxp3, CD8 staining. Quantification of Sirius Red staining was done using 
SlidePath TissueIA image analysis software. 
2.2.2.5 Grading 
Steatosis was graded on H&E-stained sections based on semi-quantitative 
estimation of percentage of steatotic hepatocytes, according to the following 
criteria: grade 0- less than 5 %, grade 1- 5 to 25 %, grade 2- 26 to 50 %, grade 3- 
51 to 75 % and grade 4- more than 75 %. 
For grading lung metastasis in DEN-induced HCC studies, each slide was given a 
score from 0 to 5 based on the extent of metastasis, taking into consideration 
the number and size of metastatic lesions. 
  Ex vivo Imaging of Melanoblasts 2.2.3
Apoptotic morphological features was analysed in skin explants from E15.5 
embryos resulting from homozygous Tyr-Cre:Lifeact-GFP:ROCK1wt and Tyr-
Cre:Lifeact-GFP:ROCK1nc breeding pairs. The appearance of the mating plug 
indicated embryonic day 0.5 (E0.5) and 15 days later, pregnant females were 
euthanized and uterine horns containing embryos were extracted. Embryos were 
separated from the placenta and embryonic sac and washed in PBS. Lifeact 
positive embryos were identified by looking for GFP expression in the retina 
using Olympus CX41 Inverted Microscope. A small piece of embryonic tissue was 
sent to Transnetyx for genotyping. Embryonic trunk skin was carefully dissected 
and the sample was sandwiched between a Nucleopore membrane (Whatman) 
and a gas permeable Lumox membrane in Greiner Lumox 35 mm culture dish. 
The assembly was arranged with the epidermal side of skin in contact with 
Lumox membrane to allow time-lapse confocal imaging. Around 50-70 µl of 
Matrigel was added on top of the Nucleopore membrane in order to immobilize 
the sample. The dishes were incubated at 37°C for 10 min to allow the matrigel 
to set. Culture medium (Phenol red free RPMI-1640 containing 10 % FBS, 5 mM L-
Glutamine and Pen/Strep) was added after the matrigel had set. Prior to 
imaging, media was replaced with fresh media contain 100 µM PI3-Kinase 
inhibitor (LY-294002). Time-lapse images were captured using Nikon A1R 
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confocal microscope in a 37°C chamber with 5% CO2 at 20× magnification for 19 
hours. 
  Cell Culture Techniques 2.2.4
All cell cultures were incubated at 37°C in a humidified 5% CO2 incubator. 
Composition of culture media used for different cells is listed in table below. 
Table 2-8 Media composition for different cell lines 
 
Cells Media Components 
Hepatocytes William’s E media with 3 % FBS, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine 
Lymphocytes RPMI 1640 with 10 % FBS, 5 x 10
-5 M 2-Mercaptoethanol, 100 U/ml 
penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine 
MEFs DMEM (w/o L-Glutamine) with 10 % FBS, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine 
Melanocytes F-12 with 10 % FBS, 200 nM TPA, 100 U/ml penicillin and 100 µg/ml streptomycin 
NIH-3T3 DMEM (w/o Sodium Pyruvate) with 10 % DBS, 100 U/ml penicillin and 100µg/ml streptomycin  
RAW 264.7 DMEM (w/o L-Glutamine) with 10 % FBS, 100 U/ml penicillin, 100µg/ml streptomycin and 2 mM L-glutamine 
 
 
2.2.4.1 Isolation and Culture of Primary Cells 
2.2.4.1.1  Mouse Embryonic Fibroblasts (MEFs) 
 
MEFs were generated from E13.5 embryos resulting from homozygous ROCK1wt 
and ROCK1nc breeding pairs. The appearance of the mating plug indicated 
embryonic day 0.5 (E0.5) and 13 days later the pregnant females were 
euthanized and uterine horns containing embryos were extracted. Embryos were 
dissected from the uterus and washed in PBS. Embryonic heads and livers were 
removed and a part of the head was sent for genotyping. The remaining tissue 
from all embryos was pooled and roughly chopped before incubation in 0.05% 
trypsin-EDTA (1ml/embryo) for 10 min at 37°C. Embryos were then further 
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dissociated by trituration in serological pipettes, starting with 25 ml pipette and 
then re-incubated in trypsin-EDTA for another 10 minutes at 37 °C. Cells clumps 
were further dissociated using 10 ml, 5 ml and finally 1 ml pipette. The cell 
suspension was plated in pre-warmed MEF media in 15 cm petri dish (around 6 
plates for 8-9 embryos). Cells were split at 1:2 ratio the next day (Day 2) when 
they reached ~80% confluency. On Day 3, cells from each plate was trypsinized 
and resuspended in 2 ml of freeze medium (10% DMSO in FBS) for 
cryopreservation. Typically ROCK1wt and ROCK1nc MEFs thawed back to culture 
proliferated to passage 4-5 before senescing. 
2.2.4.1.2  Hepatocytes 
 
Hepatocytes were isolated from mice by collagenase digestion and Percoll 
gradient method. Isolated cells were seeded on collagen-coated plates. For 
collagen coating, 50 mg/ml collagen was prepared in water containing glacial 
acetic acid (6 µl in 5ml water). Plates were coated for 1 hour after which excess 
liquid was aspirated and plates were left to dry in the hood.  For hepatocyte 
isolation, mice were anesthetized before opening the thoracic cavity and 
peritoneal cavity. Livers were perfused with Liver Perfusion Media (37°C) via the 
right atrium and out through the portal vein. Once the liver became pale, 
Perfusion Media was switched to Liver Digest Media. Digested livers were 
excised, gall bladder removed and then transferred to a dish containing Liver 
Perfusion Media. Livers were gently teased with forceps to release the cells into 
solution. Cell suspensions were then filtered through 70 µm cell strainer to 
remove undigested tissue and connective tissue. Cells were centrifuged at 135 x 
g for 1 minute and resuspended in 6 ml of hepatocyte media. 
Hepatocytes were separated using a three-layer discontinuous Percoll gradient. 
Three different Percoll density solutions used were 1.12 g/ml, 1.08 g/ml and 
1.06 g/ml. For 1.12 g/ml solution: 2.63 ml of Percoll, 0.3 ml of PBS and 64.6 μl 
of water; for 1.08 g/ml solution: 2.86 ml of Percoll, 0.5 ml of PBS and for 1.63 
ml of water and for 1.06 g/ml solution: 2.085 ml of Percoll, 0.5 ml of PBS and 
2.42 ml of water. Percoll gradient was generated by layering 3 ml of 1.12 g/ml 
solution at the bottom over which 5 ml of 1.08 g/ml solution was carefully 
layered followed by 5 ml of 1.06 g/ml solution. Over this, 6 ml of cell suspension 
was carefully layered while avoiding gradient disturbance. The cell suspension 
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was fractionated by centrifugation without brakes at 750 x g for 20 minutes. 
After centrifugation, the layer of cells between 1.06 and 1.08 that contained 
live hepatocytes were collected and added to 10 ml of hepatocyte media. Cell 
suspension was centrifuged at 135 rcf for 1 minute. Cell pellet was then 
resuspended in hepatocyte media and seeded in collagen coated plates for 
analysis. 
2.2.4.1.3 Lymphocytes from Tumours 
 
Tumours (thymus, spleen or lymph nodes) were disaggregated aseptically in 4-5 
ml of PBS by pushing through a 70 µm cell strainer into a 50 ml centrifuge tube. 
Lymphocytes were isolated on a Ficoll-Paque density gradient. For this, the 
disaggregated cell suspension was carefully layered on 5 ml of Ficoll-Paque PLUS 
in a 15 ml centrifuge tube. The tubes were centrifuged at 3000 rpm for 10 
minutes (brake 5). The interphase layer containing live lymphocytes was 
extracted and washed in 5-10 ml of RPMI medium and centrifuged at 1500 rpm 
for 5 minutes. The supernatant was discarded and the cells were resuspended in 
5-10 ml of RPMI medium. A viable cell count was carried out either on a Coulter 
Counter or by trypan blue exclusion on a haemocytometer. Cells were frozen at 
a concentration of 5-10 x 106 cells/ vial in freeze medium (10% DMSO and 30% 
FBS in RPMI medium) for immunophenotyping. For tumour cell line 
establishment, cells were cultured in 25 cm2 tissue culture flasks or 12 well 
plates at a concentration of 2.5 x 106 cells/ ml in lymphocyte medium. Cells are 
normally split at either 1:2 or 1:3. Cell lines were frozen down at passage 6 or 12 
at a concentration of 5-10 x106 cells/ vial. 
2.2.4.2 Induction of Apoptosis 
Apoptosis induction was usually preceded by overnight incubation (~ 16 hours) in 
starve medium (media without serum). For MEFs and NIH 3T3 cell line, apoptosis 
was generally induced using 50 ng/ml of TNFα and 10 µg/ml of Cycloheximide 
(CHX) diluted in starve media. For some experiments, other apoptosis inducers 
including a combination of 2 µg/ml of anti-CD95 and 10 µg/ml of CHX or 
ultraviolet radiation (0.1 J/cm2) was used. For primary hepatocytes, 1 µM ABT-
199 was used and for melanocytes, 100 µM LY-294002 was used. 
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2.2.4.3 C1q binding on Apoptotic MEFs 
ROCK1wt and ROCK1nc MEFs were seeded on collagen-coated coverslips in 6-well 
dishes at a density of 5 x 104 cells per well. Cells were serum-starved overnight 
prior to induction of apoptosis with 50 ng/ml of TNFα and 10 µg/ml of CHX 
diluted in starve media. After 1 hour, media was aspirated and cells were fixed 
in 4 % PFA for 5 minutes. Cells were washed carefully with PBS. 10 µg/ml of C1q 
diluted in PBS was added to the cells and incubated for 1 hour at room 
temperature. Cells were washed carefully with PBS. For C1q detection, mouse 
anti-human C1q, diluted in PBS (1:1000) was added and incubated for 30 minutes 
at room temperature. After washing cells with PBS, anti-mouse secondary 
antibody, diluted in PBS (1:3000) was added and incubated for 10 minutes at 
room temperature. Cells were washed with PBS. To visualize cell membranes, 
cells were incubated with Vybrant DiO Cell Labelling Solution for 5 minutes. 
Cells were washed before mounting them with Vectashield DAPI (hardset). 
Confocal images were captured with Nikon A1R microscope. 3D reconstruction 
and volumetric rendering of Z-stacks were done using Imaris software. 
2.2.4.4 Caspase Activity Assay 
Cells were seeded on 96-well plates. Following treatment with appropriate 
apoptosis inducers, cells were subjected to caspase 3/7 activity measurement 
using Caspase-Glo assay kit. Briefly, plates containing cells were removed from 
the incubator and allowed to equilibrate to room temperature for at least 30 
minutes. 100 µl of Caspase-Glo reagent was added to each well, contents mixed 
gently and then incubated for 30 minutes at room temperature. The 
luminescence for each sample was measured in a plate-reading luminometer. 
  Microscopy 2.2.5
2.2.5.1 Time-lapse Microscopy for MEFs 
ROCK1wt and ROCK1nc MEFs were plated on 6-well glass bottom dishes at a 
density of 2 x 106 cells per well. Cells were serum-starved overnight prior to 
induction of apoptosis with 50 ng/ml of TNFα and 10 µg/ml of CHX diluted in 
starve media. Bright field time-lapse microscopy images were acquired with a 
10x objective using Nikon TE 2000 microscope with a heated stage and 5% CO2 
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gas line. Immediately after induction of apoptosis, the dishes were transferred 
to the microscope, 3-4 random positions were chosen from each well and time 
lapse images were taken every 3 minutes for 15-17 hours. 
2.2.5.2 Time-lapse Microscopy for Hepatocytes 
ROCK1wt and ROCK1nc primary hepatocytes were plated on 6-well glass bottom 
dishes pre-coated with collagen. Cells were serum-starved overnight prior to 
induction of apoptosis with 1 µM of ABT-199 diluted in starve media. Bright field 
time-lapse microscopy images were acquired with a 10x objective using Nikon TE 
2000 microscope with a heated stage and 5% CO2 gas line. Immediately after 
induction of apoptosis, the dishes were transferred to the microscope, 3-4 
random positions were chosen from each well and time lapse images were taken 
every 3 minutes for 18 hours. 
2.2.5.3 Electron Microscopy 
For scanning electron microscopy (SEM) studies, MEFs from ROCK1wt and 
ROCK1nc mice were seeded on coverslips pre-coated with collagen in a 12-well 
plate. Cells were serum starved overnight prior to induction of apoptosis with 50 
ng/ml of TNFα and 10 µg/ml of CHX diluted in starve media. After 2 hours of 
incubation, cells were fixed with 2.5 % glutaraldehyde in 0.1 M phosphate buffer 
for 1 hour at room temperature. After fixation, cells were washed with 
phosphate buffer (3 washes for 10 minutes each). Samples were then further 
processed for SEM analysis by Electron Microscopy Facility at University of 
Glasgow. Images of apoptotic MEFs were taken at different magnifications. 
For transmission electron microscopy (TEM) studies, very small pieces (around 1 
mm thickness) of kidney from ROCK1wt and ROCK1nc mice was fixed with 2.5 % 
glutaraldehyde in 0.1 M sodium cacodylate buffer for 1 hour at room 
temperature. After fixation, samples were rinsed in sodium cacodylate buffer (3 
times for 5 minutes each). Samples were stored at 4°C until ready for 
processing. Samples were processed at the Electron Microscopy Facility at 
University of Glasgow. TEM images of kidneys were taken at different 
magnification. 
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 Flow Cytometry 2.2.6
2.2.6.1 Flow Cytometric Determination of PS Externalization 
MEFs were plated on 10 cm plates at a density of 1.5 x 106 cells/ plate. Cells 
were serum-starved overnight prior to induction of apoptosis with 50 ng/ml of 
TNFα and 10 µg/ml of CHX diluted in starve media. Starve medium alone was 
added to control cells. After 4 hours of treatment, conditioned media was 
collected. Cells were washed with PBS before detaching cells with Accutase. 
Detached cells were collected and added to the tube containing conditioned 
media. Cell suspension was centrifuged at 1000 rpm for 5 minutes and 
supernatant was aspirated. Cells were resuspended in 1 ml of ice-cold 1% BSA in 
PBS. The cell suspension was centrifuged at 1800 rpm for 3 minutes and 
resuspended in 1% BSA. After another centrifugation at 1800 rpm for 3 minutes, 
supernatant was aspirated and cells were resuspended in 400 µl of 1X Binding 
Buffer (FITC Annexin V Apoptosis Detection Kit). To 100 µl of cell suspension, 5µl 
of FITC Annexin V and 5µl of PI was added, mixed well by vortexing and 
incubated in the dark for 15 minutes. After incubation 400 µl of 1X Binding 
Buffer was added and analysed by flow cytometry. 
2.2.6.2 Immunophenotyping of Lymphocytes 
Frozen vials of lymphocytes isolated from Eµ-myc tumours were thawed and 
resuspended in 5 ml of RPMI (with 10 % FBS). This was centrifuged at 1500 rpm 
for 5 minutes at 4°C. Pellet was resuspended in 5 ml of FACS buffer (PBS with 5-
10 % FBS) and centrifuged at 1500 rpm for 5 minutes at 4°C. Cell pellet was 
resuspended in FACS buffer (volume depended on the size of the pellet). Cells 
were counted and divided for different staining combinations. Around 5 x 105 or 
less cells were used for staining (96 well plate or eppendorfs). Cells were 
centrifuged at 1500 rpm for 5 minutes at 4°C. Pellet was resuspended in 100 µl 
of FACS buffer with Fc block (1:250) and incubated for 15 min at 4°C. Meanwhile 
primary antibody master-mixes were made in FACS buffer (1:500 for Biotinylated 
Antibodies and 1:100 for FITC/APC antibodies). After Fc block, cells were 
centrifuged at 1500 rpm for 5 minutes and cell pellet was resuspended in 100 µl 
of the relevant antibody mastermix and incubated for 30 min at 4°C in the dark. 
Unstained and single-stained sample controls were also included. Cells were 
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washed twice with FACS buffer. Samples containing biotinylated antibodies were 
resuspended in 100µl of Streptavidin (1:500 in FACS buffer) and incubated for 30 
min at 4°C in the dark. Cells were washed again and finally resuspended in FACS 
buffer containing 7AAD (1:1000) for FACS analysis. 
  Cellular protein extraction and analysis 2.2.7
2.2.7.1 Preparation of cell lysates 
After cells had been grown to the desired confluence and treated with apoptotic 
inducers for the required period of time, they were lysed to extract proteins. 
For this, culture dishes were placed on ice and the conditioned medium 
containing apoptotic bodies was collected in cold eppendorf tubes. 10 ml of ice-
cold PBS was added to the dishes and using a cell scraper, cell lysates were 
collected and transferred to the corresponding cold eppendorf tubes. This was 
centrifuged at 3000 rpm for 5 minutes at 4°C. Supernatant was discarded and 
the pellet was washed in 1 ml of PBS followed by another centrifugation at 3000 
rpm for 5 min at 4°C. Supernatant was discarded and the pellet was resuspended 
in 200-250 µl of SDS lysis buffer. This was then transferred to QIAshredder tubes 
and centrifuged for 1 min at 14,000 rpm. The flow-through was transferred to 
fresh eppendorf tubes and frozen (either rapid freezing or overnight freezing at -
80°C). Lysates were then thawed on ice before being centrifuged at 14,000 rpm 
for 15 minutes at 4°C. The supernatant was transferred to a fresh centrifuge 
tube, protein concentration determined and samples stored at -20°C or -80°C. 
For macrophages treated with histone H2A for 2 hours, cells were washed with 
PBS twice and collected by scraping. The cell suspension was then centrifuged at 
3000 rpm for 5 minutes. Cells were lysed using 8 M Urea and passed through 
QIAshredder. The flow through was collected for western blotting. 
2.2.7.2 Determination of protein concentration 
Protein concentration of cell lysates was determined using the bicinchoninic acid 
(BCA) assay. Briefly, standards (0.08, 0.1, 0.2, 0.4, 1 and 2 mg/ml) were 
prepared in SDS lysis buffer using a 2 mg/ml albumin standard stock solution. 10 
μl of blank (buffer alone), standards and samples were added to a Greiner Bio-
One 96-well plate. 1:2 dilutions of protein samples were also included. 200 μl of 
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developing solution (50:1, bicinchoninic acid: copper sulphate solution) was 
added to each well, mixed well. Plate was sealed with microplate sealing film 
and incubated at 37oC for 30 minutes. Absorbance was measured using Molecular 
Devices Microplate Reader and sample concentrations were determined from the 
standard curve generated. 
2.2.7.3 SDS-polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (PAGE) was used to separate protein 
samples based on their molecular weight. Protein samples were first diluted in 
6x loading buffer and heated at 95°C for 5 minutes. After heating, samples were 
briefly centrifuged and loaded on 4-12 % NuPAGE Bis-tris gels alongside 
Prestained Protein ladder molecular weight marker. Gels were run in tanks 
containing 1X MOPS/MED SDS running buffer at 100 V for the first 10 minutes and 
then increased to 160 V and run until the tracking dye front reaches the lower 
end of the gel. Afterwards, gels were either stained or used for western 
blotting. 
2.2.7.4 Gel Staining 
Following protein separation, some gels were stained to detect protein bands as 
follows. Gels were washed three times in distilled water (dH2O) for 5 minutes 
each. Gels were then incubated in SimplyBlueTM SafeStain for 1 hour at room 
temperature. Following this, gels were washed in dH2O for 1 hour and then 
overnight. Images of stained gels were acquired on a LI-COR Odyssey® system. 
2.2.7.5 Western Blotting 
Following protein separation, some gels were used for western blotting. Proteins 
were transferred to PVDF membrane in transfer buffer containing 20 % methanol 
using a Bio-Rad Mini Trans-Blot® Cell. Briefly, prior to transfer, PVDF membrane 
was pre-wet in methanol for 15 seconds and then washed in transfer buffer. 
Sponges and Whatman papers were also pre-wet and then stacked with the gel 
and membrane. All transfers were run at 100 V for 1 hour using an ice pack in 
the apparatus. Successful transfer and equal loading of proteins was confirmed 
by staining the membrane with Ponceau staining solution. After the Ponceau 
stain was washed off using TBS-T, the membrane was blocked with 5% (w/v) milk 
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powder or 3% BSA in TBS-T for 1 hour. Primary antibodies were diluted to the 
required concentration in TBS-T and membranes incubated with these solutions 
for 2 hours at room temperature or 4oC overnight. This was followed by three 
washes in TBS-T for 10 minutes each. The membrane was then incubated with 
the secondary antibody that had been diluted to the required concentration in 
TBS-T for 45 minutes at room temperature. After the blot was washed in TBS-T 
three times for 10 minutes each, protein bands were visualised on the LI-COR 
Odyssey® system. Protein bands were quantified using Image Studio Version 2.1. 
  Multiplex Cytokine Analysis 2.2.8
Milliplex System (Millipore) allows the simultaneous measurement of different 
cytokines from the same sample. For my experiment, I custom tailored 15 
cytokines (INF-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL12p40, IL12p70, IL-
17, MCP-1, MIP-1α, MIG, TNFα) to be analysed. The serum levels (pg/ml) of 
these cytokines were analysed using the Mouse Cytokine/Chemokine Magnetic 
Bead Panel Kit following manufacturer’s instructions. Briefly, 200 μl of wash 
buffer was added to each well of the 96-well plate, sealed and mixed on a plate 
shaker for 10 minutes at room temperature after which the wash buffer was 
decanted. Inverting the plate and tapping it onto absorbent towels removed any 
residual amount of wash buffer. 25 µl of standards or controls was added to the 
appropriate wells and 25 µl of assay buffer was added to the sample wells. 25 µl 
of serum matrix was added to the background, control and standard wells. 25 μl 
of serum samples diluted 1:2 in assay buffer was added to the sample wells. All 
serum samples were measured in duplicates. 25 μl of premixed magnetic beads 
conjugated to antibodies for all 15 analytes were added to each well. Plate was 
sealed, protected from light and incubated overnight at 4° C on a plate shaker. 
This was followed by a wash step (two times with 200 μl of wash buffer) on a 
magnetic plate washer. 25 µl of detection antibodies was added to each well, 
and plate was sealed and incubated with agitation for 1 hour at room 
temperature. Streptavidin-phycoerythrin (25 μl) was added to each well, and 
plates was sealed and incubated with agitation for another 30 minutes at room 
temperature, followed by a final wash step. Magnetic beads were then re-
suspended in sheath fluid and assayed on a Luminex 200 analyser using xPOTENT 
software. 
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 SILAC 2.2.9
2.2.9.1 SILAC Labelling of NIH 3T3 cells 
NIH 3T3 cells were grown in DMEM supplemented with dialysed FBS (10 kDa cut 
off), 4 mM L-glutamine and labelled arginine (Arg) and lysine (Lys) amino acids 
for 5 passages. Cells were labelled with light/unlabelled (Lys-0, Arg-0), medium 
(Lys4, Arg6), and heavy (Lys8, Arg10) medium. Amino acids are labelled with the 
following isotopes: Lys4- 2H4; Lys8- 13C6, 15N2; Arg6- 13C6; Arg10- 13C6, 15N4. Label 
incorporation was checked on cell pellets suspended in 8M Urea and confirmed 
to be >95% by mass spectrometry before cells were used for further 
experiments. 
2.2.9.2 Treatment of SILAC Labelled Cells 
Apoptosis was induced with a combination of 50 ng/ml of TNFα and 10 µg/ml of 
CHX and further supplemented with 10 µM Y-27632 or 50 µM Blebbistatin. 
Control cells left in starve medium. Briefly, each labelled populations of NIH 3T3 
were assigned the following treatments: Light, control; Medium, TNFα + CHX; 
Heavy, TNFα + CHX + Y-27632. Each labelled population of NIH 3T3 was used in 
each treatment condition, with Blebbistatin substituting for Y-27632 in one set 
of replicates, for a total of six replicates. After 4 hours, conditioned media was 
collected and concentrated. 
2.2.9.3 Concentration of Conditioned Media using Strataclean 
Conditioned media was collected in falcon tubes and centrifuged at 300 rcf for 
10 minutes at 4°C. Supernatant was collected and centrifuged at 2000 rcf for 10 
minutes at 4°C. Supernatant was collected in polypropylene tubes (snap on caps) 
and centrifuged at 10,000 rcf for 30 minutes at 4°C. Supernatant collected was 
maintained on ice. The pH of the solution was adjusted to 5 with 10 % 
trifluoroacetic acid. 100 µl of Strataclean Beads was added to the solution, 
vortexed thoroughly and incubated for 30-60 minutes in the rotor wheel at 4°C. 
The solution was centrifuged at 872 rcf for 1 minute at 4°C to pellet the beads. 
Supernatant was removed and 120 µl of 6X loading buffer was added to the 
beads and mixed thoroughly. Samples were boiled at 95°C for 5 minutes and 
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then centrifuged at 400 rcf for 1 minute. Supernatant was either run on gel 
immediately or frozen for later use. 
2.2.9.4  Macrophage Uptake of SILAC Labelled Proteins 
Heavy labelled population of NIH 3T3 cells were induced with apoptosis with UV 
(0.1 J/cm2). After 4 hours of incubation, conditioned media was collected and 
added to culture dishes containing RAW 264.7 macrophages which were pre-
treated with Bafilomycin A1. Macrophages were incubated with conditioned 
media for 2 hours at 37°C. After incubation, RAW 264.7 cells were washed twice 
with media and once with PBS. Cells were collected by scraping and centrifuged 
at 3000 rpm for 5 minutes. Cells were lysed with 8M Urea and the lysate was 
passed through QIAshredder. Three independent experiments were performed. 
2.2.9.5 Mass Spectrometry Analysis  
Protein concentration of macrophage cell lysate was determined. 20 µL of 
supernatant obtained after concentration using Strataclean beads was run on 10 
% SDS-PAGE. The gel was stained with Coomassie. Macrophage cell lysate and 
Coomassie-stained gel was subjected to mass spectrometry and database search 
was performed by Mass Spectrometry Service Staff, David Sumpton and Sergio 
Lilla. 
 TNFα Secretion by Macrophages 2.2.10
RAW 264.7 cells were treated with varying amounts of purified recombinant 
histone proteins (H2A, H2B, H3 and H4) for 2 hours. The media was collected and 
assayed for TNFα secretion by using TNFα ELISA kit by following manufacturer’s 
instructions. 
  Statistical Analysis 2.2.11
Statistical significance (p<0.05) of differential findings between experimental 
groups was determined by performing appropriate tests using GraphPad 6 
software. The test used for analysis is stated in the corresponding figure 
legends. 
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3 Non-cleavable ROCK1 (ROCK1nc) mouse model 
3.1 Introduction 
The importance of apoptosis in maintaining tissue homeostasis is well 
documented. Morphological features of cells undergoing apoptosis (cell 
contraction, membrane blebbing and apoptotic body formation) have been 
appreciated for more than 40 years, but the biological importance of these 
dramatic events has yet to be determined. Previously, our lab had identified 
that during apoptosis, caspase cleavage and activation of ROCK1 is important for 
formation of blebs (Coleman et al., 2001). Elucidation of the importance of 
caspase cleavage of ROCK1 and its biological significance has been limited to in 
vitro studies, often using pharmacological inhibitors. As previously discussed, 
currently available inhibitors are not isoform selective and can have off-target 
effects. Although these inhibitor-based studies provided invaluable insights into 
ROCK1-mediated apoptotic membrane blebbing, they still failed to provide proof 
that caspase cleavage of ROCK1 is necessary for the distinct morphological 
features of apoptotic cells. In order to understand the fundamental role of 
cleavage and activation of ROCK1 during apoptosis and also to investigate the 
biological significance of apoptotic blebbing, a genetically modified (GM) knock-
in mouse model was generated by the Transgenic Facility at the Beatson 
Institute, in which a non-cleavable form of ROCK1 (ROCK1nc) was created by 
mutating the terminal amino acid D1113 in the caspase cleavage site to alanine. 
This model is the first of its kind that would allow for the purpose of 
morphological changes during apoptosis to be determined in vivo. 
 Generation of ROCK1nc mouse model 3.1.1
Briefly, a targeting vector bearing two mutations in exon 27 (3338A>C and 
3339T>A) was generated with a floxed neomycin selection cassette in the 
preceding intron. The targeting vector was generated with 3.1 kb 5’ and 5.1 kb 
3’ homology arms, respectively. When translated, the mutant ROCK1 bears a 
single missense substitution (D1113A). This modifies the caspase cleavage site 
and renders the protein insensitive to caspase cleavage. The targeting vector 
was transfected into 129/Sv mouse embryonic stem cells and the cells were 
selected by neomycin resistance. Surviving clones were screened and correctly 
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modified cells were injected into fertilized mouse blastocysts and then 
implanted into pseudopregnant mice. The resulting chimeric male mice were 
then crossed with wild-type C57Bl/6 females. Thus, the offspring were of mixed 
background (129/Sv and C57Bl/6). Mice heterozygous for the mutant ROCK1nc 
gene retained the floxed neomycin selection cassette and hence were crossed 
with a Cre deleter strain (on a C57BL/6 background) to remove the cassette. The 
resulting mice were crossed with wild-type C57Bl/6 mice to remove the Cre 
transgene. Homozygous mice (ROCK1nc) generated from heterozygous breeding 
were born in expected Mendelian ratios and did not display any overt phenotype. 
ROCK1nc mice were then interbred to generate a homozygous strain for use in 
our studies. Similarly, mice not carrying the ROCK1nc mutation that were 
generated from heterozygous breeding were also interbred to generate wild-type 
mice (ROCK1wt) for comparative studies. The caspase cleavage site mutation 
had no effect on viability and fertility of these mice. 
 Experimental Aims 3.1.2
The ROCK1nc mouse strain generated at the Beatson Institute is the first genetic 
model that would enable us to answer fundamental questions regarding 
apoptotic membrane blebbing in vivo. The aim of this study was to characterize 
the ROCK1nc model by using a combination of in vitro and in vivo techniques.  
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3.2 Results 
 ROCK1nc cleavage is required for apoptotic blebbing and 3.2.1
cell contraction 
Caspase cleavage of ROCK1 removes an auto-inhibitory domain, which yields a 
constitutively active kinase fragment that drives actomyosin contractility. The 
force thus generated drives the morphological features that are typically seen in 
cells undergoing apoptosis (Coleman et al., 2001). To characterize the 
requirement for cleavage of ROCK1 for membrane blebbing during apoptosis, I 
utilized mouse embryonic fibroblasts (MEFs) from ROCK1wt and ROCK1nc mice. 
MEFs isolated from E13.5 embryos were expanded in culture and seeded on 
coverslips. Once attached, cells were starved overnight (MEF media without FBS) 
and then exposed to the apoptosis inducing agents, TNFα and Cycloheximide 
(CHX) for 4 hours. The samples were then processed for scanning electron 
microscopy at the University of Glasgow. Scanning electron micrographs of 
treated cells revealed that the morphology of membrane blebbing was 
significantly altered in ROCK1nc fibroblasts when compared to the wild-type 
fibroblasts (Figure 3-1). The cells displayed an inability to contract and bleb 
properly, thereby verifying previous in vitro studies on ROCK1 activity in 
membrane blebbing using ROCK inhibitors like Y-27632. 
To further confirm the defective apoptotic morphology, MEFs were seeded on 6-
well glass bottom dishes, starved overnight and treated with TNFα and CHX. 
Morphological features of apoptosis were observed using time-lapse microscopy. 
Images were taken at 3 minute time intervals for a maximum of 15 hours. 
Analysis of time-lapse images clearly demonstrated a profound defect in 
apoptotic morphology in ROCK1nc fibroblasts compared to wild-type fibroblasts 
(Figure 3-2). ROCK1wt fibroblasts underwent classic apoptotic morphological 
features including, membrane blebbing and forceful contraction of the cell to 
form apoptotic bodies. However, ROCK1nc MEFs showed an obvious inability to 
contract and bleb properly. They failed to retract and cellular processes 
remained adhered to the plate surface.   
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Figure 3-1 ROCK1 cleavage is required for apoptotic blebbing and cell contraction 
Scanning electron micrographs of MEFs from ROCK1wt and ROCK1nc mice treated with 
TNFα and CHX for 4 hours. Scale bars represent 10µm.  
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Figure 3-2 Apoptotic ROCK1nc MEFs demonstrate an inability to contract and bleb 
Representative time lapse images at indicated times of ROCK1wt and ROCK1nc MEFs 
induced for apoptosis with TNFα and CHX that were taken at 3 minute time intervals for 
150 minutes. 
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 ROCK1 cleavage is not required for cell death 3.2.2
The knock-in mutation that was introduced in the caspase cleavage site of 
ROCK1 was not expected to hinder caspase activity in these fibroblasts. To 
validate this, both ROCK1wt and ROCK1nc MEFs were treated with different 
inducers of apoptosis which included TNFα+CHX, CD95+CHX or UV treatment. 
Caspase 3/7 activity in untreated MEFs and MEFs treated with apoptosis inducers 
for 4 hours was evaluated with Caspase-Glo assay kit in a 96-well format. 
Initially, ROCK1wt and ROCK1nc MEFs were induced with apoptosis and the 
caspase activity was checked at 1, 2, 3 and 4 hours. The experiment was 
performed in triplicate. As expected, caspase activity in both ROCK1wt and 
ROCK1nc MEFs increased with time for all three treatments (Figure 3-3a). 
Since apoptotic morphologies were analysed using scanning electron microscopy 
at 4-hour time point, MEFs were treated with apoptotic inducers for 4 hours and 
caspase 3/7 activity was analysed. The experiment was done in triplicate and 
repeated four times. As compared to untreated controls, induction of apoptosis 
resulted in an increase in caspase activity with all three treatments (Figure 3-3b). 
The increase in caspase activity was the lowest in cells treated with CD95+CHX. 
Importantly, there was no significant difference in the caspase activity between 
the two genotypes with any of the three tested treatments (Figure 3-3b). This 
confirmed that the caspase activity was not affected by the knock-in mutation in 
ROCK1 and that cleavage of ROCK1 was not required for cell death. 
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Figure 3-3 ROCK1 cleavage is not required for cell death 
a) Line graph (mean ± SEM) shows caspase activity (determined by Caspase Glo assay) 
of MEFs from ROCK1wt and ROCK1nc mice, treated with different apoptotic inducers for 
increasing lengths of time. b) Bar graph (mean ± SEM) shows caspase activity in wild-type 
and ROCK1nc MEFs 4 hours after induction of apoptosis with different inducers. Data 
analysed by Student’s t-test. RLU=Relative Luminescence Units.   
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  ROCK1nc is resistant to caspase cleavage during 3.2.3
apoptosis 
To confirm that the knock-in mutation in ROCK1 rendered the protein resistant 
to caspase cleavage during apoptosis in MEFs, western blotting was performed on 
lysates from wild-type and ROCK1nc fibroblasts that were treated with TNFα and 
CHX for 4 hours as well as untreated fibroblasts. This work was performed by Dr. 
Grant Wickman and Dr. Nicola Rath. 
ROCK1 expression remained unaltered in untreated MEFs (Figure 3-4). However, 
upon induction of apoptosis, cleavage of ROCK1 was observed in ROCK1wt MEF 
lysates with the appearance of two bands. In ROCK1nc MEFs, apoptosis induction 
using TNFα and CHX did not result in cleavage of ROCK1 protein, which 
confirmed that the knock-in mutation indeed rendered the protein resistant to 
caspase cleavage during apoptosis. Induction of apoptosis was confirmed by the 
presence of cleaved poly (ADP-ribose) polymerase (PARP), which is a classical 
marker of apoptosis. PARP cleavage was observed in both ROCK1wt and ROCK1nc 
MEFs that were treated with TNFα and CHX, while the untreated counterparts 
did not reveal a cleaved PARP product. Caspase cleavage and activation of 
ROCK1 was confirmed by blotting for phosphorylated MLC (pMLC), a marker of 
ROCK1 activation. Apoptosis in wild-type fibroblasts resulted in increased 
phosphorylation of MLC when compared to untreated samples. This however, 
was not observed in apoptotic ROCK1nc MEFs, confirming that caspase cleavage 
of ROCK1 during apoptosis results in phosphorylation of MLC, which would then 
induce actomyosin contractility, thus driving classical apoptotic features 
including cell contraction and membrane blebbing. 
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Figure 3-4 ROCK1nc is resistant to caspase cleavage during apoptosis 
Representative western blot image of MEF lysates from ROCK1wt and ROCK1nc treated 
with and without TNFα and CHX for 4 hours as indicated. Membrane was probed for 
ROCK1, PARP, pMLC and α-tubulin. Cleaved ROCK1 and PARP were detected as lower 
molecular weight bands as indicated. Figure courtesy of Dr. Nicola Rath. 
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 Inhibition of ROCK1 cleavage does not affect 3.2.4
phosphatidylserine externalization 
Loss of membrane asymmetry and the concomitant externalization of 
phosphatidylserine (PS) is a common feature of apoptotic cells. The ability of PS 
to act as a recognition signal for clearance of apoptotic cells by phagocytes was 
demonstrated many years ago (Fadok et al., 1992b, Fadok et al., 1992a). The 
seminal report that revealed the caspase cleavage site of ROCK1 also reported 
that externalization of PS was independent of ROCK1 activity (Coleman et al., 
2001). To verify whether MEFs from ROCK1nc mice also showed similar results, 
PS externalization was evaluated using flow cytometry by exploiting the property 
of Annexin V to bind specifically to PS. This work was kindly performed by June 
Munro. MEFs from wild-type and ROCK1nc mice were either left in starve 
medium (untreated) or treated with TNFα and CHX. After 4 hours, cells were 
collected and stained with fluorescently labelled Annexin V and propidium iodide 
(PI) (Figure 3-5a). This work was done in quadruplicates and repeated four times. 
Within 4 hours of treatment, almost 40 % of cells from both ROCK1wt and 
ROCK1nc mice bind Annexin V, and thus externalize PS, when compared to less 
than 10 % in control untreated cells (Figure 3-5b). Notably, no significant 
difference in Annexin V binding was observed between MEFs expressing wild-type 
ROCK1 and non-cleavable ROCK1 (Figure 3-5b). Thus, the defect in caspase 
cleavage of ROCK1 appears to disturb the morphological features associated with 
apoptosis and does not affect externalization of PS during apoptosis. 
 Apoptotic blebs focalize complement C1q 3.2.5
C1q, a component of the classical complement cascade, has been shown to 
enhance recognition and clearance of apoptotic cells by phagocytes (Ogden et 
al., 2001). C1q binds through its globular head to the membrane blebs on 
apoptotic keratinocytes (Korb and Ahearn, 1997) and endothelial cells (Navratil 
et al., 2001). When C1q protein was added to apoptotic MEFs (TNFα and CHX) 
from ROCK1wt and ROCK1nc mice, there was high-density localization 
specifically on the surface blebs on ROCK1wt cells (Figure 3-6). However, C1q 
binding was minimal on apoptotic ROCK1nc MEFs that lacked prominent surface 
blebs, suggesting that membrane blebs were essential for C1q binding (Figure 
3-6).  
  96 
 
 
Figure 3-5 Phosphatidylserine externalization is not dependent on ROCK1 cleavage 
a) Representative FACS dot plots of ROCK1wt and ROCK1nc MEFs treated with and 
without TNFα and CHX for 4 hours. Cells were stained with Annexin to detect 
externalization of phosphatidylserine and with propidium iodide (PI) to determine 
membrane integrity b) Bar graph (mean ± SEM) shows percentage of Annexin V positive 
cells (quadrant Q2 + quadrant Q3) in untreated and treated MEFs from ROCK1wt and 
ROCK1nc mice. Data analysed by Student’s t-test.  
  97 
 
 
 
 
 
 
 
 
 
Figure 3-6 Apoptotic blebs focalize complement C1q 
Representative images of 3D reconstruction and volumetric rendering of apoptotic MEFs, 
showing. C1q (red) binding specifically to surface blebs. Cell membrane was stained with 
lipid dye DiO (green), and nucleus with DAPI (blue). Scale bars represent 7 µm. Work 
done along with Dr. Grant Wickman (Wickman et al., 2012). 
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 Hepatocytes from ROCK1nc mice display morphological 3.2.6
defects during apoptosis 
Having confirmed that mesenchymal cells like fibroblasts from ROCK1nc mice 
exhibited morphological defects during apoptosis, I wondered whether this 
would hold true for epithelial cells as well. As a filter organ, the liver is 
constantly exposed to microbes and toxic substances making it vulnerable to cell 
death. The bulk of the liver is made up of hepatocytes, which are epithelial 
cells. Primary mouse hepatocytes were isolated from ROCK1wt and ROCK1nc 
mice by the two-step liver perfusion method, where first the liver is perfused 
with medium at physiological pH to clear the blood, followed by perfusion with 
medium containing collagenase for cell dissociation. 
Primary hepatocytes isolated from ROCK1wt and ROCK1nc mice were seeded on 
6-well glass bottom dishes that were coated with collagen. To induce apoptosis 
in hepatocytes, I used 1µM of ABT-199, a Bcl2-specific BH3 mimetic. 
Morphological features of apoptosis were observed using time-lapse microscopy. 
Images were taken at 3 minute time intervals for a maximum period of 17 hours. 
Analysis of time-lapse images showed that unlike fibroblasts, membrane 
blebbing was not prominent in these epithelial cells. However, comparison of 
wild-type and ROCK1nc hepatocytes demonstrated a defect in apoptotic 
morphology in ROCK1nc hepatocytes (Figure 3-7). ROCK1wt hepatocytes 
underwent forceful contraction and formed compact apoptotic bodies, however, 
ROCK1nc hepatocytes failed to retract properly. Cellular processes remained 
adhered to the plate surface thus exhibiting a failure to form compact apoptotic 
cell bodies (Figure 3-7). This confirmed that apoptotic morphological features 
were altered in epithelial cells like hepatocytes from ROCK1nc mice. 
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Figure 3-7 Apoptotic ROCK1nc hepatocytes display an inability to retract 
Two panels of representative time lapse images at indicated times of ROCK1wt and 
ROCK1nc hepatocytes induced with apoptosis with ABT-199 which were taken at 3-
minute time interval for up to 120 minutes.  
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 ROCK1nc mutation affects apoptotic morphologies in 3D ex-3.2.7
vivo tissue 
Typically, apoptotic morphological features have been observed mainly under in 
vitro conditions. Given that we now know the effect of defective caspase 
cleavage of ROCK1nc in apoptotic morphologies under in vitro conditions, we 
questioned whether these morphological defects would be manifested in vivo. 
To achieve this, I crossed ROCK1nc mice with Tyr-Cre:LifeAct-GFP mice, kindly 
provided by Prof. Laura Machesky, to generate Tyr-Cre:Lifeact-GFP:ROCK1wt 
and Tyr-Cre:Lifeact-GFP:ROCK1nc. Lifeact is a 17-amino-acid peptide isolated 
from yeast that binds specifically to F-actin (Riedl et al., 2008). Tyr-Cre:LifeAct-
GFP mice obtained by crossing Tyr-Cre mice that expresses Cre recombinase 
under the control of the Tyrosinase promoter to mice that express Lifeact-GFP 
on the HPRT locus allowed GFP expression in melanocyte lineage in vivo 
(Schachtner et al., 2012). E15.5 embryonic trunk skin was isolated and treated 
with the PI3-kinase inhibitor LY-294002 to induce cell death. Using live time-
lapse confocal imaging of embryonic skin explants, I assessed the apoptotic 
morphologies of GFP-expressing melanoblasts over a maximum period of 17 
hours. ROCK1wt melanoblasts showed evidence of blebbing and fragmentation 
into multiple small apoptotic bodies that went out of focus in a short span of 
time (Figure 3-8a). However, ROCK1nc melanoblasts also exhibited fragmentation 
but the apoptotic bodies generated remained attached to each other for long 
periods, suggesting that these cells lacked the forceful actomyosin contraction 
to form discrete apoptotic bodies (Figure 3-8a). These ex vivo observations 
correlated well with my in vitro observations. 
To confirm that ROCK1 activity did not have an effect on melanoblast death 
induced by the  PI3-kinase inhibitor, I checked for caspase 3/7 activity in 
immortalized melanocyte cells, kindly provided by Ang Li (Prof. Laura 
Machesky’s Lab), in the absence or presence of ROCK inhibitor Y-27632. Caspase 
activity was determined with Caspase Glo assay at 0, 4, 8 and 24 hours after 
treatment. The experiment was done in triplicate and repeated three times. 
There was no significant difference in caspase activity when ROCK was inhibited; 
suggesting that inhibition of ROCK activity did not affect melanoblast death 
(Figure 3-8b). 
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Figure 3-8 ROCK1 cleavage is required for apoptotic features in 3D ex vivo tissue 
a) Two panels of representative confocal time lapse images of GFP-expressing 
melanoblasts induced with apoptosis using LY-294002 in E15.5 embryonic skin mounts at 
indicated time points Arrows indicate the melanoblasts under observation. b) Bar graphs 
(mean ± SEM) shows no difference in caspase activity in immortalized melanocyte cells 
treated with LY-294002 in the absence or presence of ROCK inhibitor Y-27632. 
RLU=Relative Luminescence Units. Data analysed by Student’s t-test.  
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 ROCK1nc mice do not display a strong autoimmune 3.2.8
phenotype 
Given the compelling evidence of defective morphological features during 
apoptosis in ROCK1nc mice, we wondered whether this would lead to defective 
clearance of apoptotic cells eventually resulting in autoimmunity. As previously 
mentioned, ROCK1nc mice did not display any overt phenotype when compared 
to wild-type controls. I further examined these mice at the histological level for 
signs of autoimmunity. 
Glomerulonephritis is a chronic kidney condition frequently seen in autoimmune 
disease like Systemic Lupus Erythematosus (SLE) and has been linked with 
defective clearance of apoptotic cells (Botto et al., 1998). I examined H&E- 
stained liver sections for signs of glomerular hypercellularity but did not observe 
any apparent anomalies. Thickening of the glomerular basement membrane due 
to deposition of antibodies or immune complexes is a common feature in 
glomerulonephritis. Periodic acid-Schiff (PAS) stain that is used to highlight the 
basement membrane of glomerular capillaries did not reveal any obvious 
variations between ROCK1wt and ROCK1nc mice (Figure 3-9a). Transmission 
electron microscopy (TEM) of kidneys revealed indications of electron dense 
deposits in the basement membrane as well as loss of podocyte foot processes 
(podocyte effacement) in ROCK1nc mice (Figure 3-9b), although this was not 
confirmed in more samples. Symptoms of podocyte effacement include 
proteinuria or leakage of proteins into urine. However, both ROCK1wt and 
ROCK1nc mice exhibited only trace amounts of proteins (negative in some cases) 
in urine as detected by Protein Reagent Strips for Urinalysis. 
The spleen is responsible for the destruction of old and damaged erythrocytes. 
Splenic macrophages phagocytose erythrocytes and the iron from the 
haemoglobin is converted to hemosiderin for storage in spleen (Bennett and Kay, 
1981). Increased hemosiderin indicates high rate of erythrocyte removal, usually 
observed in autoimmune diseases like haemolytic anaemia (Suttie, 2006).Perls 
Prussian Blue stain was used to visualize hemosiderin. However, spleen sections 
from both wild-type and mutant mice showed hemosiderin deposition in the 
spleen, but with no difference (Figure 3-9c). Moreover, splenomegaly, a typical 
finding in an autoimmune phenotype was also not observed in ROCK1nc mice   
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Figure 3-9 ROCK1nc mice do not display a strong autoimmune phenotype 
a) Representative PAS-stained kidney sections from ROCK1wt and ROCK1nc mice 
showing no difference in basement membrane thickening (arrows). Scale bars represent 
100 µm. b) Representative transmission electron micrographs of kidneys showing electron 
dense deposits (arrows) in the basement membrane (BM) as well as abnormal foot 
processes (FP) in ROCK1nc mice. Scale bars represent 1 µm. c) Representative Perls 
Prussian Blue-stained spleen sections showing no difference in hemosiderin deposition 
between the two genotypes. Scale bars represent 500 µm.   
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 Haematological analysis of ROCK1nc mice 3.2.9
Blood collected from 10 week-old mice were sent to the Clinical Pathology lab at 
Veterinary School for complete haematology analysis (Figure 3-10). On review, 
ROCK1nc mice displayed significantly lower haematocrit (HCT) and mean 
corpuscular volume (MCV) when compared to wild-type. HCT is the amount of 
space occupied in the blood by RBCs, and the reduced size of the RBC (MCV) 
correlates well with reduced HCT.  However, it should be noted that the total 
haemoglobin level and the number of RBCs remained the same. Analysis of white 
blood cell (WBCs) revealed no major differences in WBC numbers between the 
two genotypes except for eosinophil numbers, which was significantly more in 
ROCK1nc mice. In addition to platelet (PLT) numbers, different platelet indices 
including mean platelet volume (MPV), plateletcrit (PCT) and platelet 
distribution width (PDW) were also analysed. Similar to RBC, size of platelets 
(MPV) and the percentage of whole blood occupied by platelets (PCT) were also 
significantly reduced in ROCK1nc mice, even though platelet numbers remained 
similar between the two genotypes. 
 Decreased cytokine levels in ROCK1nc mice 3.2.10
Cytokines are messengers produced mainly by the cells of the innate and 
adaptive immune system in response to a number of environmental stimuli 
including infection and tissue damage. The functions of cytokines are often 
redundant and vary depending on the immunological milieu as well as the 
presence or absence of other cytokines. To investigate whether defective 
cleavage of ROCK1 during apoptosis was affecting the immunological milieu, 
serum obtained from 10-week old mice were analysed for levels of 15 cytokines 
and chemokines using mouse Milliplex magnetic bead panel. This included 
cytokines like INF-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70, 
IL-17, TNFα and chemokines MCP-1, MIP-1α and MIG. All analytes measured 
except for MIG was reduced in ROCK1nc mice with IL-1β, IL-2, IL-4, IL-6, IL-10, 
IL-12p40, IL-12p70, IL-17 and TNFα reaching significance (Figure 3-11). 
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Figure 3-10 Haematological analysis of ROCK1nc mice 
Scatter dot-plots (Mean ±SEM)  for a) red blood cell count (RBC), b) haemoglobin (Hb), c) 
haematocrit (HCT), d)mean corpuscular volume (MCV), e) mean corpuscular 
haemoglobin (MCH), f) mean corpuscular haemoglobin concentration (MCHC), g) RBC 
distribution width (RDW), h) white blood cell count (WBC), i) neutrophils, j) lymphocytes, 
k) monocytes, l) eosinophils, m) platelet count (PLT), n) mean platelet volume (MPV), o) 
plateletcrit (PCT) and p) platelet distribution width (PDW) from ROCK1wt and ROCK1nc 
mice. Data analysed using Student’s t-test. *=p<0.05, **=p<0.01, ***=p<0.001, 
****=p<0.0001.  
  106 
 
 
 
Figure 3-11 Decreased cytokine levels in ROCK1nc mice 
Scatter dot-plots (mean ± SEM) showing serum levels of 15 different immune analytes 
from 10-week old ROCK1wt and ROCK1nc mice. Data analysed using Student’s t-test. 
*=p<0.05, **=p<0.01, ***=p<0.001.  
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3.3 Discussion 
Morphological features of apoptosis were described more than 40 years ago. Yet, 
the biological significance of these dramatic events still remains unclear. In this 
chapter, I have introduced a novel mouse model that was generated at the 
Beatson Institute that would enable us to understand the in vivo role of 
apoptotic membrane blebbing. The ROCK1nc model carries a knock-in mutation 
at the caspase cleavage site of ROCK1 which makes the protein resistant to 
activation during apoptosis. To confirm the role of caspase cleavage of ROCK1 in 
mediating the morphological features of apoptosis, MEFs and hepatocytes were 
isolated from wild-type and ROCK1nc mice and induced with apoptosis. 
Apoptotic morphological features as observed by time-lapse microscopy and 
scanning electron microscopy showed obvious defects in cells from ROCK1nc 
mice even though cell death as measured by caspase activity was not different 
between cells from the two genotypes. ROCK1nc cells lacked the forceful 
contraction due to inactivation of ROCK1 and hence displayed an inability to 
contract and bleb. In addition, by imaging death of GFP-expressing melanoblasts 
in ex vivo embryonic skin explants, we confirmed that the knock in mutation in 
ROCK1 inhibited the typical morphological features seen during apoptosis. 
In spite of the strong phenotype exhibited by apoptotic ROCK1nc cells both in 
vitro and ex vivo, ROCK1nc mice were viable and fertile. As discussed in 
Introduction, several GM mouse models have shown that accumulation of 
apoptotic debris can lead to the development of autoimmune-induced 
pathologies. There are some minor indications of mild autoimmune pathologies 
in ROCK1nc mice, including reduced haematocrit, mean RBC volume and RBC 
distribution width that are consistent with a form of autoimmune anaemia. 
However, histologically ROCK1nc mice did not show an increased hemosiderin 
deposition in the spleen, which is a typical finding of haemolytic anaemia. There 
were slight perturbations in the kidney, suggestive of an autoimmune pathology, 
for example, the presence of dense electron deposits in the basement 
membrane as evidenced by TEM. Despite the absence of a strong autoimmune 
phenotype, an interesting finding was the significantly decreased cytokine levels 
in ROCK1nc mice. In the upcoming chapters, I will address the role of apoptotic 
morphological features in tissue homeostasis and tumour development. 
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Results 
Caspase Cleavage of ROCK1 in Tissue Homeostasis  
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4 Apoptotic blebbing is required for the 
maintenance of tissue homeostasis during acute 
damage in the liver 
4.1 Introduction 
 Role of ROCK1 dependant apoptotic blebbing in the liver 4.1.1
Apoptosis is a well-choreographed physiological process of cell death that is 
essential for the elimination of superfluous and damaged cells. Dying cells 
undergo several biochemical and morphological alterations during the execution 
phase of apoptosis that aid in the efficient recognition and prompt clearance of 
cell debris (Julian and Olson, 2015). This is believed to prevent the release of 
potentially noxious intracellular contents into the surrounding milieu. Hence, 
the rapid clearance of apoptotic debris is well suited to a role in the 
maintenance of tissue homeostasis. 
This liver is a crucial organ for detoxification of chemicals and metabolizing 
drugs, and is constantly exposed to microbes and toxic substances, thus making 
it susceptible to cell death. N-nitrosodiethylamine, also known as 
diethylnitrosamine (DEN), is a genotoxic carcinogen that is bioactivated in the 
liver by cytochrome P450 enzymes leading to the formation of DNA adducts by 
ethylation (Williams et al., 1996). DEN treatment also results in the depletion of 
nicotinamide adenine dinucleotide in hepatocytes leading to a blockade in 
oxidative phosphorylation, thereby driving the cells to a hypoxic state (Rawling 
et al., 1993). 
The role of ROCK1 in the execution phase of apoptosis was previously established 
using pharmacological inhibitors such as Y-27632 and/or RNAi approaches that 
alter ROCK1 expression. Although these data implicate ROCK1 activity as being 
important, they did not prove that ROCK1 activation by caspase cleavage is the 
critical mechanism. Using our ROCK1nc mouse model, I sought to determine the 
in vivo physiological function of caspase cleavage of ROCK1 during acute damage 
in the liver by using DEN as a damage-inducing agent. I hypothesized that 
defects in apoptotic membrane blebbing as a consequence of non-cleavage of 
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ROCK1 during apoptosis would result in inefficient apoptotic cell clearance thus 
affecting homeostasis in the liver. 
 Experimental Aims 4.1.2
The objective of this study was to examine the biological significance of 
apoptotic blebbing in the maintenance of homeostasis in the liver by using the 
caspase cleavage resistant ROCK1 (ROCK1nc) mouse model. To achieve this, I 
investigated the following. 
a) Do ROCK1nc mice show a defect in prompt apoptotic cell clearance? 
b) Does defective apoptotic blebbing affect the immunological milieu in the 
liver? 
c) Is ROCK1-dependant apoptotic blebbing required to protect the liver and 
maintain homeostasis in response to acute damage?  
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4.2 Results 
 Liver histology and histopathology 4.2.1
Histologically, the liver is composed of a vast network of hepatocytes arranged 
in single- cell thick plates, separated by sinusoids that are lined by Kupffer cells 
(resident macrophages) and endothelial cells. There are two sources of blood 
supply to the liver, with the oxygenated arterial blood coming through the 
hepatic artery and the nutrient/metabolite rich blood from the gastrointestinal 
tract emerging through the hepatic portal vein. These two blood vessels, along 
with the bile duct and lymphatic vessels form the portal tract or portal triad 
(Figure 4-1a). Blood traverses through the hepatic sinusoids and ultimately drains 
through the central vein (CV) (Figure 4-1a). For the purpose of histopathological 
evaluation, the liver acinus is divided into three regions. The area located close 
to the portal tract is known as periportal region (zone 1) and is the first to be 
supplied with oxygen and nutrients. The region most distant from the portal 
triad and close to the central vein is the perivenular or centrilobular region 
(zone 3). The region between zone 1 and 3 is called intermediate or mid zonal 
region (zone 2) (Figure 4-1a). 
Hepatotoxic drugs produce various histopathological lesions, most of which can 
be identified from H&E sections. Some of them relevant to this project will be 
discussed here. An inflammatory reaction, which involves the accumulation of 
immune cells, is often seen in drug-induced liver damage. If the inflammatory 
foci are in close proximity to the vessels, they are named after the zone in 
which they accumulate, for example centrilobular or periportal inflammation 
(Figure 4-1c). If the inflammatory foci appear in the liver parenchyma, they are 
commonly referred to as lobular inflammation. Steatosis or accumulation of fat 
in the hepatocytes is also often seen in drug-induced liver injuries. By 
convention, any quantity of lipid that occupies more than 5% of the liver mass 
may be considered ‘pathological’. Macrovesicular steatosis involves the 
accumulation of large lipid droplets within hepatocytes causing the nucleus to 
be displaced peripherally (Figure 4-1b). In contrast, microvesicular steatosis 
involves smaller lipid droplets giving the hepatocyte a foamy appearance (Figure 
4-1b). If steatosis is companied by inflammation, necrosis and hepatocyte injury 
including hepatocyte ballooning, then it is termed steatohepatitis.  
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Figure 4-1 Histology and histopathology of liver 
Representative H&E stained liver sections showing a) different zones of the liver, b and c) 
different types of liver lesions. Scale bars represent 100 µm. CV= Central vein.   
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 Optimal dosage of liver damaging agent DEN 4.2.2
Firstly, to determine the optimal concentration of DEN required for studying the 
effects of defective apoptotic blebbing in liver, I tested two different doses, 50 
mg/kg (body weight) and 100mg/kg (body weight) in ROCK1wt and ROCK1nc 
mice. Single doses of DEN were administered by intraperitoneal injection and 
mice were monitored for lethargy and weight loss. Animals that were given 50 
mg/kg of DEN did not display overt clinical signs even after 6 days. Assessment 
of H&E stained liver sections from ROCK1wt and ROCK1nc mice did not reveal 
gross histological anomalies (Figure 4-2a). However, with 100 mg/kg, mice were 
lethargic and suffered weight loss by 72 hours. Analysis of H&E stained sections 
revealed that DEN triggered more hepatocellular damage, inflammation and 
both micro and macrovesicular steatosis in ROCK1nc livers (Figure 4-2b). This 
provided preliminary evidence that defective apoptotic blebbing in ROCK1nc 
mice caused more tissue damage and that a higher dose of damage inducing 
agent was required to delineate the role of apoptotic blebbing in the liver. 
Next, to investigate the consequences of defective apoptotic blebbing in 
apoptotic cell clearance, I decided to perform a time-course experiment to see 
if ROCK1nc mice were exhibiting a delay in apoptotic cell clearance. With the 
surety from pilot experiments, 100 mg/kg was finalized as the dose of DEN to be 
used for the time-course experiment on ROCK1wt and ROCK1nc mice. 10-week 
old mice were intraperitoneally injected with DEN. Blood (via cardiac puncture) 
and livers were collected at 24, 48, 72 and 96 hours after DEN treatment. 
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Figure 4-2 Optimal dosage of DEN 
Representative H&E stained ROCK1wt and ROCK1nc liver sections with single 
intraperitoneal injection of a) 50 mg/kg of DEN and collected after 6 days showing no 
overt histopathological lesions and b) 100 mg/kg of DEN and collected after 3 days 
showing more inflammation, steatosis and hepatocellular damage in ROCK1nc liver. 
Scale bars represent 100 µm.  
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 Defective blebbing in ROCK1nc mice results in increased 4.2.3
accumulation of apoptotic debris 
To investigate accumulation of apoptotic debris in the livers of ROCK1wt and 
ROCK1nc mice, I utilized the TUNEL assay to detect apoptotic cells. The terminal 
deoxynucleotidyl transferase-mediated dUTP Nick-End Labelling (TUNEL) assay 
exploits a biochemical feature of apoptosis, namely DNA fragmentation, and 
relies on the ability of the enzyme terminal deoxynucleotidyl transferase to 
incorporate labelled dUTP (deoxyuridine triphosphate) into free 3’-hydroxy 
termini of fragmented DNA. TUNEL staining was performed on paraffin 
embedded liver sections and the nuclei were counterstained with DAPI. An 
apoptotic index was calculated as the percentage of TUNEL-positive cells 
relative to the total number of DAPI-positive cells. 
Analysis of TUNEL staining revealed that in untreated control mice, there were 
few apoptotic cells (Figure 4-3a, f). By 24 hours after the DEN administration, 
there was a marked increase in apoptotic debris in both genotypes when 
compared to untreated mice (Figure 4-3b, f). The amount of cellular debris 
continued to increase 48 hours after DEN administration in ROCK1wt and 
ROCK1nc livers (Figure 4-3c, f). 
However, by 72 hours, there was a decrease in the apoptotic index in ROCK1wt 
mice (Figure 4-3f). Yet, in ROCK1nc livers, apoptotic debris continued to 
accumulate, with a significant increase when compared to ROCK1wt mice at 72 
hours (Figure 4-3d, f). This suggested a delay in the clearance of apoptotic 
remnants in the ROCK1nc mice. At 96 hours, the livers from both genotypes 
showed a reduction in the apoptotic index suggesting clearance of apoptotic 
debris by that time (Figure 4-3e, f).  
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Figure 4-3 Accumulation of apoptotic debris in ROCK1nc livers 
a-e) Representative images of immunofluorescence analysis of liver sections showing TUNEL-
positive apoptotic debris (green), and counterstained with DAPI (blue). Scale bars represent 100 
µm.  f) Bar graph represents percentage apoptotic index analysed using TUNEL assay (n=3-11 per 
group). Data analysed by Student’s t-test. Error bars represents SEM. **= p<0.01.  
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 Defective blebbing in ROCK1nc mice aggravated 4.2.4
hepatocellular damage 
Mice were euthanized at different time points after a single dose of DEN and 
livers were subjected to histopathological analysis using H&E stained slides in 
order to assess the hepatocellular damage caused by blebbing defects. To 
quantify the necrotic area, ten random fields from H&E stained liver sections 
were assessed for each liver. 
At 24 hours, both ROCK1wt and ROCK1nc livers exhibit hepatocyte ballooning 
and mild microvesicular steatosis around the centrilobular region (Figure 4-4a). 
One ROCK1wt liver also exhibited mild macrovesicular steatosis near the 
periportal region along with microvesicular steatosis. Occasional apoptotic and 
necrotic cells were seen in the liver parenchyma of both genotypes, sometimes 
associated with lobular inflammation. 
 By 48 hours, there was evidence of necrosis and inflammation in the 
centrilobular region in both genotypes (Figure 4-4b). The necrotic area and 
associated inflammatory foci was greater in the ROCK1nc livers when compared 
to the wild-type (Figure 4-4e). There was also evidence of mild microvesicular 
steatosis in many of the ROCK1nc liver sections after 48 hours of DEN treatment. 
72 hours after DEN treatment, the liver sections showed marked 
histopathological differences between the two genotypes. ROCK1nc livers 
exhibited significantly more centrilobular necrotic area associated with 
inflammation when compared to wild-type livers (Figure 4-4e). The ROCK1nc 
livers also displayed hepatocellular ballooning, micro and macrovesicular 
steatosis at the centrilobular zone (Figure 4-4c). 
By 96 hours, livers from both genotypes exhibited a lesser extent of damage-
associated lesions (Figure 4-4d). There was a drop in the necrotic area 
associated with inflammatory foci when compared to livers from 72 hours. 
However, the ROCK1nc livers continued to display significantly more necrotic 
area when compared to the wild-type livers (Figure 4-4e).  
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Figure 4-4 Increased hepatocellular damage in ROCK1nc livers 
a-d) Representative H&E stained liver sections. Scale bars represent 100 µm. e) Bar graph 
represents percentage necrotic area with inflammation analysed using H&E staining (n=3-11 per 
group). Data analysed by Student’s t-test. Error bars represent SEM. *=p<0.05.  
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 Accumulation of apoptotic debris is associated with 4.2.5
neutrophil recruitment in ROCK1nc livers 
Neutrophils are an essential component in the defence against microbes or any 
other agent that elicits tissue damage. To combat infection, neutrophils can 
perform phagocytosis, form neutrophil extracellular traps, produce toxic 
metabolites and release proteolytic enzymes (Kruger et al., 2015). Infiltration of 
neutrophils in the liver is an acute response to on-going damage accompanied by 
inflammatory signals. I therefore examined the accumulation of neutrophils in 
the DEN-treated livers from both wild-type and ROCK1nc livers by 
immunohistochemistry and quantified the number of neutrophils per mm2 by 
analysing five random fields for each liver section. 
In untreated age-matched control livers, neutrophils constitute a very small 
percentage of non-parenchymal cells in both genotypes (Figure 4-5a). The 
number of neutrophils remained relatively constant 24 hours after DEN 
treatment (Figure 4-5b). By 48 hours, there was a slight increase in neutrophil 
numbers in both genotypes, with ROCK1nc livers exhibiting more; albeit not 
significant numbers when compared to the wild-type livers (Figure 4-5c, f). This 
observation coincided with the histopathological finding of larger area of 
inflammatory foci in the ROCK1nc liver (Figure 4-4e). 
By 72 hours, as supported by the significant increase in apoptotic debris and 
significantly larger inflammatory foci in the ROCK1nc mice, there was a drastic 
increase in the number of neutrophils in their livers (Figure 4-5d, f). 96 hours 
after DEN treatment, neutrophil numbers in both genotypes had returned to 
steady state levels, which again coincided with the drop in accumulated debris 
and the histopathological evidence at this time point (Figure 4-5e, f).  
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Figure 4-5 Increased recruitment of neutrophils to ROCK1nc livers 
a-e) Representative S100A9 stained liver sections showing neutrophils (brown) and counterstained 
with haematoxylin. Scale bars represent 100 µm. f) Bar graph represents number of 
neutrophils/mm2 (n=3-11 per group). Data analysed by Student’s t-test. Error bars represent SEM. 
*=p<0.05.  
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 Accumulation of apoptotic debris increases the number of 4.2.6
macrophages in ROCK1nc livers 
Owing to its unique function of filtering blood-borne pathogens from the 
digestive tract and also detoxifying and metabolizing drugs, the liver has its own 
resident macrophages, known as Kupffer cells. Indeed, the liver harbours the 
most abundant pool of resident macrophages in the body (Ishibashi et al., 2009). 
Due to their potent phagocytic activity, macrophages play central roles in the 
clearance of pathogens and cellular debris. They are also responsible for the 
maintenance of immunological tolerance in the surrounding milieu, thus 
balancing the incessant toxic insults. In order to examine whether defective 
blebbing was altering the number of macrophages in the liver, I quantified the 
number of F4/80-positive macrophages per mm2 by analysing five random fields 
for each liver section. 
As expected, liver sections from untreated steady state animals displayed high 
numbers of macrophages in both genotypes (Figure 4-6a, f). These numbers 
remained the same even 24 hours after DEN treatment (Figure 4-6b, f). After 48 
hours, compared to the 24-hour time point, there was a minor dip in the number 
of macrophages in both livers, albeit more in ROCK1nc livers (Figure 4-6c, f). 
The increased number of macrophages in the ROCK1nc livers became 
significantly higher by 72 hours after DEN treatment (Figure 4-6d, f). By 96 
hours, there was no significant difference in the number of macrophages 
between the two genotypes (Figure 4-6e, f). However, when compared to the 72 
hour time point, the number of macrophages showed a moderate increase and 
approached steady-state levels in the ROCK1wt livers, but there was an abrupt 
decline in macrophage numbers in the ROCK1nc livers (Figure 4-6f).  
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Figure 4-6 Accumulation of macrophages in ROCK1nc livers by 72 hours 
a-e) Representative F4/80 stained liver sections showing macrophages (brown) and counterstained 
with haematoxylin. Scale bars represent 100 µm. f) Graph represents number of 
macrophages/mm2 (n=3-11 per group). Data analysed by Student’s t-test. Error bars represent 
SEM. **=p<0.01.  
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 Increased hepatocellular damage in ROCK1nc mice elevates 4.2.7
serum levels of alanine aminotransferase and bilirubin 
Apart from its obvious role in detoxification and filtering blood borne pathogens, 
the liver produces enzymes that are required to perform various functions. 
Alterations in the levels of liver enzymes in the serum are considered as a good 
indicator of hepatocellular damage. In order to determine whether increased 
hepatocellular damage, as demonstrated by histopathological studies, was 
reflected in the serum levels of liver enzymes, I collected serum from untreated 
and DEN-treated animals. Alanine aminotransferase (ALT) is a standard clinical 
biomarker of hepatotoxicity (Au et al., 2011) and analysis revealed very low 
levels in untreated mice (Figure 4-7b). The levels remained low even after 24 
hours after DEN treatment. By 48 hours, there was a sharp increase in the levels 
of ALT in both genotypes, with the ROCK1nc mice exhibiting higher levels when 
compared to the wild-type (Figure 4-7b). 72 hours after DEN administration, 
there was a decline in serum ALT levels in the ROCK1wt that coincided with the 
clearance of apoptotic debris in these mice. ALT levels in ROCK1nc mice 
remained high after 72 hours, and it was significantly more than their wild-type 
counterparts (Figure 4-7b). The high serum ALT values were in accordance with 
the accumulation of apoptotic debris and the increased hepatocellular damage 
in the ROCK1nc mice (Figure 4-7a). By 96 hours, the level of ALT in serum 
dropped sharply in ROCK1nc mice and reached similar levels to the wild-type 
mice (Figure 4-7b). This observation reflected the histopathological analysis at 
this time point. 
The level of bilirubin was also significantly higher in the ROCK1nc mice by 72 
hours (Figure 4-7c) (Au et al., 2011), which in conjunction with elevated ALT 
levels provided a clear indication of hepatotoxicity. Other clinical parameters 
analysed in the serum include levels of alkaline phosphatase, which surprisingly 
decreased significantly in the ROCK1nc mice at 72 hours (Figure 4-8a). The liver 
is also responsible for the production of serum proteins like albumin and 
globulin. ROCK1nc mice displayed a significant increase in the level of globulin 
at 72 hours, which can also be a general response to inflammation (Figure 4-8d). 
Although not significant, there was a decrease in the albumin to globulin ratio, 
which is also an indicator of hepatocellular injury (Figure 4-8e).  
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Figure 4-7 Elevated levels of serum ALT and bilirubin in ROCK1nc mice 
a) Representative H&E stained liver sections after 72 hours of DEN treatment showing increased 
centrilobular inflammation and hepatocellular damage in ROCK1nc liver. Scale bars represent 100 
µm. b) and c) Serum collected from untreated and DEN treated ROCK1wt and ROCK1nc mice at 
indicated time points and assayed for ALT and total bilirubin, respectively (n=6-11 per group). Data 
analysed by Student’s t-test. Error bars represent SEM. *=p<0.05.  
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Figure 4-8 Additional parameters of liver function 
Serum collected from untreated and DEN treated ROCK1wt and ROCK1nc mice at 
indicated time points and assayed for a) alkaline phosphatase, b) total protein, c) albumin, 
d) globulin and e) albumin to globulin ratio (n=6-11 per group). Data analysed by 
Student’s t-test. Error bars represent SEM. *=p<0.05.   
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 Defective blebbing increases the levels of serum cytokines 4.2.8
in ROCK1nc mice at 72 hours 
Cytokines are messengers produced by cells that regulate various inflammatory 
responses in the body. Levels of serum cytokines have been used as biomarkers 
for many liver diseases including alcoholic steatohepatitis and cirrhosis (Tilg et 
al., 1992). A high level of serum cytokines was an indicator of poor prognosis 
(Felver et al., 1990). Owing to the fact that defective blebbing had a significant 
impact on the clearance of cellular debris resulting in hepatocellular damage 
and necrotic inflammation at 72 hours, I wanted to investigate whether this had 
an influence on the levels of serum cytokines. For this, serum was collected 
from ROCK1wt and ROCK1nc mice 72 hours after DEN treatment and from the 
untreated control mice. Concentrations of 15 cytokines in sera were determined 
using a mouse 15-plex assay (INF-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5 IL-6, IL-10, 
IL12p40, IL12p70, IL-17, MCP-1, MIP-1α, MIG and TNFα). The values from the DEN 
treated samples were normalized to the respective control group. 
The levels of all 15 cytokines analysed was increased in DEN- treated ROCK1nc 
mice after 72 hours when compared to the wild-type. This correlated well with 
previous findings demonstrating a positive correlation between the level of 
serum cytokines and hepatic inflammation (Neuman et al., 2002, Neuman et al., 
2007). Of these, IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL12p40, MCP-1 and TNFα 
were significantly higher in the treated ROCK1nc mice and increase in IFN-γ 
levels almost reached significance (p=0.0506). 
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Figure 4-9 Increased levels of serum cytokines by 72 hours  
Serum levels of 15 different immune analytes relative to their respective control group collected 
from wild-type and ROCK1nc mice 72 hours after DEN injection (n=5 per genotype). * = p<0.05; * p 
= 0.0506 (Student’s t-test).  
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4.3 Discussion 
 ROCK1-mediated membrane blebbing is required for swift 4.3.1
clearance of apoptotic debris 
The liver performs a wide range of fundamental physiological functions and also 
plays a vital role as a metabolic organ to detoxify drugs and other harmful 
substances in the blood. Its role in detoxification and drug metabolism owes to 
the expression of metabolic enzymes and to its unique vascular supply that 
brings in blood from the gastrointestinal tract. This also makes it quite 
susceptible to drug-induced hepatocellular damage. Young mice of around 10 
weeks old were administered a high dose of DEN and their livers were examined 
at different time points for the accumulation of apoptotic debris by TUNEL 
assay. Wild-type mice showed an increase in the accumulation of cellular debris 
from 24 to 48 hours. By 72 hours, there was a dramatic decrease in debris in 
wild-type mice, which continued to decrease by 96 hours. However, in ROCK1nc 
mice, although the increase in debris was similar to the wild-type mice at 24 and 
48 hours, debris continued to accumulate even 72 hours after DEN treatment. 
The debris was cleared only by 96 hours in the ROCK1nc mice, where the debris 
levels dropped to the same level as the wild-type mice. This clearly suggested a 
delay in the clearance of apoptotic debris in ROCK1nc mice. Hence, during 
apoptosis, caspase-cleavage mediated ROCK1 induced membrane blebbing is 
essential for the prompt removal of apoptotic debris. An alternative or 
additional factor that could contribute to the pattern of increased apoptotic 
debris in ROCK1nc mice is that inflammatory response, such as neutrophil 
recruitment, might feed-forward to further increase the levels of cell death 
induced by DEN treatment. 
 Increased number of immune sentinels at the site of debris 4.3.2
accumulation 
Neutrophils are generally the first cell type to arrive at sites of inflammation. 
Infiltration of neutrophils is a hallmark of the innate immune response and forms 
the first line of defence during infection and injury. In response to chemotactic 
factors released at inflammatory sites, neutrophils migrate from the blood 
stream to the target site (Butcher, 1991). During steady-state, neutrophils 
constitute a very small percentage of non-parenchymal cells in the liver. Unlike 
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during bacterial infection in the liver, when the neutrophil numbers increase by 
almost 10 to 20-fold within two hours (Gregory et al., 1996), neutrophil numbers 
remained almost similar to steady state levels even 24 hours after DEN 
administration. Accumulating apoptotic debris in the wild-type and ROCK1nc 
mice by 48 hours onwards correlated with an increase in the number of 
neutrophils infiltrating the livers. In response to the significant increase in 
apoptotic debris in ROCK1nc mice at 72 hours, there were significantly more 
neutrophils as well. By 96 hours, neutrophil numbers returned to basal levels in 
both genotypes, which again correlated well with the decreased cellular debris 
at this time point. 
Owing to its inherent role in encountering pathogens and environmental toxins 
from the gut, the liver is endowed with its own resident macrophage population, 
known as Kupffer cells. These cells represent almost 35% of the non-
parenchymal liver cells in normal adult mice (Gregory and Wing, 1990). These 
phagocytes line the liver sinusoids and play an important role in the homeostasis 
of the liver. Whether circulating monocytes contribute to the Kupffer cell pool 
or whether the Kupffer cells self-renew during adult life has been a topic of 
debate over many years (Zimmermann et al., 2012). However, recent studies 
have highlighted that during liver injury, the resident macrophage population is 
in fact expanded by circulating monocytes (Holt et al., 2008, Karlmark et al., 
2009, Zimmermann et al., 2010). 
In steady-state conditions, there were large numbers of resident macrophages in 
both wild-type and ROCK1nc mice. The number of macrophages remained similar 
even 24 hours after DEN treatment. However, by 48 hours, there was slight 
decrease in the macrophage numbers in both genotypes, the reason for which is 
not known. A previous study had also shown a similar decrease in F4/80- positive 
macrophages after paracetamol-induced liver injury (Dambach et al., 2002). 
However, a recent study aimed at characterizing macrophages in paracetamol-
induced liver injury identified two populations in the liver, the resident Kupffer 
cells (CD11b-low, F4/80-high) and infiltrating monocytes (CD11b-high; F4/80-
low) (Holt et al., 2008). They identified an increase in circulating monocytes 
accompanied by a decrease in the resident macrophage population at 24 and 48 
hours after paracetamol challenge (Holt et al., 2008). This could be a possible 
explanation for the decrease in macrophage numbers seen in my experiment 
  130 
 
since I had employed immunohistochemical identification of macrophages using 
the F4/80 monoclonal antibody, which presumably failed to detect the 
increasing number circulating monocytes at 48 hours. By 72 hours, with 
accumulating apoptotic debris, there was a significant increase in the number of 
macrophages in the ROCK1nc livers when compared to the wild-type livers. 
However, it is highly likely that in this study, the macrophage numbers at 48, 72 
and 96-hour time points are under-represented because of the aforementioned 
limitation in immunohistochemical detection. 
 Delayed clearance of cellular debris causes increased 4.3.3
hepatocellular damage 
Combining histological analysis of liver sections and clinical liver function tests is 
often employed for the assessment of drug-induced liver injury. Depending on 
the drug used, the liver can exhibit a plethora of histological injury patterns 
including steatosis, necrosis with or without inflammation, cholestasis, 
hepatocellular ballooning and vascular abnormalities (Ramachandran and Kakar, 
2009). In this experiment, histomorphological features of DEN-induced liver 
damage included steatosis, hepatocyte ballooning and centrilobular necrosis 
with inflammation. At 72 hours, parallel to the delayed clearance and 
significantly higher numbers of inflammatory cells, ROCK1nc livers also revealed 
increased centrilobular necrosis, steatosis and hepatocyte ballooning. By 
definition, steatosis when accompanied by inflammation and hepatocellular 
injury is termed as steatohepatitis. 
The higher degree of steatohepatitis seen in ROCK1nc livers at 72 hours was also 
echoed in the liver function tests. The elevation of alanine aminotransferase 
(ALT) in the serum is an excellent marker for hepatocellular injury and liver 
damage (Au et al., 2011). Serum collected from ROCK1nc mice showed 
significantly high levels of ALT when compared to wild-type at 72 hours. Total 
bilirubin was also significantly higher in the ROCK1nc serum at the same time 
point. Elevated levels of bilirubin can indicate cholestasis or impaired bile flow. 
Yet, upon histological analysis, I did not see any indication of this pathology in 
any of the liver sections. This was not surprising since increased bilirubin with 
minimal or no increase in ALT can indicate cholestasis. An elevated bilirubin 
level along with increased ALT levels is a good marker for liver damage (Au et 
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al., 2011). At 72 hours, serum from ROCK1nc mice also showed a significant 
increase in the level of globulin proteins, which can also be a general response 
to inflammation. Although not significant, albumin to globulin ratio in ROCK1nc 
serum was decreased, which is an additional indicator of hepatocellular injury. 
Hepatocellular damage seen in the centrilobular zone of ROCK1nc liver sections 
can be attributed to the presence of increased numbers of immune cells in 
addition to the presence of accumulating apoptotic debris. Despite its role as a 
defence mechanism against infection and injury, infiltrating neutrophils have a 
dark side in that they can cause tissue damage in the liver. In fact, neutrophils 
exacerbating tissue injury has been reported in a number of liver-damage 
models (Gujral et al., 2003, Liu et al., 2006). After accumulating in the hepatic 
sinusoids, neutrophils extravasate into the liver parenchyma in response to 
signals released by dying or distressed hepatocytes (Jaeschke and Hasegawa, 
2006). Once in the liver parenchyma, neutrophils make contact with the 
hepatocytes through integrins and subsequently release reactive oxygen 
intermediates and serine proteases which contribute to hepatocellular damage 
(Jaeschke and Hasegawa, 2006). 
Similarly, liver-resident macrophages also can have damaging effects in the 
liver.  Despite their well-known role in the maintenance of homeostasis in the 
liver, several studies have implicated Kupffer cells in the pathogenesis of drug –
induced liver damage (Michael et al., 1999, Ito et al., 2003). The strategic 
position in the liver sinusoidal space enables them to easily traverse this barrier 
and directly interact with hepatocytes. Activated Kupffer cells release a number 
of cytokines and other mediators including reactive oxygen species and 
proteases that aggravate acute injury in the liver (Roberts et al., 2007). Thus it 
is possible that along with the detrimental effects of uncleared apoptotic debris, 
the resident and recruited immune cells may contribute to exacerbating the 
damage in the liver. 
 Increased hepatocellular damage owing to clearance 4.3.4
defects increases the level of serum cytokines 
Cytokines are messengers produced mainly by the cells of the innate and 
adaptive immune system in response to a number of environmental stimuli 
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including infection and tissue damage. The functions of cytokines are often 
redundant and vary depending on the immunological milieu as well as the 
presence or absence of other cytokines. Levels of serum cytokines have been 
used as biomarkers for the pathogenesis of many chronic liver diseases (Tilg et 
al., 1992). The levels of serum cytokines correlate with the degree of hepatic 
inflammation and fibrosis (Neuman et al., 2007). 
As expected, serum levels of 15 cytokines were high in the mice treated with 
DEN after 72 hours when compared to the wild-type. Of these, IL-1α, IL-1β, IL-2, 
IL-4, IL-6, IL-10, IL12p40, MCP-1 and TNFα were significantly higher in the 
treated ROCK1nc mice and the increase in IFN-γ levels almost reached 
significance. The high level of serum cytokines in ROCK1nc mice is a good 
biomarker for the on-going hepatocellular damage upon DEN administration. The 
accumulating immune cells in the ROCK1nc livers are the conceivable source of 
these cytokines in the serum. Elevated levels of cytokines including TNFα, 
primarily released by Kupffer cells, have been implicated in aggravating drug-
induced liver damage (Roberts et al., 2007). Cytokines including IL-1 and IL-6 
produced by Kupffer cells can mediate neutrophil accumulation in the hepatic 
microvasculature (Ramaiah and Jaeschke, 2007). Monocyte chemoattractant 
protein 1 (MCP-1), produced by hepatic stellate cells, hepatocytes and 
macrophages, is responsible for the recruitment of pro-inflammatory monocytes 
to the liver thus counteracting resolution of inflammation (Baeck et al., 2014). 
Interestingly, anti-inflammatory cytokines like IL-10 are also elevated in the 
serum of ROCK1nc mice. IL-10 is produced by Kupffer cells and normally has a 
protective role by inducing tolerance in drug-induced liver damage (Erhardt et 
al., 2007). It could be possible that increased numbers of macrophages in the 
ROCK1nc liver by 72 hours are attempting to restore tolerance by the release of 
cytokines involved in resolution. 
4.4 Summary 
Apoptotic membrane blebbing by caspase cleavage of ROCK1 is essential for the 
maintenance of liver homeostasis. Defective blebbing causes tissue damage 
possibly by the release of toxic intracellular contents from the uncleared 
apoptotic debris. The assembly of immune cells at the site of damage can 
aggravate the damage and ultimately cause a breakdown in tissue homeostasis. 
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5 Damaging effects of defective blebbing is 
mediated by HMGB1 
5.1 Introduction 
 Secondary necrotic cells release DAMPs to signal the 5.1.1
immune system 
The robust nature of apoptotic clearance mechanisms is illustrated in the 
difficulty to detect apoptotic cells even in tissues with high turnover. If 
apoptotic cells are not removed efficiently, they proceed to a necrotic stage, 
which was termed as ‘secondary necrosis’ (Wyllie et al., 1980). Secondary 
necrotic cells release their cytotoxic intracellular contents, thus instigating 
inflammation (Gaipl et al., 2004). Accumulation of apoptotic cell remnants due 
to inefficient clearance affects tissue homeostasis and contributes to the 
establishment and progression of a number of pathologies including 
autoimmunity, respiratory and neurological diseases (Elliott and Ravichandran, 
2010). Release of danger signals from necrotic cells is considered as a major 
distinction from apoptotic cells. These endogenous danger signals, known as 
damage-associated molecular patterns (DAMPs) are molecules released by 
stressed or necrotic cells. They have the ability to promote and exacerbate 
immune responses. An ever growing list of DAMPs have been identified over the 
years including HMGB1, S100 proteins, heat shock proteins and IL-1α (Kang et 
al., 2015). Of these, one of the most extensively characterized DAMP is high-
mobility group box protein 1 (HMGB1). 
 High-Mobility Group Box 1 (HMGB1) 5.1.2
HMGB1 is a small protein of 215 amino acid residues. The protein structure is 
composed of three distinct domains: two consecutive positively charged L-
shaped basic domains (called HMG boxes A and B) of approximately 80 amino 
acids and a negatively charged 30 amino acid-long acidic tail at the C-terminal, 
connected by short flexible linkers. HMGB1 also has two close relatives, HMGB2 
and HMGB3, with 80% amino acid identity amongst the three proteins. HMGB1 is 
a non-histone DNA binding protein that binds to the minor groove of double-
stranded DNA without sequence specificity (Bianchi et al., 1989). It facilitates 
the assembly of nucleoprotein complexes and also regulates gene transcription, 
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replication and repair (Bianchi and Agresti, 2005). Its physiological importance 
was highlighted in studies in which HMGB1 knockout mice died within 24 hours 
due to hypoglycaemia (Calogero et al., 1999). 
Apart from its structural role in the nucleus, HMGB1 can also function as a 
cytokine. Secretion of HMGB1 to the extracellular milieu occurs either actively 
by immune cells or passively from damaged or necrotic cells (Lotze and Tracey, 
2005). Secretion of HMGB1 requires the shuttling of the protein from the nucleus 
into the cytoplasm. Post–translational modifications including methylation, 
acetylation and phosphorylation, results in the translocation of HMGB1 to the 
cytosol, where it is packaged into specialized secretory lysosomes and finally 
released into extracellular space via fusion of these lysosomes to the plasma 
membrane (Sims et al., 2010). HMGB1 is secreted by macrophages, monocytes, 
dendritic cells and natural killer cells, in response to activation by pro-
inflammatory stimuli such as LPS, IL-1β, interferon (IFN)-γ, or TNFα (Lotze and 
Tracey, 2005). Once secreted, HMGB1 can act as a cytokine by triggering the 
release of additional cytokines from monocytes and neutrophils. On the other 
hand, HMGB1 passively released from the nucleus due to loss of membrane 
integrity is a signal of necrotic cell death. Although early investigators concluded 
that apoptotic cells do not significantly secrete HMGB1, since apoptotic cells 
modify the chromatin so that HMGB1 binds irreversibly (Scaffidi et al., 2002), 
these findings were subsequently re-evaluated (Bell et al., 2006). Further 
studies showed that cells undergoing apoptosis do release considerable amounts 
of HMGB1 but induces a tolerogenic response instead of an inflammatory one 
(Kazama et al., 2008). 
The role of HMGB1 as a potent pro-inflammatory cytokine was underpinned by 
an early study that showed it could mediate endotoxin lethality in mice (Wang et 
al., 1999). Whether HMGB1 can promote pro-inflammatory activity directly, or 
indirectly by attracting inflammatory cells, has been a topic of debate. Once 
secreted, HMGB1 induces inflammatory responses through many binding 
receptors including receptor for advanced glycation end products (RAGE), and 
toll-like receptors TLR4 and TLR2. When HMGB1 binds to these receptors, it 
results in NF-kB activation, which would eventually promote the transcription of 
pro-inflammatory genes, such as IL-1β, IL-6, and TNFα (Sims et al., 2010). 
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 Glycyrrhizin- an inhibitor of HMGB1 5.1.3
Glycyrrhizin (GLZ) is a glycoconjugated triterpene produced by the liquorice 
plant, Glycyrrhiza glabra and is responsible for its sweet taste. This compound 
has been associated with different pharmacological effects, including anti-viral, 
anti-inflammatory, anti-tumour and hepato-protective functions (Asl and 
Hosseinzadeh, 2008). Moreover, it is extensively used in Japan to treat patients 
with chronic hepatitis (Arase et al., 1997). GLZ can bind directly to HMGB1 (Kd ~ 
150 µM), where it interacts with two shallow concave surfaces formed by the 
arms of both HMG boxes (Mollica et al., 2007). It was reported that upon binding 
to the specific pocket, GLZ inhibits the cytokine activities of HMGB1 by 
inhibiting its chemoattractant and mitogenic activities (Mollica et al., 2007, Sitia 
et al., 2007). Over the years, GLZ has been used to alleviate HMGB1-associated 
damage in a number of organs including the liver (Ogiku et al., 2011, Wang et 
al., 2013), heart (Zhai et al., 2012), pancreas (Xiang et al., 2014) and brain 
(Zhang et al., 2014). 
 Experimental Aims 5.1.4
The aim of this study is to examine whether blocking the cytokine activity of 
HMGB1 released by accumulating apoptotic debris, using Glycyrrhizin, can 
reduce the damaging effects of defective blebbing in ROCK1nc mice. To achieve 
this, I examined the following 
a) Does Glycyrrhizin treatment affect the accumulation of apoptotic debris 
caused by DEN? 
b) Does Glycyrrhizin treatment affect the immunological milieu in mice with 
defective blebbing? 
c) Would blocking the cytokine activity of HMGB1 reduce the damage caused 
by defective blebbing in ROCK1nc mice? 
  
  136 
 
5.2 Results 
 Increased cytoplasmic translocation of HMGB1 in DEN- 5.2.1
induced damage in ROCK1nc livers 
As discussed above, HMGB1 is a non-histone nuclear protein that plays an 
important role in the regulation of gene transcription. However, extracellular 
release of HMGB1 contributes to the pathogenesis of various inflammatory 
diseases as it has the potential to function as damage associated molecular 
pattern protein (Bianchi, 2007). 
72 hours after DEN treatment, livers from ROCK1nc mice exhibited significantly 
more centrilobular necrosis, and infiltration of immune cells when compared to 
ROCK1wt livers. To determine the cellular localization of HMGB1 in livers from 
DEN- treated ROCK1wt and ROCK1nc mice, immunohistochemical staining was 
performed on paraffin sections. Following immunostaining with HMGB1, it was 
evident that the subcellular localization of HMGB1 in hepatocytes was different 
between the two genotypes (Figure 5-1a). ROCK1wt livers exhibited 
predominantly nuclear localization of HMGB1, with some cells showing the 
presence of HMGB1 in the cytoplasm as well (Figure 5-1b). In contrast, HMGB1 
was typically found both in the nucleus and cytoplasm in ROCK1nc hepatocytes 
(Figure 5-1b). In some ROCK1nc hepatocytes, HMGB1 staining was observed in 
the cytoplasm alone and was barely detectable in the nucleus (Figure 5-1b). 
Hepatocytes with cytoplasmic localization of HMGB1 with or without nuclear 
expression were mostly restricted to the inflamed centrilobular regions. Liver 
sections from both genotypes also exhibited strong HMGB1 staining in some 
immune cells as well (Figure 5-1 b). 
Analysis of the percentage of hepatocytes with cytoplasmic translocation of 
HMGB1 from three random fields revealed significantly more translocation in 
ROCK1nc hepatocytes when compared to ROCK1wt (Figure 5-1c). Cytoplasmic 
translocation of HMGB1 has been reported both in animal models as well as in 
patients with acute liver failure and it has been suggested that its presence in 
the cytoplasm is a necessary step for extracellular release (Zhou et al., 2011). 
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Figure 5-1 Increased cytoplasmic translocation of HMGB1 in ROCK1nc hepatocytes 
Representative images from HMGB1- stained liver sections, from ROCK1wt and ROCK1nc mice 
72 hours after DEN treatment at, a) 20x and b) 40x magnification, showing predominantly 
cytoplasmic staining in ROCK1nc hepatocytes. Scale bars represent 100 µm. c) Scatter dot plot 
(mean ± SEM) represents percentage cytoplasmic translocation of HMGB1 in hepatocytes. Data 
was analysed using Student’s t-test. **** = p<0.0001.  
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 Inhibiting the cytokine activity of HMGB1 using Glycyrrhizin 5.2.2
Induction of acute liver damage using DEN resulted in the accumulation of 
apoptotic debris and recruitment of inflammatory cells in ROCK1nc mice after 72 
hours. Interestingly, livers from these mice exhibited cytoplasmic translocation 
of HMGB1 that is indicative of an immediate extracellular release. Extracellular 
HMGB1 is a well-known damage associated molecular pattern that has been 
shown to exacerbate inflammation. To better understand the role of HMGB1 in 
ROCK1 dependent apoptotic cell clearance, I investigated whether GLZ, an 
inhibitor of HMGB1, can reduce the accumulation of apoptotic debris and 
inflammation and in turn alleviate hepatocellular damage in ROCK1nc mice that 
have been administered with the damage-inducing agent, DEN. 
To achieve this, mice were injected intraperitoneally with two doses of GLZ 
(200mg/kg per injection) prior to DEN (100 mg/kg) or vehicle (PBS) injection. 
Following administration of DEN/Vehicle, mice were again given GLZ, twice daily 
for the next two days. Mice were necropsied three days after DEN/Vehicle 
treatment (Figure 5-2a). Intraperitoneal injection of a total of six doses of GLZ 
(200 mg/kg per dose) without DEN injection over a period of four days did not 
have an untoward effect on the mice, as evidenced by their body weight and 
liver weight measurements (Figure 5-2c) and histopathological analysis (Figure 
5-2b). H&E stained liver sections from ROCK1wt and ROCK1nc from both 
genotypes did not exhibit any overt histopathological lesions but maintained 
healthy tissue architecture (Figure 5-2b). Administration of six doses of GLZ over 
a period of four days did not have a significant impact on body weight, with both 
genotypes losing around 5 % weight (Figure 5-2c). Having confirmed that GLZ on 
its own had no undesirable effects in the mice, I proceeded to combine GLZ 
treatment with DEN-induced damage by following the treatment regimen as 
detailed in Figure 5-2a. 
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Figure 5-2 Using Glycyrrhizin as an inhibitor for HMGB1 
a) Schematic representation of the treatment regimen with Glycyrrhizin (GLZ) and 
Diethylnitrosamine (DEN) in ROCK1wt and ROCK1nc mice. b) Representative H&E stained liver 
sections from ROCK1wt and ROCK1nc mice treated with GLZ and Vehicle (PBS) exhibiting no 
overt histopathological lesions. Scale bars represent 100 µm. c) Table shows the effect of GLZ on 
body weight and liver weight in mice. Numbers represent mean values ± standard deviation (n= 6-8 
per genotype).  
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 Glycyrrhizin treatment reduced accumulation of apoptotic 5.2.3
debris in ROCK1nc mice 
Accumulation of apoptotic debris was significantly greater in ROCK1nc livers 
compared to the wild-type within 72 hours of DEN-induced damage (Figure 5-3a). 
To examine whether treatment with GLZ in mice exposed to the damaging 
effects of DEN had an impact on the accumulation of apoptotic cells by 72 hours, 
TUNEL staining was performed on paraffin-embedded liver sections and 
counterstained with DAPI. Three representative fields from each sample were 
imaged by fluorescence microscopy and analysed using Image J software. An 
apoptotic index was calculated as a percentage of TUNEL positive apoptotic 
debris relative to the number of DAPI positive nuclei. Data was analysed by one-
way ANOVA and multiple comparisons with a Bonferroni post-hoc test. 
The apoptotic indices in ROCK1wt and ROCK1nc treated with GLZ and vehicle 
were similar to the respective untreated controls suggesting that GLZ on its own 
had no effect on apoptotic cell accumulation (Figure 5-3c).  However, analysis of 
TUNEL staining in ROCK1wt and ROCK1nc mice treated with DEN and GLZ showed 
a decrease in apoptotic index, which reflected a decrease in the accumulation of 
apoptotic debris upon GLZ treatment (Figure 5-3b, c). This decrease was 
significant in ROCK1nc (Figure 5-3c). The percentage of apoptotic cell debris 
accumulating in hepatic tissue following treatment with GLZ and DEN was still 
slightly higher in ROCK1nc when compared to wild-type although not significant 
(Figure 5-3c). Hence, blocking the cytokine activity of HMGB1 with GLZ resulted 
in a significant decrease in accumulation of apoptotic remnants in damaged 
ROCK1nc livers. 
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Figure 5-3 Accumulation of apoptotic remnants is reduced upon Glycyrrhizin treatment 
Representative merged images of liver sections stained with TUNEL (green) and counterstained 
with DAPI (blue) from a) ROCK1wt and ROCK1nc mice after 72 hours of DEN treatment showing 
increased accumulation in ROCK1nc liver (Fig 4-3d), b) GLZ-treated ROCK1wt and ROCK1nc 
treated mice 72 hours after DEN treatment showed less apoptotic debris in both genotypes. Scale 
bars represent 100 µm. c) Bar graph represents percentage apoptotic index under different 
treatment conditions (n=3-10 per group). DEN alone data is from the primary experiment 
mentioned in the previous chapter. Data was analysed using one-way ANOVA and multiple 
comparisons with a Bonferroni post-hoc test. Error bars represent SEM. *** = p<0.001.  
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 Glycyrrhizin treatment alleviated hepatocellular damage 5.2.4
caused by DEN 
To determine whether administration of GLZ could alleviate DEN-induced liver 
damage, I performed histopathological analysis of H&E stained liver sections. As 
shown in Figure 5-4a, typical pathological lesions found in DEN- induced damage 
including hepatocellular ballooning, large necrotic areas around the 
centrilobular regions, as well as the prevalence of steatohepatitis, were 
effectively lessened upon GLZ administration (Figure 5-4b). ROCK1wt livers from 
GLZ treated animals exhibited reduced centrilobular damage and associated 
inflammation when compared to DEN treatment alone. Livers sections looked 
relatively healthy, with very small areas of damage around the centrilobular 
region that is evident in Figure 5-4b.  
In the same way, GLZ also alleviated hepatic injury in ROCK1nc livers caused by 
DEN injection. Except for two ROCK1nc livers, none of the other eight sections 
showed any signs of steatosis. Also evident was the lack of large numbers of 
inflammatory cells in the damaged areas of livers from both genotypes (Figure 
5-4b). Analysis of the percentage of damaged area with associated inflammation 
in livers from both genotypes treated with GLZ and DEN revealed a decrease 
when compared to livers from the respective genotype treated with DEN alone 
(Figure 5-4c). A sharp decrease in the percentage of necrotic area in ROCK1nc 
mice with GLZ treatment resulted in values similar to that obtained in ROCK1wt 
mice treated with GLZ. These findings suggest that blocking HMGB1 activity with 
GLZ treatment can mitigate the increased hepatocellular damage caused by 
blebbing defects. 
Alterations in body weight as well as the relative liver weight (liver weight/body 
weight) of experimental mice exposed to GLZ and DEN/Vehicle were also 
recorded during necropsy. DEN treatment in GLZ-treated ROCK1nc mice, 
however, caused significant weight loss (Figure 5-5a) and significant reduction in 
relative liver weight (Figure 5-5b), when compared to GLZ-treated ROCK1wt 
mice.  
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Figure 5-4 Glycyrrhizin treatment alleviates hepatocellular damage 
a) Representative H&E stained liver sections after 72 hours of DEN treatment showing increased 
hepatocellular damage in ROCK1nc mice (Fig 4-7a). b) Representative H&E stained liver sections 
from GLZ-treated mice after 72 hours of DEN showing decreased hepatocellular damage in both 
genotypes. Scale bars represent 100 µm. c) Bar graph represents percentage necrotic area with 
inflammation analysed using H&E stained liver sections (n=5-6 per group). DEN alone data is from 
the primary experiment mentioned in the previous chapter. Data was analysed using one-way 
ANOVA and multiple comparisons with Bonferroni post-hoc test. Error bars represent SEM. ** = 
p<0.01, ****= p<0.0001.   
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Figure 5-5 Effect of Glycyrrhizin on body weight and liver weight in mice exposed to DEN 
Box and whisker plots showing a) percentage body weight loss and b) relative liver weight in 
ROCK1wt and ROCK1nc mice with GLZ and DEN/Vehicle treatment (n= 6-10 per group). Data was 
analysed using one-way ANOVA and multiple comparisons with Bonferroni post-hoc test. Whiskers 
represent 5-95 percentiles. * = p<0.05.   
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 Recruitment of neutrophils to ROCK1nc liver decreased 5.2.5
upon Glycyrrhizin treatment  
Having demonstrated that administration of GLZ reduced DEN-induced 
hepatocellular damage and accumulation of apoptotic debris, I further 
investigated whether neutrophil infiltration to the liver was also affected. As 
stated in the previous chapter, DEN treatment significantly increased neutrophil 
recruitment in ROCK1nc livers after 72 hours (Figure 5-6a). Since HMGB1 is a 
potent inducer of inflammation, I speculated that blocking HMGB1 would reduce 
recruitment of inflammatory cells to the liver. Moreover, since it is possible that 
infiltrating neutrophils are capable of aggravating DEN-induced hepatocellular 
damage, it is highly likely that the lesser damage seen in GLZ-treated mice 
might be a reflection of lower neutrophil infiltration. To test this, I quantified 
the number of S100A9-positive neutrophils from five random fields in the liver 
section from each mouse sample. Data was analysed by one-way ANOVA and 
corrected for multiple comparisons with a Bonferroni test. 
Treatment with GLZ alone did not result in a discernible change in neutrophil 
numbers in the livers when compared to the respective untreated controls 
(Figure 5-6c). Consistent with the findings from TUNEL assays, inhibiting the 
cytokine activity of HMGB1 significantly reduced infiltration of neutrophils when 
compared to DEN treatment alone (Figure 5-6b, c). The reduction in neutrophil 
numbers in ROCK1nc mice was quite dramatic since it achieved almost similar 
levels to ROCK1wt mice treated with both DEN and GLZ (Figure 5-6c). This 
suggested that blocking the cytokine activity of HMGB1 affected the recruitment 
of neutrophils to the damaged areas in livers. 
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Figure 5-6 Glycyrrhizin reduced neutrophil infiltration to damaged liver 
Representative images from S100A9- stained liver sections staining neutrophils (brown) and 
counterstained with haematoxylin from, a) ROCK1wt and ROCK1nc mice after 72 hours of DEN 
treatment showing increased infiltration in ROCK1nc liver (Fig 4-5d), b) GLZ- treated ROCK1wt 
and ROCK1nc treated mice 72 hours after DEN treatment showing reduced infiltration in ROCK1nc 
liver. Scale bars represent 100 µm. c) Bar graph represents number of neutrophils per mm2 under 
different treatment conditions (n=3-10 per group). DEN alone data is from the primary experiment 
mentioned in the previous chapter. Data was analysed using one-way ANOVA and multiple 
comparisons with Bonferroni post-hoc test. Error bars represent SEM. ** = p<0.01.   
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 Macrophage numbers in ROCK1nc livers exposed to DEN 5.2.6
were not affected by Glycyrrhizin treatment 
Macrophages in the liver, which play an important role in the maintenance of 
homeostasis, were significantly more numerous 72 hours after DEN-induced 
damage in ROCK1nc mice relative to ROCK1wt mice (Figure 5-7a). Whether the 
increase in macrophage numbers observed in ROCK1nc livers was a consequence 
of increased number of infiltrating monocytes differentiating into macrophages 
or proliferation of the resident Kupffer cells, could not be determined from my 
experiments (discussed in previous section). 
However, I wanted to examine if GLZ treatment, with or without DEN treatment, 
had an impact on macrophage numbers in the liver. For this, number of F4/80-
positive macrophages from five random fields in the liver section from each 
mouse sample was quantified. Data was analysed by one-way ANOVA and 
corrected for multiple comparisons with a Bonferroni test. 
Interestingly, GLZ treatment on its own increased macrophage numbers in 
ROCK1wt livers when compared to the wild-type untreated control (Figure 5-7c). 
However, a similar increase was not observed in ROCK1nc livers. In wild-type 
livers, compared to DEN treatment alone, there was significant increase in 
macrophage numbers when GLZ was combined with DEN treatment. This 
however was not observed in ROCK1nc livers. Instead, macrophage numbers 
remained constant between DEN and DEN+GLZ treatments (Figure 5-7a, b). 
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Figure 5-7 Effect of Glycyrrhizin on macrophage numbers in mice exposed to DEN 
Representative images from F4/80- stained liver sections staining macrophages (brown) and 
counterstained with haematoxylin from, a) ROCK1wt and ROCK1nc mice after 72 hours of DEN 
treatment, b) GLZ- treated ROCK1wt and ROCK1nc treated mice 72 hours after DEN treatment 
showing an increase in wild-type liver but no difference in ROCK1nc. Scale bars represent 100 µm. 
c) Bar graph represents number of macrophages per mm2 under different treatment conditions 
(n=3-10 per group). DEN alone data is from the primary experiment mentioned in the previous 
chapter. Data was analysed using one-way ANOVA and corrected for multiple comparisons with 
Bonferroni test. Error bars represent SEM. ** = p<0.01.   
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 Decreased hepatocellular damage with Glycyrrhizin 5.2.7
treatment correlated with serum liver profile 
As discussed before, levels of liver enzymes and proteins in the serum are good 
indicators of hepatocellular damage and liver injury. Serum collected from 
experimental mice were analysed for levels of ALT, total bilirubin, alkaline 
phosphatase, total protein, albumin and globulin. Data was analysed by one-way 
ANOVA and corrected for multiple comparisons with Bonferroni test. 
Serum levels of liver enzymes such as ALT are routinely analysed to assess 
hepatic parenchymal damage. 72 hours after DEN treatment, ROCK1nc mice 
exhibited significantly high levels of ALT, which correlated with greater 
hepatocellular damage seen in these mice. As expected, GLZ treatment 
drastically reduced serum ALT levels in DEN-treated ROCK1nc mice, which was 
consistent with the decrease in hepatocellular damage observed by 
histopathological analysis (Figure 5-8a). A similar trend was observed with total 
bilirubin levels in serum (Figure 5-8b). Treatment with GLZ resulted in ALT and 
bilirubin reaching similar levels in both ROCK1wt and ROCK1nc mice (Figure 
5-8a, b). Concomitant decrease in ALT and bilirubin levels was a good indicator 
of the positive effect of GLZ in reducing liver damage. 
Reduction in alkaline phosphatase with higher DEN-induced damage observed in 
ROCK1nc mice was reversed with GLZ treatment (Figure 5-9a). Alkaline 
phosphatase levels in ROCK1nc mice were significantly more with DEN injection 
combined with GLZ treatment compared to DEN treatment alone. However, in 
ROCK1wt mice, these levels remained similar. 
Level of serum proteins also showed alterations with GLZ treatment. Serum 
levels of albumin significantly dropped to levels similar to that seen in control 
animals with GLZ treatment in DEN-treated ROCK1wt and ROCK1nc mice (Figure 
5-9c). With GLZ treatment, increased globulin levels recorded in DEN-treated 
ROCK1nc mice also dropped to levels similar to that seen in ROCK1wt mice, 
although not significant (Figure 5-9d). 
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Figure 5-8 Glycyrrhizin reduced serum ALT and bilirubin levels in ROCK1nc mice 
Bar graphs represent a) ALT and b) total bilirubin values in serum collected from ROCK1wt and 
ROCK1nc mice under different treatment conditions (n=3-10 per group). DEN alone data is from 
the primary experiment mentioned in the previous chapter. Data was analysed using one-way 
ANOVA and multiple comparisons using Bonferroni post-hoc test. Error bars represent SEM. ** = 
p<0.01; ****p<0.0001.   
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Figure 5-9 Additional parameters of liver function with Glycyrrhizin treatment 
Bar graphs represent a) alkaline phosphatase, b) total protein, c) albumin, d) globulin and e) 
albumin to globulin ratio values in serum collected from ROCK1wt and ROCK1nc mice under 
different treatment conditions (n=3-10 per group). DEN alone data is from the primary experiment 
mentioned in the previous chapter. Data was analysed using one-way ANOVA and multiple 
comparisons using Bonferroni post-hoc test. Error bars represent SEM. ** = p<0.01.   
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5.3 Discussion 
Rapid elimination of apoptotic cells is essential for the maintenance of tissue 
homeostasis. In the previous section, I showed that the defect in caspase-
cleavage of ROCK1 resulted in accumulation of apoptotic remnants and 
infiltration of immune cells in response to DEN-induced damage in the liver after 
72 hours. Histopathological analysis revealed extensive liver damage in ROCK1nc 
mice. Detrimental effects of uncleared apoptotic debris along with the presence 
of massive numbers of recruited immune cells may contribute to exacerbating 
liver damage. 
If apoptotic cells are not removed promptly by phagocytes, they undergo self-
elimination by secondary necrosis. Two possible scenarios may lead to secondary 
necrosis in vivo. The first setting involves excessive apoptosis leading to 
accumulation of apoptotic cells that may overwhelm the capacity of the 
phagocytic system. For example, secondary necrosis of hepatocytes was 
reported in a rat model with extensive hepatocyte apoptosis (Farghali et al., 
2003). The second scenario involves defects in efferocytosis mechanisms 
resulting in the accumulation of apoptotic debris that may eventually undergo 
transition to secondary necrosis. For example, deficiency in the clearance of 
apoptotic cells was reported in mouse models which lack phagocytic receptor 
Mer (Cohen et al., 2002, Thorp et al., 2008). 
Secondary necrotic cells that lose their membrane integrity, releases toxic 
intracellular components known as damage associated molecular patterns 
(DAMPs) with inflammatory and immunogenic capacities. Of the several DAMPs 
identified so far, high-mobility group box 1 (HMGB1) is the most extensively 
studied. It is a non-histone nuclear protein that is actively released by immune 
cells or passively by damaged or necrotic cells (Scaffidi et al., 2002). Secreted 
HMGB1 acts as a potent pro-inflammatory cytokine either directly by binding to 
receptors and promoting transcription of pro-inflammatory genes or indirectly by 
attracting more inflammatory cells to sites of damage or necrosis. 
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 Blocking cytokine activity of HMGB1 using Glycyrrhizin 5.3.1
reduced accumulation of apoptotic debris in DEN-induced 
ROCK1nc mice 
Since ROCK1nc livers exhibited larger necrotic areas 72 hours after DEN 
treatment, I examined the subcellular localization of HMGB1 in these liver 
sections. Interestingly, ROCK1nc hepatocytes showed significant cytoplasmic 
translocation of HMGB1 when compared to ROCK1wt (Figure 5-1). Cytoplasmic 
translocation of HMGB1 in hepatocytes has been shown to precede an impending 
extracellular release in both mouse models and patients with acute liver failure 
(Zhou et al., 2011). This led me to hypothesize a possible link between HMGB1 
and increased DEN-induced liver damage with accumulation of apoptotic debris 
as seen in ROCK1nc mice. To test whether HMGB1 released by the secondary 
necrotic cells in ROCK1nc was responsible for increased hepatocellular damage, I 
used Glycyrrhizin (GLZ), which inhibits the cytokine activity of HMGB1. Mice 
injected with a single intraperitoneal injection of 100 mg/kg of DEN, also 
received several doses of 200 mg/kg of GLZ until 72 hours after DEN injection 
(Figure 5-2a). 
Analysis of TUNEL staining in ROCK1wt and ROCK1nc mice treated with GLZ 
revealed a significant reduction in the accumulation of apoptotic debris in 
ROCK1nc mice 72 hours after DEN treatment (Figure 5-3 a, b). With GLZ 
treatment, the levels of apoptotic debris in ROCK1wt and ROCK1nc mice were 
almost identical (Figure 5-3 c). This suggested that HMGB1 was playing a crucial 
role in the accumulation of apoptotic remnants in ROCK1nc mice with defects in 
caspase- cleavage of ROCK1. Necrotic hepatocytes may not be the only source of 
HMGB1. It is possible that the activated immune cells in the liver may also be 
actively secreting HMGB1 (Figure 5-1 b). 
 Administration of Glycyrrhizin reduced neutrophil 5.3.2
infiltration in DEN-induced ROCK1nc mice 
The role of HMGB1 in the regulation of inflammation has been highlighted in a 
number of instances including LPS-induced shock (Wang et al., 1999), tissue 
injury (Scaffidi et al., 2002) and UV irradiation (Bald et al., 2014). Inhibiting 
HMGB1 abrogated UV-dependent neutrophilic infiltration in mice skin (Bald et 
al., 2014). A recent study demonstrated the role of HMGB1 in neutrophil 
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recruitment to necrotic liver using two different injury models (Huebener et al., 
2015). Consistent with these data, blocking the cytokine activity of HMGB1 using 
GLZ in the DEN-induced damage model, ROCK1nc mice displayed a profound 
reduction in neutrophil infiltration to the liver (Figure 5-6 a, b). Moreover, with 
GLZ treatment there was no significant difference between neutrophil 
infiltrations to the liver in response to DEN-induced damage between the two 
genotypes (Figure 5-6 c). From this observation, it is conceivable that HMGB1 
released by the accumulating debris in ROCK1nc liver is a potent inducer of 
neutrophilic infiltration. 
In contrast to neutrophils, which are mainly recruited to the liver in the event of 
an injury, large numbers of resident macrophages, known as Kupffer cells, are 
present in the liver. Figure 5-7c shows an increase in macrophage numbers in 
ROCK1wt mice upon administration of GLZ without DEN-induced damage. This 
was an unexpected result and GLZ treatment has not been reported to increase 
macrophage numbers in the liver. As described in the earlier section, since I had 
employed an immunohistochemical method for the detection of macrophages, 
my experiments failed to identify whether the increase was due to increased 
monocyte infiltration or due to proliferation of the resident Kupffer population. 
Moreover, GLZ treatment resulted in a significant increase in macrophage 
numbers in DEN-induced ROCK1wt livers compared to DEN treatment alone in 
these mice. However, analysis of macrophage numbers revealed that the 
increase in macrophage numbers only reached baseline levels seen in untreated 
wild-type livers. It is possible that GLZ mediated reduction in hepatocellular 
injury (discussed later on) might be responsible for the repopulation of Kupffer 
cells in ROCK1wt livers. With respect to ROCK1nc livers, GLZ seems to have no 
effect on macrophage numbers in the DEN-induced damage model. This is not 
surprising since HMGB1 does not increase macrophage numbers in the liver 
following injury (Huebener et al., 2015). 
Recent studies had shown that HMGB1 has the ability to inhibit the phagocytic 
activity of macrophages (Liu et al., 2008a, Friggeri et al., 2010). It is possible 
that the increased secretion of HMGB1 by damaged hepatocytes in ROCK1nc 
livers had an inhibitory effect on the Kupffer cells, which was reduced by GLZ 
treatment, thus resulting in less apoptotic debris in the livers. 
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 Glycyrrhizin treatment alleviated DEN-induced 5.3.3
hepatocellular damage in ROCK1nc mice 
Histopathological analysis of liver sections combined with clinical liver function 
tests was employed to assess the effect of GLZ on DEN-induced liver damage. 
Analysis of H&E-stained liver sections revealed that the higher degree of 
pathological lesions including centrilobular necrosis, steatohepatitis and 
hepatocellular ballooning seen in ROCK1nc mice, were effectively alleviated 
with GLZ treatment (Figure 5-4 a, b). Analysis of the percentage of necrotic area 
revealed a significant decrease with GLZ treatment when compared to DEN 
treatment alone. This decrease was highly significant in ROCK1nc livers 
considering the larger areas of necrosis seen in these mice after 72 hours of DEN 
injections (Figure 5-4 c). Of importance was the similar percentage of necrotic 
area between the genotypes, which highlighted the role of HMGB1 in aggravating 
hepatocellular damage in a defective blebbing setting. 
Measurement of serum levels of ALT and total bilirubin correlated well with the 
histopathological analysis. Administration of GLZ in DEN-treated animals resulted 
in significant decreases in ALT and bilirubin levels in ROCK1nc mice, thus 
bringing the values down to levels similar to ROCK1wt mice (Figure 5-8). These 
findings were in concert with previous reports which showed the protective 
effects of GLZ in different models of liver injury (Abe et al., 2008, Ogiku et al., 
2011). 
As discussed in the previous section, neutrophils can exacerbate tissue injury in 
liver damage models. To test whether neutrophils were responsible for the 
increased liver injury in ROCK1nc mice, I had used the 1A8 monoclonal antibody 
to deplete neutrophils. However, this treatment resulted in more neutrophil 
numbers in the livers as evidenced by S100A9 immunohistochemical staining, the 
reason for which is not known (data not shown). If the uncleared apoptotic 
debris and the presence of inflammatory cells are responsible for exacerbating 
tissue damage, it is conceivable that GLZ mediated reduction in accumulation of 
apoptotic debris and reduction in neutrophil infiltration work in concert to 
reduce hepatocellular damage in ROCK1nc mice. 
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5.4 Summary 
Defective blebbing results in the accumulation of apoptotic debris, which may 
progress to secondary necrosis. HMGB1 released by necrotic hepatocytes 
aggravates hepatocellular damage by recruiting more neutrophils to the liver. 
Inhibiting the cytokine activity of HMGB1 with Glycyrrhizin reduced neutrophil 
infiltration to the liver, which in turn alleviated hepatocellular damage in DEN-
induced liver injury model. 
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Results 
Caspase cleavage of ROCK1 in Tumour Development  
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6 Hepatocellular Carcinoma Model 
6.1 Introduction 
 DEN-induced Hepatocellular Carcinoma 6.1.1
Hepatocellular carcinoma (HCC), a dominant form of primary liver cancer, ranks 
third on the list of most lethal cancers, and worldwide is the fifth most common 
cancer in men and seventh among women (Mittal and El-Serag, 2013). Risk 
factors include chronic hepatitis B or C infection, alcohol consumption, toxic 
exposure to aflatoxin, vinyl chloride and non-alcoholic fatty liver disease 
(NAFLD) or non-alcoholic steatohepatitis (NASH) caused by obesity or diabetes. 
HCC is more common in men than women as hepatitis B or C infection and 
alcohol consumption are more prevalent in men.  Several mouse models have 
been developed over the years that have contributed immensely in defining the 
pathogenesis of HCC. This includes chemically induced models, xenograft models 
and genetically modified models. Of these, chemically induced models are 
generally favoured owing to their similarity to disease pathogenesis seen in 
humans. 
To date, the most frequently used genotoxic carcinogen is Diethylnitrosamine 
(DEN), also known as N-nitrosodiethylamine. From a clinical perspective, DEN is 
found in a number of products to which humans are exposed including tobacco 
smoke and whisky. DEN is bioactivated to α-hydroxynitrosamine, by a 
cytochrome P450 enzyme that has its highest activity in centrilobular 
hepatocytes (Verna et al., 1996). An electrophilic ethyldiazonium ion thus 
formed causes DNA damage by ethylation of DNA bases. Furthermore, reactive 
oxygen species (ROS) generated by the P450 enzyme induces oxidative stress by 
the formation of hydrogen peroxide and superoxide anions that can contribute to 
HCC formation (Qi et al., 2008). 
Several mechanisms are believed to be involved in the complex pathogenesis of 
HCC including oncogene activation, abrogation of DNA-damage checkpoints, 
telomere dysfunction, activation of inflammatory pathways, and formation of 
ROS, which lead to malignant transformation and disease progression (Sanyal et 
al., 2010). However, the exact role of these pathways still remains unclear. DEN-
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induced ethyl DNA adducts can interrupt base pairing, thus resulting in tumours 
that frequently harbour mutations in the H-ras proto-oncogene (Buchmann et 
al., 1991, Chen et al., 1993) and p53 (Smith et al., 1991).  Although mutations in 
Ras-oncogenes are rarely seen in human HCC (Schwarz et al., 1995), Ras-
activation is enhanced in human HCC when compared with non-neoplastic 
regions (Calvisi et al., 2006). However, gene expression pattern analysis of 
several HCC models revealed that the DEN model was a good representation of 
human HCC with poor prognosis (Lee et al., 2004). 
Several dosing strategies have been tested over the years for inducing HCC in 
mice using DEN. The dose administered, along with age, sex and strain of mice 
had an effect on the time needed for HCC development (Heindryckx et al., 
2009). In some studies, two-stage models of HCC induction were utilized. One 
model involves DEN being used as the initiating agent and phenobarbital (PB) 
acting as a promoting agent that enhances carcinogenesis (Heindryckx et al., 
2009). Another model, known as the Solt-Farber model, mostly performed in 
rats, involves HCC induction using hepatocarcinogen like DEN in conjunction with 
partial hepatectomy, which induces rapid proliferation of the initiated cells 
(Farber et al., 1977). Over the years, DEN-induced HCC model has been 
successfully used to study the effect of specific genetic changes in carcinogen-
induced tumours. 
 Experimental Aim 6.1.2
The objective of this study was to elucidate the role of caspase-cleavage of 
ROCK1 in hepatocellular carcinoma. 
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6.2 Results 
 DEN-induced hepatocellular carcinoma in ROCK1nc mice 6.2.1
To address the role of caspase-cleavage of ROCK1 in carcinogenesis, I utilized 
the well-established model of hepatocellular carcinoma using the same 
carcinogen that was used for the acute liver studies, specifically DEN. A single 
intraperitoneal injection of DEN to two-week old mice results in the induction of 
HCC (Vesselinovitch et al., 1984). Over the years, several laboratories have used 
different doses, resulting in HCC induction after 40-104 weeks depending on the 
age, strain and sex of mice (Heindryckx et al., 2009) . Young mice are generally 
used for DEN-induction since the developing liver is more susceptible to 
genotoxic carcinogens. For the present study, 14-day old ROCK1wt and ROCK1nc 
mice were given 400 µg of DEN by intraperitoneal injection (Figure 6-1a). Mice 
were routinely monitored for lethargy, weight loss, immobility and palpable 
tumours. 
By 41 weeks of age, some mice exhibited palpable tumours and signs of 
discomfort. Hence, 41 weeks (9 months) was selected as the end point for this 
experiment and all DEN-induced mice were sacrificed at this time point. 
Additionally, some mice were sacrificed at 28 weeks of age (6 months) to assess 
for preneoplastic lesions in wild-type and ROCK1nc mice (Figure 6-1a). By 41 
weeks, all male mice showed gross evidence of liver tumours from both ROCK1wt 
and ROCK1nc mice (Figure 6-1b). However, female mice from both genotypes did 
not show any evidence of tumours at this time point. Some DEN-induced female 
mice were aged to 50-70 weeks, but still failed to display any signs of liver 
tumours (Figure 6-1b). This was not surprising, as genetic disparity has been 
previously reported in DEN-induced HCC models, with only 10-30% females 
developing tumours, which was attributed to the inhibitory effect of estrogen on 
hepatocarcinogenesis (Nakatani et al., 2001). Gender disparity in HCC 
development has been attributed to higher levels of the cytokine IL-6 in the 
serum of male mice when compared to females where estrogen hormone inhibits 
IL-6 secretion (Naugler et al., 2007). 
  161 
 
 
 
 
 
 
Figure 6-1 DEN-induced hepatocellular carcinoma 
a) Schematic representation of the treatment regimen for DEN-induced hepatocellular 
carcinoma. Mice were injected with 400µg of DEN at two weeks of age and then sacrificed 
at 6 months or 9 months. b) Table shows incidence of gross evidence of tumours in male 
mice at 41 weeks of age and female mice after 50 weeks of age, demonstrating gender 
disparity. Incidence is represented as the number of animals with gross evidence of 
tumours over the total number of mice in that group. 
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 Fewer hepatic tumours in ROCK1nc mice 6.2.2
DEN-induced mice were sacrificed at 41 weeks of age. All mice were injected 
intraperitoneally with BrdU two hours prior to sacrifice. After euthanasia, body 
weights were recorded and blood collected via cardiac puncture. Liver weights 
were recorded and the number of visible tumours in each liver lobe counted. 
Each tumour was measured using digitised vernier callipers to calculate the 
volume. Macroscopic examination of tumour numbers,  9 months after DEN 
induction revealed that ROCK1nc mice had significantly fewer hepatic tumours 
when compared to the wild type (Figure 6-2a, e and f). The majority of ROCK1nc 
livers had fewer than 20 tumour foci, with the exception of one exhibiting 29 
tumour foci. However, tumour numbers in wild-type mice ranged from 25 to 70 
in most samples. Few livers from wild type mice had less than 20 visible tumour 
foci. Analysis of tumour volume revealed that there was no significant difference 
in tumour volume 9 months after a single injection of DEN between the two 
genotypes (Figure 6-2b). Although most ROCK1nc livers had lower tumour volumes 
(less than 2500 mm3) when compared to wild type (mostly ranging between 
2000-5000 mm3), three ROCK1nc samples exhibited high tumour volume, 
accounting for the loss of significance. Additionally, there was no significant 
difference in absolute liver weight and relative liver weight between the two 
genotypes (Figure 6-2c, d). Macroscopic examination of ROCK1wt and ROCK1nc 
livers revealed that tumours were clearly demarcated from the surrounding 
tissue and involved different liver lobes. Tumours from both genotypes were 
often paler than the surrounding hepatic parenchyma. However, some tumours 
appeared red and highly vascularized (Figure 6-2e). Tumours were typically 
nodular with most livers from both genotypes presenting multiple nodules with 
one or two dominant, large ones. In some samples, multiple small nodules 
coalescing to form a single large nodule were also observed. 
Metastases to the lungs have been reported in DEN-induced HCC (Heindryckx et 
al., 2009). Analysis of H&E-stained lung sections revealed presence of metastatic 
nodules and thickening of the alveolar septa (Figure 6-3a). Blinded analysis of 
metastatic score did not reveal any significant difference; however most 
ROCK1nc mice had a lower metastatic score when compared to the wild type 
(Figure 6-3b). 
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Figure 6-2 Decreased tumour number in ROCK1nc mice 
Scatter dot plots (mean ± SEM) showing a) tumour number, b) tumour volume, c) absolute 
liver weight and d) relative liver weight in male mice injected with DEN and maintained for 
9 months (n=12 per genotype). Data was analysed using Student’s t-test. ** = p< 0.01. e) 
Macroscopic view of representative livers from ROCK1wt and ROCK1nc mice 9 months 
after HCC initiation with DEN. Scale bars represent 1 cm. f) Representative H&E stained 
liver sections from ROCK1wt and ROCK1nc mice showing more tumours in wild-type 
liver. Scale bars represent 1 mm. 
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Figure 6-3 Lung metastasis in DEN-induced HCC 
a) Representative H&E-stained lung sections from ROCK1wt and ROCK1nc male mice 9 
months after DEN-induction (n=7-12 per genotype). Black arrow indicates metastatic 
nodules and blue arrow indicates thickening of the alveolar septa. Scale bars represent 
100 µm b) Scatter dot plot (mean ± SEM) shows lung metastatic score in ROCK1wt and 
ROCK1nc lungs. Data analysed using Mann-Whitney test. 
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 Histopathological evaluation of HCC tumours 6.2.3
Histopathological evaluation of HCC tumours from wild-type and ROCK1nc mice 
using H&E stained sections revealed typical features of HCC in both genotypes. 
Most tumour nodules had a well-defined border with compression of the 
adjacent hepatic parenchyma (Figure 6-4a). Some tumours from both genotypes 
displayed a trabecular pattern where the hepatocytes are arranged in plates of 
various thicknesses and separated by sinusoidal spaces (Figure 6-4b). The 
trabeculae sometimes increased in thickness to form macrotrabecular structures 
(Figure 6-4c) or compressed to form a compact mass (Figure 6-4d). Large areas of 
necrotic foci were seen in the bigger tumours obtained from both wild-type and 
ROCK1nc tumours (Figure 6-4e). Some ROCK1nc tumours exhibited large 
inflammatory foci as well (Figure 6-4f). 
Using H&E-stained sections, liver tumours in this study were classified into three 
types: Hepatic nodule 1 (HN1), Hepatic nodule 2 (HN2) and HCC in increasing 
order of tumour grade as described by Yanagi and co-workers (Yanagi et al., 
1984). HN1 type mainly comprised of tumour nodules with slight difference from 
the normal hepatic architecture but produced obvious compression of the 
surrounding parenchyma. HN2 category consisted of two to three- cell thick 
irregular trabecular arrangements with well- maintained sinusoidal spaces. The 
highest grade type, namely HCC exhibited irregular macrotrabecular 
arrangement with dilated sinusoidal spaces. 
12 ROCK1wt and 12 ROCK1nc end-point tumours were scored based on this 
classification. For specimens that exhibited mixed morphology, the most 
advanced classification was taken into consideration. Analysis revealed that 8 
out of 12 of both genotypes exhibited full-blown HCC. Rest of them displayed 
tumours of lower grade, namely HN1 or HN2 (Figure 6-4g). 
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Figure 6-4 Histopathological features of DEN-induced HCC 
Representative H&E stained liver sections from male mice with DEN-induced HCC 
showing a) tumour border (dotted line), b) trabecular pattern (arrow), c) macrotrabecular 
structures (arrow), d) compact tumour mass, e) necrotic foci (arrow) and f) inflammatory 
foci (arrow). Scale bars represent 100 µm. g) Stacked bar graph shows the percentage of 
ROCK1wt and ROCK1nc mice with different grades of tumours. 
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 Higher steatotic grade in ROCK1nc tumours 6.2.4
Tumours from wild-type and ROCK1nc mice also exhibited microvesicular and 
macrovesicular steatosis which was evident on H&E-stained liver sections (Figure 
6-5a). Out of the 12 ROCK1nc liver sections analysed, all samples exhibited 
steatosis (Figure 6-5b). In the wild-type, 10 out of 12 liver sections showed signs 
of steatosis (Figure 6-5b). Steatosis was graded on H&E-stained sections based on 
semi-quantitative estimation of percentage of steatotic hepatocytes, according 
to the following criteria: grade 0- less than 5%, grade 1- 5 to 25%, grade 2- 26 to 
50%, grade 3- 51to 75% and grade 4- more than 75%. 33% of ROCK1nc mice 
displayed grade 4 steatosis while only 8% of ROCK1wt mice exhibited the highest 
grade (Figure 6-5c). More than 80% of ROCK1wt livers had a steatotic grade of 2 
or less while only around 50% of ROCK1nc liver exhibited these low grades of 
steatosis (Figure 6-5c). 
Presence of fibrosis or excessive accumulation of extracellular matrix proteins 
including collagen is an indicator of persistent or progressive hepatic injury and 
was detected by staining liver sections with Sirius red and Fast Green (Figure 
6-6a). Sirius Red specifically binds to collagen and Fast Green is used as a 
counterstain as it binds to non-collagenous proteins. Both wild-type and 
ROCK1nc tumours presented a small degree of fibrosis which was mostly portal.  
Perivenular fibrosis (centrilobular zone) as well as pericellular fibrosis 
(extending along the sinusoids) was also observed in both genotypes. Analysis of 
Sirius Red stained liver sections using TissueAnalyzer software showed no 
significant difference in the percentage of fibrotic area between the two 
genotypes (Figure 6-6b). 
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Figure 6-5 Higher steatotic grade in ROCK1nc mice 
a) Photomicrographs of liver sections from ROCK1wt and ROCK1nc male mice with HCC 
9 months after DEN injection showing steatosis in the tumours. Scale bars represent 100 
µm. b) Table shows incidence of steatosis in the two genotypes. Incidence is represented 
as the number of animals with evidence of steatosis over the total number of mice in that 
group. c) Stacked bar graph shows the percentage of ROCK1wt and ROCK1nc mice with 
different grades of steatosis (n=12 per genotype).  
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Figure 6-6 Fibrosis in DEN-induced HCC 
a) Photomicrographs of liver sections from ROCK1wt and ROCK1nc male mice 9 months 
after DEN injection stained with Sirius Red and counterstained with Fast Green. Scale 
bars represent 100 µm. b) Scatter dot plot (mean ± SEM) of percentage fibrotic area 
measured as Sirius Red positive area relative to the total area analysed, showing no 
significant difference between the two genotypes (n=7-8 per genotype). Data analysed 
using Student’s t-test. 
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 Higher rates of immune cell proliferation in ROCK1nc mice 6.2.5
Proliferation rates in DEN-induced HCC from ROCK1wt and ROCK1nc mice were 
determined by either BrdU (5-bromo-2’-deoxyuridine) incorporation or Ki67 
staining. Mice were injected with BrdU two hours prior to sacrifice and paraffin-
embedded liver sections were stained with BrdU antibody. I quantified the 
number of BrdU-positive cells per mm2 by analysing five random fields for each 
liver section. Analysis of BrdU-stained liver sections revealed no significant 
difference in the tumours between the two genotypes (Figure 6-7a, b).  
Tumours were also stained for Ki-67 and five random fields were analysed for 
each liver section (Figure 6-7c). Ki-67 score was calculated as a percentage of 
positively stained tumour cells to the total number of tumour cells. Analysis of 
Ki-67 stained tumour sections revealed no significant difference in proliferation 
rates in the hepatocytes (Figure 6-7d). Additionally, I observed large numbers of 
immune cells with their distinctive small nuclei also stained positive for Ki-67. 
Analysis of Ki-67 score in immune cells alone showed a significant increase in 
ROCK1nc tumours when compared to wild-type tumours 9 months after DEN 
injection suggesting that the immune cells in ROCK1nc livers were more 
proliferative (Figure 6-7e).  
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Figure 6-7 Higher rates of immune cell proliferation in ROCK1nc mice 
a) & b) Representative BrdU-stained liver sections and corresponding bar graph (mean ± 
SEM) showing no significant difference between the two genotypes. c) Representative 
Ki67-stained liver sections and d) & e) corresponding bar graphs (mean ± SEM) showing 
no significant difference in Ki67 score in hepatocytes and significant difference in immune 
cells between the two genotypes respectively (n=7-8 per genotype). Scale bars represent 
100 µm. Data analysed using Student’s t-test. *** =p<0.001 
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 Increased infiltration of immune cells in ROCK1nc tumours 6.2.6
H&E-stained liver sections from tumours exhibited more immune cells in 
ROCK1nc mice. Tumours were hence further analysed for the presence of 
neutrophils, macrophages, and T cells by immunohistochemistry. 
Infiltration of neutrophils was analysed by staining tumour sections with S100A9 
antibody (Figure 6-8a). Analysis revealed significant increase in neutrophil 
infiltration in ROCK1nc tumours when compared to the wild-type and the 
neutrophils were mostly localized within the tumour nodules (Figure 6-8b). 
Analysis of macrophage numbers in tumours sections stained with F4.80 revealed 
no significant difference between the two genotypes (Figure 6-8 c, d). However, 
in most ROCK1nc tumours, macrophages appeared in clusters within the tumours 
and also strongly localized at the tumour borders. Infiltration of T cells was 
quantified using CD3 antibody, which is a pan T cell marker. Analysis revealed a 
trend towards more T cell infiltration in ROCK1nc tumours that was not 
significant (Figure 6-8 e, f). 
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Figure 6-8 Increased infiltration of immune cells in ROCK1nc tumours 
a) Representative images of S100A9-stained liver sections showing increased neutrophils 
(brown) in ROCK1nc tumours and, b) corresponding bar graph. c) Representative F4/80-
stained liver sections showing macrophages (brown) and, d) corresponding bar graph. e) 
Representative CD3-stained liver sections showing increased T cell infiltration (brown) in 
ROCK1nc tumours and, f) corresponding bar graph. Sections counterstained with 
haematoxylin (blue) (n=7-10 per genotype). Scale bars represent 100 µm. Bar graphs 
represent mean ± SEM. Data analysed using Student’s t-test. **= p<0.01. 
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 Increased infiltration of CD8+ T cells in ROCK1nc tumours 6.2.7
Of the different tumour infiltrating lymphocytes, CD8+ T cells or cytotoxic T 
lymphocytes (CTLs) play a key role in antitumor immunity (Tanaka et al., 1999). 
Given the data that there was a trend towards more T cell infiltration in 
ROCK1nc tumours, I wanted to find out if these were CD8+ T cells. Since CD8 
staining does not work on paraffin embedded section, I utilized frozen liver 
sections obtained from the caudate lobe of the liver. Immunofluorescence 
staining with CD8 antibody revealed significantly more CD8+ T cells in ROCK1nc 
tumours (Figure 6-9 a, b). 
Natural killer (NK) cells are a subset of cytotoxic lymphoid cells that have the 
ability to distinguish and kill tumour cells (Vivier et al., 2012). Analysis of frozen 
tumour sections by immunofluorescence using NK1.1 antibody, which is specific 
for natural killer cells, revealed that HCC from both genotypes did not harbour 
many NK cells (Figure 6-10a). In addition to NK cells, natural killer T cells (NKT) 
have also been shown to have a role in tumour immunosurveillance (Vivier et al., 
2012). NKT cells will be double positive for NK1.1 and CD3 staining; however, I 
did not observe any NKT cells in tumour sections from both genotypes (Figure 
6-10 a). 
Along with CTLs, NKs and NKTs, another population of T cells that have gained 
considerable interest over the years are the regulatory T cells (Tregs) that 
maintain self-tolerance and hence hinder effective tumour immunity (Nishikawa 
and Sakaguchi, 2010). These cells specifically express the transcription factor 
Foxp3 (Forkhead box P3) that can be exploited for immunohistochemical 
detection on paraffin embedded sections. However, analysis of Foxp3-positive 
cells did not reveal any significant difference between the two genotypes (Figure 
6-10 b, c). Interestingly, hepatocytes with tumour regions displayed reduced 
cytoplasmic staining of Foxp3 in both ROCK1wt and ROCK1nc mice when 
compared to the strong cytoplasmic expression in the surrounding hepatic 
parenchyma (Figure 6-10 d). Although increased cytoplasmic localization of Foxp3 
when compared to the surrounding normal cells has been reported in many 
cancer types (Triulzi et al., 2013), its reduced expression in tumour regions 
compared to normal tissue regions has not been reported yet. 
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Figure 6-9 Increased infiltration of CD8+ T cells in ROCK1nc tumours 
a) Representative images of CD8-stained (red) frozen liver sections and merged images 
(CD8 + DAPI), showing increased CD8+T cell infiltration in ROCK1nc tumours. Scale bars 
represent 100 µm. b) Bar graph (mean ± SEM) shows significant increase in the number 
of CD8+ T cells/ mm2 in ROCK1nc tumours (n=5 per genotype). Data analysed using 
Student’s t-test. * = p<0.05.  
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Figure 6-10 Presence of natural killer cells and Foxp3 cells in HCC tumours 
a) Representative image of NK1.1-stained (red), CD3-stained (green) frozen liver sections 
and merged images (NK1.1 + CD3 + DAPI) in tumours. b) & c) Representative Foxp3-
stained liver sections and the corresponding bar graph (mean ± SEM) showing no 
significant difference between the two genotypes. d) Representative Foxp3-stained liver 
sections showing reduced expression in the tumour regions. Sections counterstained with 
haematoxylin (blue) (n=6 per genotype). Dotted line represents tumour border. Scale bars 
represent 100 µm. Data analysed using Student’s t-test.  
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 Decreased tumour numbers in preneoplastic ROCK1nc 6.2.8
livers 
DEN-induced mice were sacrificed at 6 months of age to look at preneoplastic 
livers. After euthanasia, body weights were recorded and blood collected via 
cardiac puncture. Weights of the livers were recorded and the number of visible 
tumours in each liver lobe counted. Each tumour was measured using digitised 
vernier callipers to calculate the volume.  
Analysis of tumour number 6 months after DEN induction revealed that ROCK1nc 
mice had significantly lower number of hepatic tumours when compared to the 
wild type (Figure 6-11 a). Two out of five ROCK1nc livers did not exhibit any 
tumour foci while all preneoplastic livers obtained from wild-type mice showed 
evidence of tumour nodules. Analysis of tumour volume revealed that there was 
no significant difference in tumour volume 6 months after a single injection of 
DEN between the two genotypes (Figure 6-11 b). ROCK1nc livers had lower 
tumour volumes (less than 10 mm3) when compared to wild type which ranged 
between 2-50 mm3. Additionally, there was no significant difference in absolute 
liver weight and relative liver weight between the two genotypes (Figure 6-11 c, 
d). 
Metastases to the lungs were also scored in preneoplastic mice. Analysis of H&E-
stained lung sections revealed a drastic difference between lungs obtained from 
the two genotypes (Figure 6-12 a). All ROCK1wt mice exhibited presence of 
metastatic nodules and thickening of the alveolar septa in the lungs. On the 
other hand, two out of five ROCK1nc lungs did not show any evidence of 
metastasis and the other three mice had small metastatic nodules. In 
accordance with this observation, blinded analysis of metastatic score revealed 
a significantly lower score in ROCK1nc preneoplastic mice when compared to 
wild-type mice (Figure 6-12 b).  
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Figure 6-11 Decreased tumour numbers in preneoplastic ROCK1nc livers 
Scatter dot plots (mean ± SEM) showing a) tumour number, b) tumour volume, c) absolute 
liver weight and d) relative liver weight in male mice injected with DEN and maintained for 
6 months (n=5 per genotype). Data was analysed using Student’s t-test. * = p< 0.05. e) 
Macroscopic view of representative preneoplastic livers from ROCK1wt and ROCK1nc 
mice 6 months after HCC initiation with DEN. Scale bars represent 1 cm. 
  
  179 
 
 
 
 
 
Figure 6-12 Decreased lung metastasis in preneoplastic ROCK1nc mice 
a) Representative H&E-stained lung sections from ROCK1wt and ROCK1nc male mice 6 
months after DEN-induction (n=5 per genotype). Scale bars represent 100 µm b) Scatter 
dot plot (mean ± SEM) shows decreased metastatic score in ROCK1nc lungs. Data 
analysed using Mann-Whitney test. ** =p<0.01. 
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 Increased macrophage numbers in preneoplastic ROCK1nc 6.2.9
livers 
Preneoplastic tumours were analysed for the presence of neutrophils, 
macrophages, and T cells by immunohistochemistry. Infiltration of neutrophils 
was analysed by staining tumour sections with S100A9 antibody. Analysis 
revealed no difference in neutrophil infiltration in preneoplastic tumours from 
both genotypes (Figure 6-13 a, b). However, analysis of F4/80-stained liver 
sections from preneoplastic tumours at 6 months after DEN-induction revealed 
significantly more macrophages in ROCK1nc tumours when compared to wild-
type tumours (Figure 6-13 c, d). Infiltration of T cells was quantified by 
immunohistochemistry using CD3 antibody, which is a pan T cell marker. Analysis 
revealed a trend towards more T cell infiltration in ROCK1nc tumours which was 
not significant (Figure 6-13 e, f). 
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Figure 6-13 Increased macrophage numbers in preneoplastic ROCK1nc livers 
a) Representative images of S100A9-stained liver sections showing neutrophils (brown) in 
preneoplastic livers and, b) corresponding bar graph. c) Representative images of F4/80-
stained liver sections showing increased number of macrophages (brown) in ROCK1nc 
preneoplastic liver and, d) corresponding bar graph. e) Representative images of CD3-
stained liver sections showing T cell infiltration (brown) in preneoplastic livers and, f) 
corresponding bar graph. Sections counterstained with haematoxylin (blue) (n=5 per 
genotype). Scale bars represent 100 µm. Bar graphs represent mean ± SEM. Data 
analysed using Student’s t-test. * = p<0.05. 
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 Liver function test for DEN-induced HCC 6.2.10
Serum collected from ROCK1wt and ROCK1nc mice during necropsy at 6 months 
and 9 months were assayed for different liver parameters. Serum ALT and AST 
levels were not different between the two groups at 6 months and 9 months 
(Figure 6-14). However, both values were higher after 9 months of DEN induction 
when compared to the control group, possibly reflecting liver injury induced by 
DEN. Alkaline phosphatase on the other hand decreased in both ROCK1wt and 
ROCK1nc mice with DEN induction. Total protein concentration, albumin, 
globulin and albumin: globulin ratio was significantly different in preneoplastic 
mice between the two genotypes (Figure 6-14 e, f, g, h). However, this 
difference was lost by 9 months of DEN-induction. Significant low levels of 
albumin and low albumin: globulin ratio values were seen in ROCK1wt mice when 
compared to ROCK1nc mice is associated with liver disease and correlates well 
with more tumour numbers observed in the wild-type preneoplastic mice (Figure 
6-14f, h). These differences seen in serum protein levels are also lost 9 months 
after DEN induction.  
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Figure 6-14 Parameters of liver function test in DEN-induced HCC 
Serum collected from ROCK1wt and ROCK1nc mice during necropsy from control mice, 
DEN-induced HCC preneoplastic mice (6 months) and end-point DEN-induced HCC (9 
months) and assayed for a) total bilirubin, b) alkaline phosphatase, c) ALT, d) AST, e) 
total protein, f) albumin, g) globulin and e) albumin to globulin ratio (n=5-12 per group). 
Data analysed by Student’s t-test. * =p<0.05, ** =p<0.01, **** =p<0.0001.  
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6.3 Discussion 
 Defective caspase cleavage of ROCK1 reduced tumour 6.3.1
numbers in DEN-induced HCC 
In the previous chapters, ROCK1-dependant apoptotic blebbing was shown to be 
important for the maintenance of homeostasis in the liver. In this chapter, the 
role of caspase cleavage of ROCK1 in tumourigenesis was studied by utilizing the 
DEN-induced HCC model. DEN has been extensively used as a carcinogen and 
several strategies of HCC induction have been developed over the years. While 
some strategies involved using DEN on its own as a tumour initiator, others 
employed a promoting agent like phenobarbital along with DEN to induce 
hepatic tumours. Since the efficacy of phenobarbital as a tumour promoter has 
come under scrutiny especially in C57BL/6 strain (Lee et al., 1989, Bursch et al., 
2005), I decided to utilize DEN on its own for my experiments. ROCK1wt and 
ROCK1nc mice were injected with DEN at two weeks of age and monitored for 
tumour formation. 
Gender disparity in HCC formation was observed in both genotypes with the 
female mice not showing macroscopic evidence of tumours, possibly due to 
difference in IL-6 production in response to liver injury as previously reported 
(Naugler et al., 2007). Remarkably, ROCK1nc male mice presented with 
significantly lesser tumour numbers both in preneoplastic stage (6 months) as 
well as at end point (9 months) suggesting that defective caspase cleavage of 
ROCK1 during apoptosis had reduced tumour initiation in these mice. Although 
tumour volumes after 9 months of DEN injection were generally lower in 
ROCK1nc mice, three of them had large tumours that were comparable to 
ROCK1wt tumours, which accounted for the loss of significance in tumour 
volume.  Lung metastasis was observed in both end-point as well as 
preneoplastic stage. ROCK1nc mice exhibited significantly lower metastatic 
score at preneoplastic stage. However, after 9 months even though most 
ROCK1nc mice had a lower metastatic score, this was not significantly different 
when compared to wild type, possibly because of the lower number of ROCK1nc 
lungs analysed. Liver damage, evaluated by the measurement of various liver 
enzymes and proteins did not reveal any differences between the two genotypes 
9 months after DEN-induction. However, in preneoplastic mice significant low 
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levels of albumin and low albumin: globulin ratio were seen in ROCK1wt mice 
when compared to ROCK1nc mice and this may be associated with greater 
hepatocellular damage due to greater tumour numbers seen in wild-type 
preneoplastic mice. 
Histopathological evaluation of ROCK1wt and ROCK1nc tumours at end point did 
not reveal any obvious differences between the two genotypes.  Classification of 
hepatic tumours using the H&E-stained sections revealed that more than 60% 
mice from both genotypes exhibited full-blown HCC and the rest exhibited 
hepatic nodules of lower grade. Although HCC development in humans often 
features fibrotic liver damage, commonly used rodent models including DEN-
induced HCC model are seldom accompanied by fibrosis (Uehara et al., 
2014).This study reaffirmed previous findings demonstrating very low percentage 
of fibrotic areas with an average of less than 1% of the total tumour area in both 
genotypes. Microvesicular and macrovesicular steatosis was observed in end 
point tumours of both genotypes and analysis revealed that 4 out of 12 ROCK1nc 
mice had a higher steatotic grade compared to just 1 out of 12 ROCK1wt mice. 
Detailed analysis revealed that ROCK1nc mice with higher steatotic grade had 
large tumours as well, with the exception of one. Although hepatic steatosis has 
been linked with HCC development (Ohata et al., 2003, Park et al., 2010), it is 
not clear why ROCK1wt mice with large tumours failed to display higher 
steatotic grade. 
Nonetheless, hepatic steatosis has been conceptualised as a precursor for 
inflammation (Peverill et al., 2014) and this correlated well with the large 
inflammatory infiltrates seen in ROCK1nc tumours. Detailed analysis of these 
immune cells by immunohistochemistry revealed that these infiltrates were 
mainly composed of neutrophils, macrophages and T cells. There was increased 
infiltration of neutrophils in ROCK1nc tumours and a trend towards increased T-
cell infiltration as well. Similar to the acute liver damage model where defective 
ROCK1 cleavage exacerbated infiltration of inflammatory cells like neutrophils, 
as detailed in the previous chapter, it is possible that a similar scenario unfolded 
in a tumour microenvironment as well. 
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 Defective caspase cleavage of ROCK1 results in increased 6.3.2
infiltration of CD8+ T cells 
Human HCC is an inflammation-induced cancer, with risk factors like viral 
hepatitis and alcohol abuse causing chronic inflammation. Role of infiltrating 
immune cells in the development and progression of liver cancer was neatly 
demonstrated in a recent study where reduced immune cell trafficking to the 
liver resulted in dramatic reduction in tumour development (Barashi et al., 
2013). In this study, ROCK1nc mice presented with significantly more 
macrophages at preneoplastic stage and significantly more neutrophils at the 
timed end-point of 9 months after DEN injection. Also increased in ROCK1nc 
tumours at end-point were the number of infiltrating T cells which however 
were not in significant numbers when compared to wild type tumours. 
Infiltration of neutrophils is associated with poor prognosis in a variety of human 
cancers including HCC (Dumitru et al, 2013). As discussed in the previous 
chapter, damage to the hepatic parenchyma triggers neutrophil infiltration and 
their persistence in the liver subsequently can promote more damage through 
the production of ROS and proteases in an acute damage scenario. Recent study 
by Wilson et al showed that in DEN-induced HCC model, neutrophils promote 
HCC by causing telomere damage in hepatocytes (Wilson et al., 2015). Hence 
their increased presence in ROCK1nc tumours was puzzling. The role of 
macrophages in tumour progression has been extensively studied and as 
discussed earlier, inhibiting macrophage recruitment in a spontaneous model of 
HCC resulted in a reduction in liver tumours (Barashi et al., 2013). Another set 
of immune cells that has received considerable attention are tumour infiltrating 
T cells. Different subsets of T cells including CD4+, CD8+ and regulatory T cells 
(Tregs) have been identified in solid tumours mostly by immunohistochemical 
techniques, and the presence of CD8 as well as high CD8/Foxp3 ratios had a 
positive effect on survival (Gooden et al., 2011). Remarkably, analysis of 
infiltrating CD8+ T cells revealed a significant increase in ROCK1nc tumours 
when compared to wild type tumours. Analysis of Foxp3 positive Treg cells did 
not show a significant difference between the two genotypes. It is possible that 
the infiltrating CD8+ T cells keep tumour numbers in check in ROCK1nc mice, but 
the high numbers of infiltrating neutrophils promote tumourigenesis in the 
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already formed tumours hence accounting for the lack of difference in tumour 
volume between the two genotypes. 
6.4 Summary 
DEN-induced HCC was repressed in ROCK1nc mice but exhibited higher grade of 
steatosis. Defective caspase-cleavage of ROCK1 resulted in increased infiltration 
of CD8+ cytotoxic T cells in ROCK1nc livers which may be responsible for the 
decreased tumour numbers seen in ROCK1nc mice. As shown in the previous 
chapter, in the liver, apoptotic blebbing suppresses inflammation which may be 
beneficial for maintenance of homeostasis in an acute scenario. However; in a 
tumour setting, suppression of inflammation may prove detrimental since this 
can curb immunosurveillance and subsequent elimination of tumours. 
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7 Eµ-myc lymphoma model 
7.1 Introduction 
 Eµ-myc lymphoma 7.1.1
The Eµ-myc transgenic mice model resembles human Burkitt lymphoma that 
bears the MYC/Ig gene translocation t(8;14)(q24;q32). Myc is a nuclear 
transcription factor that regulates several target genes involved in proliferation, 
differentiation, apoptosis, metabolism and DNA repair (Dang, 2012). The myc 
family of oncogenes (c-myc, N-myc and L-myc) is activated in most rapidly 
dividing malignancies and elevated myc levels lead to hyperproliferative DNA 
damage responses as well as apoptosis (Soucek and Evan, 2010). Of these, the c-
myc oncogene has been extensively studied using one of the earliest models, the 
Eµ-myc model, described by Adams and colleagues in 1985 (Adams et al., 1985). 
In this transgenic model, expression of c-myc is deregulated as it is under the 
control of immunoglobulin heavy chain enhancer (Eµ). Hence, Eµ-myc transgenic 
mice overexpress c-myc in the B cell lineage and hence succumb to B cell 
lymphomas with a mean survival of 4-6 months (Adams et al., 1985, Harris et al., 
1988). 
c-myc expression not only confers a proliferative advantage but also induces 
apoptosis. Therefore, Myc-induced lymphoma is preceded by a prolonged 
precancerous phase in which the increased proliferative rates of B cells is offset 
by a high apoptotic index (Jacobsen et al., 1994). This latency period reflects an 
ability of c-myc to induce a p53-dependant apoptotic program. However, 
additional mutations in the p53 tumour suppressor pathway result in the 
emergence of a clonal B-cell lymphoma (Eischen et al., 1999, Jacobs et al., 
1999). Since its creation more than three decades ago, this model is frequently 
crossed with other genetically altered mice to investigate the effect of different 
genes in how they alter lymphoma onset time or modulate response to 
chemotherapy. 
 Experimental Aim 7.1.2
To determine whether defective caspase cleavage of ROCK1 affects 
tumourigenesis in Eµ-myc-lymphoma model. 
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7.2  Results 
 Defective caspase cleavage of ROCK1 increases lymphoma-7.2.1
free survival 
Eµ-myc transgenic mice which express the c-myc oncogene under the control of 
the immunoglobulin heavy chain enhancer (Eµ) die from tumours of the B 
lymphocyte lineage (Adams et al., 1985). To determine whether defective 
caspase cleavage of ROCK1 influences the development of Eµ-myc-induced 
lymphoma, Eµ-myc transgenic male on a C57Bl/6 background, kindly provided by 
Dr. Karen Blyth, were crossed with ROCK1nc mice (Figure 7-1). Eµ-myc/ROCK1het 
males were then crossed with ROCK1wt or ROCK1nc females to generate Eµ-
myc/ROCK1wt and Eµ-myc/ROCK1nc mice, respectively (Figure 7-1). Female mice 
carrying the Eµ-myc gene were not used for breeding because of their high risk 
of developing lymphomas before their pups reached weaning age. 
Mice bearing the Eµ-myc transgene were examined three times a week for signs 
of morbidity and lymphoma emergence. This included presence of enlarged 
lymph nodes, hunched posture, slow movement, ruffled fur, swollen abdomen 
and/or tachypnoea/dyspnoea. Mice were sacrificed once they displayed any of 
these symptoms and the date of necropsy was utilized for survival analysis. As 
expected, Eµ-myc/ROCK1wt mice succumbed to lymphoma at a median age of 
106 days (15 weeks). However, Eµ-myc/ROCK1nc mice displayed a significantly 
delayed onset of lymphoma with a median age of 152 (21 weeks) (Figure 7-2 a). 
All Eµ-myc/ROCK1wt mice died before 184 days while 26% of Eµ-myc/ROCK1nc 
mice survived beyond 200 days (Figure 7-2 a). Kaplan Meier survival analysis was 
only done for 3rd (F3) and 4th generation (F4) animals as I noticed a difference in 
survival in both genotypes between generations and this was significant in Eµ-
myc/ROCK1wt mice (Figure 7-2 b and c). Since the numbers of 2nd generation Eµ-
myc/ROCK1wt mice were not enough for comparison (n=3), this generation was 
omitted from the final analysis (Figure 7-2 a).  
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Figure 7-1 Generation of Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc mice 
Schematic representation of breeding strategy shows generation of Eµ-myc/ROCK1wt 
and Eµ-myc/ROCK1nc mice. Matings are indicated with an X and the resultant desired 
offspring with an arrow. 
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Figure 7-2 Increased survival of Eµ-myc/ROCK1nc mice 
a) Kaplan-Meier survival curve for Eµ-myc/ROCK1wt (n = 29) and Eµ-myc/ROCK1nc (n = 
36) showing delayed lymphoma development in mice carrying ROCK1nc mutation. b) & c) 
Kaplan-Meier curves showing differences in survival between different generations in Eµ-
myc/ROCK1wt [2nd (n = 3), 3rd (n = 8), 4th (n = 21)] and Eµ-myc/ROCK1nc [2nd (n = 18), 3rd 
(n = 16), 4th (n = 20)] mice, respectively Data analysed by Mantel-Cox test. ** = p<0.01; 
**** = p<0.0001. 
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  Analysis of Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc 7.2.2
tumours 
Mice exhibiting morbidity and lymphoma emergence were euthanized by carbon 
dioxide inhalation. Blood was collected for haematological analysis via cardiac 
puncture and body weights were recorded prior to necropsy. During necropsy, all 
lymphoid organs including the thymus, spleen and lymph nodes were harvested 
and their weights recorded. 
Haematological analysis revealed high number of WBCs, namely lymphocytes and 
neutrophils in Eµ-myc mice as expected, but otherwise did not show any 
significant differences across the blood parameters analysed (data not shown). 
Analysis of body weight at necropsy did not reveal any significant differences 
between the two genotypes (Figure 7-3 c). Necropsy of tumour bearing Eµ-
myc/ROCK1wt and Eµ-myc/ROCK1nc mice revealed disseminated disease mostly 
involving the thymus spleen and lymph nodes, particularly the axillary, brachial, 
inguinal and mesenteric lymph nodes. Based on the major lesions identified, 
tumours were classified as follows; a)thymic lymphoma, if the mice succumbed 
to an enlarged thymic tumour that was the predominant lesion, b) lymphoma, if 
the mice exhibited spleen and lymph node enlargement without thymic 
involvement and c) multicentric lymphoma, if all the lymphoid organs were 
enlarged. Analysis revealed that 47% of Eµ-myc/ROCK1nc mice exhibited thymic 
lymphoma when compared to 10.5% in Eµ-myc/ROCK1wt mice (Figure 7-3 a, b). 
High incidence of thymic lymphoma was reported in the initial characterisation 
of Eµ-myc transgenic mice and they were shown to be B-lineage tumours (Harris 
et al, 1988). Nonetheless, analysis of weights of thymus did not reveal any 
significant differences between the two genotypes, albeit some Eµ-
myc/ROCK1nc mice displayed very high thymic weights (Figure 7-3 d). Analysis of 
spleen and lymph node weights also did not unveil any significant difference 
(Figure 7-3 e, f). Immunophenotyping of tumours by FACS analysis with B220 and 
sIg (IgM and IgD) revealed that most of lymphomas analysed from Eµ-
myc/ROCK1nc mice were mature B lymphomas (37.5%) or mixed pre-B/B- 
lymphomas (43.75%) (Figure 7-4 a, b). Additionally, only 18.75% of Eµ-
myc/ROCK1nc tumours were pre-B lymphoma when compared to 35% in Eµ-
myc/ROCK1wt mice (Figure 7-4 a, b).  
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Figure 7-3 Analysis of Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc tumours 
Pie chart shows percentages of each tumour type in a) Eµ-myc/ROCK1wt and b) Eµ-myc 
/ROCK1nc mice. Scatter dot plots (Mean ± SEM) shows no significant differences 
between c) body weight recorded at necropsy, d) relative thymus weight, e) relative 
spleen weight and f) relative lymph node weight (n=19 per genotype). Data analysed by 
Student’s t-test.   
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Figure 7-4 Immunophenotyping of lymphoma tumours 
a) Representative FACS plots (FL1- B220; FL-4- sIg) show gating strategy for pre-B cell, 
mature B cell and mixed B cell lymphoma. b) Stacked bar graph shows the percentage of 
Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc mice with different tumour phenotypes.  
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7.3 Discussion 
The Myc family (c-myc, N-myc and L-myc) of transcription factors regulates 
several genes involved in regulating proliferation and apoptosis, and in several 
human tumours, myc is aberrantly activated. Of these, the c-myc proto-
oncogene has been shown to be overexpressed in over 50% of human tumour and 
hence has been extensively studied (Morton and Sansom, 2013). Eµ-myc 
transgenic mice carry a c-myc oncogene under the control of immunoglobulin 
heavy chain enhancer (Eµ) and hence c-myc is overexpressed in B lymphocytes 
(Adams et al., 1985). This results in tumours of B-cell lineage and mice succumb 
to lymphoma within 4-6 months (Adams et al., 1985). These tumours arise after 
a pre-cancerous phase in which increased proliferation of B cells is 
counterbalanced by a high apoptotic index (Jacobsen et al., 1994). Eventually, 
the cell cycle and apoptotic checkpoints fail due to additional mutations and the 
mice develop full-blown lymphomas. 
To address the role of apoptotic blebbing in tumourigenesis, I made use of this 
apoptosis-prone transgenic mouse model of lymphomagenesis (Eµ-myc) to 
investigate whether defective apoptotic blebbing can influence 
lymphomagenesis. To achieve this, ROCK1nc mice were crossed with Eµ-myc 
transgenic mice to generate Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc mice. In 
this study, I have shown that defective caspase cleavage of ROCK1 significantly 
extended the survival of Eµ-myc expressing mice. Eµ-myc on a C57Bl/6 
background was crossed with ROCK1nc which was on a mixed background 
(C57Bl/6 : 129/Sv). Hence, each generation of Eµ-myc/ROCK1wt and Eµ-
myc/ROCK1nc mice had different genetic backgrounds. The effect of genetic 
background on lymphoma onset was evident in Eµ-myc/ROCK1wt upon survival 
analysis with later generations surviving longer. To avoid the effect of genetic 
background on lymphoma development, I analysed tumours from the same 
generation henceforth. 
Based on the major lesions observed during necropsy, most Eµ-myc/ROCK1nc 
displayed enlarged thymus. Despite the delay in lymphomagenesis and the 
prevalence of thymic lymphoma in Eµ-myc/ROCK1nc mice, assessment of tumour 
load in the thymus and in other lymphoid organs did not reveal a significant 
difference between the two genotypes. However, immunophenotyping of 
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tumours from Eµ-myc/ROCK1wt and Eµ-myc/ROCK1nc revealed a difference in 
their stage of maturation. The majority of the Eµ-myc/ROCK1nc tumours were 
mature B lymphomas or mixed pre-B/B lymphomas. Eµ-myc mice mostly 
developed pre-B lymphoma because c-myc expression throughout B-cell 
development provokes an expansion of pre-B cells and reduces differentiation to 
a mature B-cell stage (Langdon et al., 1986).It is possible that defective caspase 
cleavage of ROCK1 favours the rapid clearance of premalignant B cells, thus 
contributing to the prolonged survival of these animals. Analysis of immune 
infiltration in pre-neoplastic mice will shed more light. 
7.4 Summary 
Defective caspase cleavage of ROCK1 significantly delays lymphomagenesis in 
the Eµ-myc model, probably by clearance of pre malignant B cells by the 
immune cells.  
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8 p53-deficient mouse model 
8.1 Introduction 
 Trp53-deficient mouse model 8.1.1
The high propensity for mutation in the p53 gene (TP53) in a wide range of 
human cancers, as well as deregulation of the p53 pathway in tumours that 
retain the wild-type allele implies a role as a critical tumour suppressor 
(Kenzelmann Broz and Attardi, 2010). p53 limits proliferation of tumour cells by 
inducing apoptosis, cell-cycle arrest or senescence in response to a variety of 
stresses, including genotoxic damage, oncogene activation and hypoxic 
conditions (Vousden and Prives, 2009). In addition to the frequent occurrence of 
acquired p53 mutations in spontaneously arising tumours, humans carrying germ 
line p53 mutations are associated with Li-Fraumeni syndrome, a familial cancer 
disorder characterised by predisposition to a broad spectrum of malignancies 
including breast carcinomas, bone and soft tissue sarcomas, brain tumours and 
haematological neoplasms (Varley, 2003). To complement studies on the role of 
p53 in a cell culture environment, a number of mouse models were created by 
manipulating the mouse Trp53 gene, with knockouts as well as knock-in 
mutations commonly found in humans being created. These genetically modified 
mouse models proved to be integral in providing invaluable insights into the 
function of p53 in complex tissue environments. 
Genetic knockout of the Trp53 gene in the mouse originally described in 1992 by 
Donehower et al and then in 1994 by Jacks et al, demonstrated that p53 is 
largely dispensable for normal development, but all genetically-modified mice 
eventually developed some form of malignant growth and succumbed to cancer 
(Donehower et al., 1992, Jacks et al., 1994). Most animals developed thymic 
lymphomas and a range of sarcomas. Predisposition to tumours was evident in 
Trp53 heterozygous mice as well, however the tumour spectra and latency was 
different from that seen in the Trp53 null animals with heterozygotes mostly 
developing mesenchymal cancers including fibrosarcomas, osteosarcomas and 
hemangiosarcomas at later time points. Carcinomas or epithelial cancers occur 
less frequently in Trp53 null and Trp53 heterozygous mice but humans with 
Trp53 mutation or loss are mostly diagnosed with carcinomas (Malkin et al., 
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1990). Also striking was the effect of genetic background on tumour spectra. For 
example, Trp53 heterozygous mice on a Balb/C background develop significant 
number of breast carcinomas (Kuperwasser et al., 2000) and Trp53 null mice on 
a 129/Sv background exhibited higher incidence of testicular tumours (Harvey et 
al., 1993) whereas the pioneering work on Trp53 models by Donehower et al and 
Jacks et al were performed on a mixed C57BL/6 and 129/Sv background 
(Donehower et al., 1992, Jacks et al., 1994). This strongly suggested an effect of 
genetic modifiers in influencing the cancer spectra. Crossing tumour-prone 
mouse strains to a Trp53 null background accelerated tumourigenesis, which not 
only revealed genetic interactions between p53 and other genes involved in 
tumour development but also further supported the importance of p53 in 
preventing cancer (Attardi and Jacks, 1999). 
 Experimental Aim 8.1.2
To determine whether defective caspase cleavage of ROCK1 will alter the 
tumour incidence and/or tumour spectra associated with p53-deficiency. 
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8.2 Results 
 Generation of p53-deficient ROCK1wt and ROCK1nc mice 8.2.1
The broad spectrum of tumours observed in p53-deficient mice can be utilized to 
study the effect of candidate mutations in alterations on tumour spectra and 
tumour latency. To determine whether defective caspase cleavage of ROCK1 can 
change the tumour spectra of p53-deficient mice, heterozygous 129-Trp53tm1Tyj/J 
mice were crossed with ROCK1nc mice that were already backcrossed to 129/Sv 
background for eight generations. Subsequent crosses yielded p53-/-/ROCK1wt, 
p53-/-/ROCK1nc, p53+/-/ROCK1wt and p53+/-/ROCK1nc mice (Figure 8-1 a).  
Survival of p53-deficient mice had led to the conclusion that p53 was 
dispensable for normal development (Donehower et al., 1992, Jacks et al., 
1994). Crosses between heterozygous (p53+/-) mice yielded 23 % of p53-/- at 
weaning, which approached the expected Mendelian ratio of 25% (Figure 8-1 b). 
Crosses between p53-/- male and p53+/- female yielded 50 % of p53-/- mice at the 
time of weaning which was equal to the expected Mendelian ratio (Figure 8-1 b). 
This suggested that p53 function was not necessary for mouse development. 
Nonetheless, it should be noted that 10 mice from heterozygous crosses were 
found dead prior to weaning and the cause of death is unknown. 
However, detailed analysis of the number of p53-/- males and females weaned 
from these crosses revealed that homozygous loss of p53 in both ROCK1wt and 
ROCK1nc mice resulted in fewer female homozygotes at the time of weaning. In 
both p53-/-/ROCK1wt and p53-/-/ROCK1nc, only 36% of mice weaned were 
females, which was significantly low (Figure 8-1 c). Reduced recovery of female 
homozygotes has been previously reported in other studies where subsequent 
analysis of embryos revealed defects in neural tube closure that were strongly, 
but not exclusively associated with the female gender (Armstrong et al., 1995, 
Sah et al., 1995). Defects in neural tube closure causes exencephaly in embryos 
that result from overgrowth of neural tissue in the mid-brain, and female 
preponderance has been associated with sex-dependent differences in 
neurulation during development. (Copp et al., 1990).  
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Figure 8-1 Generation of p53-deficient ROCK1wt and ROCK1nc mice 
a) Breeding strategy showing generation of p53-/-/ROCK1wt and p53-/-/ROCK1nc mice. 
Matings are indicated with an X, and the resulted desired offspring with an arrow. b) 
Tables show expected (Mendelian) and observed percentage of mice from crosses with 
the indicated genotypes. c) Table shows number of males and females born and the 
percentage for each genotype in brackets. Data analysed by Chi-squared test. ** = p < 
0.01.  
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 Defective caspase cleavage of ROCK1 does not alter 8.2.2
survival rate of mice deficient in p53 
In this chapter, I will describe the survival and tumour spectrum of p53-
nullizygous mice as the heterozygous p53-deficient mice cohort is still ongoing 
due to an expected delay in tumour formation. p53-/-/ROCK1wt and p53-/-
/ROCK1nc mice were checked thrice weekly for the presence of tumours and 
sacrificed when the animal displayed signs of discomfort and/ or presence of 
tumours either visually or by palpation. As expected, p53 wild-type control mice 
did not exhibit any tumours during monitoring. Weights of mice were recorded 
during necropsy and tumours were harvested. In addition, heart, lungs, thymus, 
spleen, pancreas, liver, kidneys, reproductive organs and brain were also 
collected routinely for histological evaluation. 
Analysis of tumour-free survival of p53-/-/ROCK1wt (n = 10) and p53-/-/ROCK1nc 
(n = 11) showed that the median time for tumour onset did not differ 
significantly between the two genotypes, with most mice succumbing to tumours 
before 5 months. Few mice developed tumours within 3 months of age. p53-/-
/ROCK1wt had a median survival of 131 days and p53-/-/ROCK1nc had 140 days 
(Figure 8-2 a). Separate analysis of males and females showed that among males, 
p53-/-/ROCK1nc mice had a shorter median age of survival of 107 days compared 
to 131 days for p53-/-/ROCK1wt mice. Among females, p53-/-/ROCK1nc mice 
exhibited slightly better tumour-free survival with 178 days, although not 
significant (Figure 8-2 b, c). However, it should be noted that the number of 
females analysed is only three per genotype and hence not conclusive. Analysis 
of body weight during necropsy did not reveal any difference between the two 
genotypes (Figure 8-2 d).  
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Figure 8-2 ROCK1nc mutation does not affect tumour free survival 
a) Kaplan Meier survival curve for p53-/-/ROCK1wt (n=10) and p53-/-/ROCK1nc (n=11). b) 
Survival curve for males p53-/-/ROCK1wt (n=7) and p53-/-/ROCK1nc (n=8). c) Survival 
curve for females p53-/-/ROCK1wt (n=3) and p53-/-/ROCK1nc (n=3). Comparison of 
survival curves by Mantel-Cox test. d) Bar graph represents weight (in grams) of mice 
recorded at necropsy showing no significant difference between the two genotypes. Error 
bars represent SEM. Data analysed by Student’s T test.  
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 Analysis of tumour spectra 8.2.3
The co-operative effect of defective caspase cleavage of ROCK1 and p53-
deficiency on tumour spectra was analysed macroscopically and by 
histopathological evaluation. A total of 21 animals were analysed for this study. 
Two animals were found dead, however necropsy did not reveal any detectable 
lesions. 
The tumour type most frequently observed was lymphoma, with 15 mice (8 p53-/-
/ROCK1wt and 7 p53-/-/ROCK1nc) displaying thymic lymphoma (Figure 8-3 a). 
These mice presented respiratory distress by 4 to 5 months due to lung 
compression caused by the enlarged thymus. Histologically, metastasis of 
lymphoid cells was frequently detected in the lungs and less frequently in the 
liver and kidney. Two of these mice, one from each genotype, also displayed 
testicular tumour of one testis. 
Two p53-/-/ROCK1nc mice displayed testicular tumour of both testes. These 
tumours arose in less than 3 months. The tumours were large in size and one of 
them weighing up to 4.7g in weight. Upon histological evaluation, these tumours 
displayed features akin to teratomas, with recognisable endodermal, 
mesodermal and ectodermal regions (Figure 8-4c, d). These mice also presented 
splenic lymphoma (Figure 8-4 b). Hence, while three p53-/-/ROCK1nc mice 
presented testicular tumours, only one p53-/-/ROCK1wt displayed the same. 
One p53-/-/ROCK1wt mice presented a large necrotic mass of around 1.47 g 
located near the testis. Unfortunately, the tissue of origin could not be 
determined. The mice also presented ascites and splenic lymphoma. One p53-/-
/ROCK1wt and one p53-/-/ROCK1nc mice exhibited stomach tumours and splenic 
lymphoma. The livers from these mice exhibited small nodular pale lesions 
which were macroscopically visible. One p53-/-/ROCK1nc mice presented 
subcutaneous sarcoma (Figure 8-4 e, f).  
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Figure 8-3 Comparison of tumour spectrum  
Pie chart shows percentages of each tumour type in a) p53-/-/ROCK1wt (n=8) and b) p53-/-
/ROCK1nc mice (n=7).  
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Figure 8-4 Histopathological evaluation of tumours 
Representative H&E-stained sections from a) thymic lymphoma, b) splenic lymphoma, c) 
and d) testicular teratoma showing tissue from the three germ layers: keratin pearl (black 
arrow; ectoderm), cartilage (yellow arrow; mesoderm), glandular epithelium (white arrows; 
endoderm) and remnant testicular tissue (green arrow), e) and f) sarcoma. Scale bars 
represent 100 µm.  
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8.3 Discussion 
Mutations in the p53 tumour suppressor gene are found at high frequency in 
most human cancers. Germline p53 mutations have been associated with an 
inherited predisposition to early onset cancer called Li-Fraumeni syndrome. 
Generation of p53-deficient mice proved to be crucial in establishing the tumour 
suppressive function of the gene. Both nullizygous and heterozygous mice 
succumb to tumours, albeit with delayed tumour latency in heterozygous mice 
(Donehower et al., 1992, Jacks et al., 1994). The types of tumours observed in 
mice are predominantly lymphomas and sarcomas, but the tumour spectrum has 
a strong dependence on the genetic background of mice (Attardi and Jacks, 
1999). Several studies have systematically defined the tumour spectra of p53-
deficient mice with different genetic backgrounds (Kenzelmann Broz and 
Attardi, 2010). In addition, a number of studies have successfully looked at the 
effect of p53-deficiency in combination with other tumour-promoting mutations 
or mutations in tumour-suppressive genes (Attardi and Jacks, 1999). 
In this study, I used the p53-deficient mouse model to investigate whether 
defective caspase-cleavage of ROCK1, and in-effect, whether defective 
apoptotic blebbing would alter tumour latency and tumour spectra. This study 
was also aimed at identifying tumours where apoptotic blebbing would play a 
crucial role. Heterozygous p53-deficient mice, on a 129 background, purchased 
from Charles River UK were crossed with ROCK1nc that were already 
backcrossed to 129/Sv background for eight generations. Generation of ROCK1wt 
and ROCK1nc mice with homozygous or heterozygous p53-deficiency with 
expected Mendelian ratios reaffirmed previous findings that p53 had no effect on 
normal development. Female-specific lethality that was observed in homozygous 
p53-deficient mice also correlated with previous reports (Armstrong et al., 1995, 
Sah et al., 1995); however ROCK1nc mutation had no influence on this gender-
related lethality. 
While studying the effect of genetic background on tumour incidence and 
spectra, it was found that the onset of tumours was earlier on a 129/Sv 
background when compared to mixed background (C57BL/6 and 129/Sv) (Harvey 
et al., 1993). Analysis of tumour-free survival of p53-/-/ROCK1wt and p53-/-
/ROCK1nc showed that the median time to tumour onset did not differ 
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significantly between the two genotypes, with most mice succumbing to tumours 
before 5 months. Analysis of tumour spectra revealed that as expected, 
lymphomas were the most frequently observed tumour in both genotypes. 
Lymphomas are quite common in both 129/Sv as well as mixed background, but 
the percentage is slightly lower in the 129/Sv background (Harvey et al., 1993). 
The second most frequently observed tumours in this study were testicular 
tumours. Three p53-/-/ROCK1nc compared to one p53-/-/ROCK1wt mice 
displayed testicular tumour either as a primary tumour or in combination with 
thymic lymphoma, thus hinting at the possibility of a role of ROCK1-dependant 
apoptotic blebbing in tumour formation in the testis. However, the small number 
of animals used in this study hampers the possibility of conclusive evidence. 
Testicular tumours were early-onset tumours in both genotypes and displayed 
features of teratoma. Sarcomas are also common in this background and one 
p53-/-/ROCK1nc mice presented subcutaneous sarcoma. The high frequency of 
lymphomas and small number of animals analysed for this study is a major 
caveat in determining the effect of apoptotic blebbing in this model. Also, 
heterozygous p53-deficient mice with a broader range of tumour types would be 
a more suitable model for this investigation. 
8.4 Summary 
Defective caspase-cleavage of ROCK1 does not change tumour-free survival in 
homozygous p53-deficient mice but hints at a possible role in testicular tumour 
formation. 
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Results 
Actomyosin-dependant protein release from 
apoptotic blebs  
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9 Actomyosin dependant protein release from 
early apoptotic cells alert the immune system 
9.1 Introduction 
 Apoptotic cells advertise their presence  9.1.1
The prompt removal of apoptotic cells by phagocytes is important for 
maintaining homeostasis in multicellular organisms. To facilitate their removal, 
apoptotic cells advertise their presence to the immune system. This is achieved 
by the display of ‘eat me’ signals like phosphatidylserine on the surface of 
apoptotic membrane. Over the years, a number of ‘find me’ signals released by 
apoptotic cells including nucleotides (ATP/UTP), lysophosphatidylcholine (LPC) 
and sphingosine-1 phosphate have been identified which act as chemoattractants 
for phagocytes (Poon et al., 2014). Prompt clearance sequesters the dying cell 
and prevents the release of potentially noxious intracellular contents into the 
surrounding environment. This is a key distinction from necrotic cell death 
where membrane integrity is lost resulting in the unregulated release of 
intracellular contents like DAMPs that can provoke a strong inflammatory 
response. In addition to display of ‘eat me’ signals, apoptotic cells can be 
distinguished from their viable counterparts based on their morphological 
features including cell contraction, nuclear condensation and fragmentation, 
membrane blebbing and apoptotic body formation. We now know that the 
driving force behind actomyosin contractility during apoptosis is caspase–
mediated cleavage and consequent activation of ROCK1 (Coleman et al., 2001, 
Sebbagh et al., 2001). Despite the widely held notion that apoptotic cells 
preserve membrane integrity, work from our lab provided evidence that blebs 
and apoptotic bodies can lose membrane integrity (Wickman et al., 2013) thus 
hinting at the possibility that membrane blebs and apoptotic bodies can release 
proteins prior to secondary necrosis. 
  Experimental Aims 9.1.2
To investigate whether membrane blebs and apoptotic bodies release proteins in 
an actomyosin dependant manner prior to secondary necrosis and to identify the 
proteins released using a SILAC-based mass spectrometry approach. 
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9.2  Results 
[The results outlined in this chapter was published in Cell Death and 
Differentiation (Wickman et al., 2013).] 
  Actomyosin-dependant blebs and apoptotic bodies release 9.2.1
proteins 
Given the importance of actomyosin contractility in mediating membrane 
blebbing and apoptotic body formation, we wanted to investigate whether the 
contractile force generated by the actin-myosin cytoskeleton can influence the 
release of proteins that can act as potential ‘find me’ signals. For this, I induced 
apoptosis in NIH3T3 fibroblasts using TNFα and CHX in the presence of 
Blebbistatin or ROCK1 inhibitor Y-27632. Blebbistatin is a myosin ATPase 
inhibitor that impairs blebbing by inhibiting actomyosin contractility (Cheung et 
al., 2002). 4 hours after apoptosis induction, the conditioned medium was 
collected. Proteins in the conditioned medium were then concentrated using 
StrataClean Resin by following a protocol kindly provided by Dr. Juan Hernandez, 
and then separated on polyacrylamide gels (Figure 9-1 a). 
Staining the polyacrylamide gel with Coomassie Blue revealed that there was a 
clear increase in bulk protein release 4 hours after treatment with the apoptotic 
inducer (lane 2 and lane 5) when compared to untreated cells (lane 1 and lane 4) 
(Figure 9-1 b). However, the amount of proteins released from apoptotic cells 
was visibly reduced if cells were treated with ROCK1 inhibitor Y-27632 (lane 3) 
or Blebbistatin (lane 6) (Figure 9-1 b). This suggested that contrary to popular 
belief, substantial amount of proteins are released from apoptotic cells and this 
occurs in an actomyosin-dependant manner.  
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Figure 9-1 Actomyosin-dependant protein release from apoptotic cells 
a) Experimental workflow for studying protein release from apoptotic cells. b) Coomassie-
stained polyacrylamide gel of concentrated proteins in conditioned media from equal cell 
numbers for indicated treatments (Wickman et al., 2013).  
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 Proteomic analysis of proteins released from apoptotic cells 9.2.2
Quantitative proteomic analysis using an adapted approach combining stable 
isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry 
was performed to identify proteins released by apoptotic cells. The SILAC 
technique relies upon labelling proteins with amino acids lysine (Lys) and 
arginine (Arg) that contains stable heavier isotopes, followed by mass 
spectrometry analysis for identification, characterization and quantitation of 
proteins. Cells are cultured in media supplemented with labelled amino acids 
instead of the natural amino acids for at least five doublings, thus allowing 
incorporation into ~97% of proteins. Proteins from unlabelled and labelled 
samples are pooled and individual proteins, due to their mass difference, can 
then be easily distinguished from different samples using liquid chromatography 
and mass spectrometry (LC-MS). 
To determine whether proteins released during apoptosis were dependant on 
membrane blebbing, profiles of proteins in the conditioned media after 
apoptosis induction with TNFα and CHX, in the absence or presence of Y-27632 
or Blebbistatin were compared. For this study, I performed the Triple SILAC 
labelling of NIH3T3 cells. Briefly, individual NIH3T3 fibroblast populations were 
grown in defined SILAC medium containing light (Lys0, Arg0), medium (Lys4, 
Arg6) or heavy (Lys8, Arg10) amino acids. Each labelled population was then 
assigned an experimental treatment: reference (control); apoptosis (TNFα and 
CHX); apoptosis with reduced apoptotic body formation (TNFα and CHX with Y-
27632 or Blebbistatin). Six replicate experiments were performed with each set 
of conditions cycled through the SILAC labels, i.e. 3 of which included Y-27632 
treatment and 3 of which included Blebbistatin treatment. After 4 hours, 
conditioned medium was collected and pooled from each of the different sets. 
The proteins in the conditioned media were concentrated using StrataClean 
Resin. This was followed by electrophoresis, tryptic digestion and analysis of 
protein tryptic fragments by mass spectrometry (Figure 9-2). 
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A list was compiled of proteins that were significantly different between 
treatment groups, which were enriched for release from apoptotic cells relative 
to untreated cells (control), and which were reduced by both Y-27632 and 
Blebbistatin treatment. Using these criteria, we identified 231 proteins that 
were released from apoptotic bodies in an actomyosin-dependent manner. Of 
these, the top 20 most enriched proteins released in an actomyosin-dependant 
manner are listed here (Table 9-1). Nucleosomal histones (H1.2, H2A, H2B, H3 
and H4) were the most highly enriched proteins in the apoptotic supernatant 
that were released in an actomyosin–dependant manner. Histones are 
characterized as potent DAMPs that activate cells of the innate immune system 
by binding to Toll-Like receptors (Huang et al., 2011, Allam et al., 2012). Gene 
ontology analysis revealed that most proteins were either structural/adapter 
proteins (61%) or enzymes (27%) (Figure 9-3 a). Upon comparison of fold 
enrichment in protein release with protein mass, it was apparent that the 
majority of the proteins were less than 100 kDa in size and of these, the smaller 
proteins were the most abundantly released (Figure 9-3 b). In addition to this, 
release of five extracellular matrix proteins were actually reduced in apoptotic 
cells (Fibronectin1, Sparc, Timp2, Thrombospondin2 and Decorin), which was at 
least partially restored by Y-27632 and Blebbistatin (Figure 9-3 c). 
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Figure 9-2 Experimental flow chart for quantitative SILAC mass spectrometry 
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Protein 
Identified 
Gene 
Name 
Permutation 
Test 
(p value) 
Fold enrichment 
(+ SEM) 
(apoptotic/ 
reference) 
Reduction 
by 
Y-27632 
(%) 
Reduction 
by 
Blebbistatin 
(%) 
Histone H4 Hist1h4a -3.50E-11 11.57 + 2.58 13.0 38.6 
Histone H2B Hist1h2bb -2.10E-11 11.27 + 2.43 2.4 43.2 
Histone H3 H3f3a -9.40E-06 11.17 + 1.52 10.7 39.7 
Histone H2A Hist1h2af -2.30E-07 10.67 + 1.82 15.9 32.5 
Histone H1.2 Hist1h1c -2.30E-04 9.34 + 3.01 31.1 37.9 
Lamin-B1 Lmnb1 -6.50E-07 7.65 + 0.93 22.4 35.5 
Heterogeneous 
nuclear 
ribonucleoprotein K 
Hnrnpk -4.90E-04 6.57 + 1.35 7.1 46.2 
Lamin-A Lmna -5.00E-15 6.29 + 0.93 22.6 32.7 
Polypyrimidine 
tract-binding protein 
1 
Ptbp1 -1.30E-02 5.78 + 1.11 13.5 52.4 
Nuclear mitotic 
apparatus protein 1 
Numa1 -1.80E-05 5.20 + 1.25 37.8 22.4 
Heterogeneous 
nuclear 
ribonucleoproteins 
C1/C2 
Hnrnpc -4.90E-02 4.08 + 0.93 4.4 17.5 
Nuclear ubiquitous 
casein and cyclin-
dependent kinases 
substrate 
Nucks1 -2.00E-02 3.98 + 0.93 20.9 40.5 
Heterogeneous 
nuclear 
ribonucleoprotein U 
Hnrnpu -3.80E-04 3.78 + 0.62 1.0 22.5 
Adenylate kinase 2 Ak2 -2.20E-05 3.68 + 0.55 21.3 37.6 
Coatomer subunit 
alpha 
Copa -1.70E-02 3.64 + 0.82 10.3 16.2 
Caldesomon Cald1 -7.80E-07 3.58 + 0.71 14.4 27.4 
Gelsolin Isoform 2 Gsn -4.20E-08 3.42 + 0.59 26.8 17.1 
Heat shock 70kDa 
protein 5 
Hspa5 -2.40E-05 3.38 + 0.75 22.2 3.4 
Eukaryotic initiation 
factor 4A-III 
Eif4a3 -2.30E-02 3.35 + 0.39 1.5 27.4 
S-methyl-5'-
thioadenosine 
phosphorylase 
Mtap -1.00E-03 3.33 + 0.35 8.0 25.0 
Heat shock protein 
90kDa beta member 
1 
Hsp90b1 -5.10E-04 3.31 + 0.71 33.6 20.6 
 
Table 9-1 Top 20 most enriched proteins released by apoptotic cells in an 
actomyosin-dependant manner 
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Figure 9-3 Analysis of proteins released from apoptotic cells 
a) Classification of proteins released from apoptotic cells based on their function as 
determined by GeneGo gene ontology analysis. b) Log-plot of fold change in individual 
protein release (apoptotic/control) in conditioned media compared with the log-plot of 
molecular weights of proteins. c) Log-plot of fold change in individual protein release 
(apoptotic/control) in conditioned media. (Wickman et al., 2013). 
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 Macrophage phagocytosis of proteins released from 9.2.3
apoptotic cells 
Mononuclear phagocytes and macrophages are integral components of the 
immune system as they have the capacity to ingest a variety of proteins that 
may influence the inflammatory response and contribute to antigen presentation 
(Underhill and Goodridge, 2012). We hypothesized that macrophages can take up 
proteins released by apoptotic cells. To identify potential protein targets that 
can be phagocytosed by macrophages, I collected conditioned medium from 
heavy (Lys8, Arg10) labelled NIH 3T3 fibroblasts that has been induced with 
apoptosis using UV (0.1 J/cm2) for 4 hours. The conditioned media was then 
added to culture plates containing RAW 264.7 cells, which is a commonly used 
macrophage cell line, and incubated for 2 hours. Prior to incubation with 
apoptotic conditioned media, the macrophages were pre-treated with 
Bafilomycin A1 to block endosome acidification and subsequent proteolysis of 
ingested proteins. Macrophage cell lysates were prepared after washing the cells 
and for each protein a minimum of two SILAC-labelled tryptic peptides were 
unambiguously identified on the basis of their mass difference from endogenous 
peptides (Figure 9-4). 
Heavy labelled proteins released from fibroblasts during apoptosis and 
phagocytosed by the macrophages were identified by mass spectrometry. 
Interestingly, four out of five nucleosomal histones (H2A, H2B, H3 and H4), 
which were the most highly enriched proteins in the apoptotic supernatant and 
released in an actomyosin-dependant manner, were identified as being 
phagocytosed by RAW 264.7 macrophage cells from conditioned medium (Table 
9-2). In addition, Vimentin was also identified as being phagocytosed by RAW 
264.7 cells (Table 9-2). 
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Figure 9-4 Experimental flowchart to study macrophage phagocytosis of proteins 
released by apoptotic cells using SILAC 
 
 
 
Protein 
Identified 
Gene 
Name 
Molecular 
Weight (kDa) 
Histone H2A Hist1h2af 14 
Histone H2B Hist1h2bb 14 
Histone H3 H3f3a 15 
Histone H4 Hist1h4a 11 
Vimentin Vim 54 
 
Table 9-2 'Heavy' labelled proteins from apoptotic cells that were phagocytosed by 
macrophages 
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 Histones released by apoptotic blebs activate macrophages 9.2.4
Apart from playing an imperative role in phagocytosis, activated macrophages 
also produce a variety of cytokines, such as TNFα, IL-1, IL-6, IL-8, etc. which can 
contribute to the cytokine cascade. We hypothesized that histones released by 
apoptotic cells in an actomyosin-dependant manner and ingested by 
macrophages can cause macrophage activation. This was confirmed by 
measuring TNFα released by macrophages upon treatment with histones using an 
ELISA kit. Treatment of RAW 264.7 cells with varying amounts of purified 
recombinant histone proteins resulted in significant release of TNFα induced by 
H2A, H2B and H3, but not H4 (Figure 9-5 a). I also checked for release of IL-1β 
and IL-6 from macrophages upon treatment with histones. 1L-β levels released 
from macrophages were below the detection limit for all histones and IL-6 levels 
showed a slight increase (38 pg/ml) with histone H2B treatment alone (data not 
shown). 
Toll-like receptors (TLRs) play a central role in macrophage activation and they 
signal through the NF-κB pathway (Kawai and Akira, 2007). In addition, as 
discussed earlier, histones activate immune cells by binding to TLRs. Consistent 
with this, treatment with 10 µg/ml of histone H2A dramatically increased NFKBIA 
(IkBa) phosphorylation (Figure 9-5 b), which was statistically significant (Figure 9-5 
c). Together, these results show that proteins released from actomyosin-
dependent blebs and apoptotic bodies engage with macrophages, revealing a 
mechanism of communication between early apoptotic cells and components of 
the innate immune system.  
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Figure 9-5 Histones released by apoptotic cells activate macrophages 
a) Bar graph (Mean ± SEM) shows TNFα release from macrophages (RAW 264.7 cell 
line) with indicated histone treatments. Data analysed by ANOVA followed by Dunnett’s 
multiple comparison test. b) Representative western blotting of phosphorylated and total 
NFKBIA from control and H2A treated macrophages. c) Bar graph (Mean ± SEM) showing 
relative phosphorylated NFKBIA (pNFKBIA) to total NFKBIA ratio, normalized to an 
average control value = 1. Data analysed by Student’s t-test. (Wickman et al., 2013). 
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9.3  Discussion 
Traditionally, apoptosis has been regarded as the ‘silent’ form of cell death 
because it does not trigger an inflammatory response. This defining feature of 
apoptotic cells is mainly attributed to its preservation of membrane integrity, 
which prevents the release of intracellular contents into the local environment. 
However, based on data from our lab, apoptotic body permeabilization can 
occur during early apoptosis, which would provide a route for the release of 
intracellular contents (Wickman et al., 2013). Indeed, induction of apoptosis 
using TNFα and CHX in fibroblasts resulted in acute protein release within 4 
hours of induction. However, inhibition of membrane blebbing and apoptotic 
body formation using ROCK1 inhibitor Y-27632 or myosin ATPase inhibitor 
Blebbistatin resulted in a reduction in bulk protein release from apoptotic cells, 
suggesting that protein release is dependent on actomyosin contractility. 
Systematic quantitative SILAC survey of conditioned media identified numerous 
proteins released during early apoptosis that were sensitive to inhibition of 
actomyosin contraction. The most highly enriched proteins were nucleosomal 
histones, which have been validated as potent DAMPs. Other DAMPs including 
S100 proteins and heat shock proteins released in an actomyosin dependant 
manner were also identified in the screen. Additionally, using SILAC approach, 
we observed that nucleosomal histones along with vimentin released by 
apoptotic cells are taken up by phagocytes like macrophages. Histones act on 
macrophages through TLRs to produce cytokines like TNFα which can contribute 
to a cytokine cascade that will alert the innate immune system. Together, these 
observations give strong indications regarding an active role for blebs and 
apoptotic bodies in allowing limited release of intracellular proteins that can 
engage with the immune system. Therefore, apart from breaking down apoptotic 
cells into bite-sized pieces for efficient phagocyte uptake, actomyosin 
contractility dependent blebbing and apoptotic body formation may have 
additional roles in promoting faster clearance by alerting the immune system of 
an impending danger prior to transition to secondary necrotic state. 
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10 Final Discussion and Future Directions 
The field of cell death has witnessed an explosive development in the past few 
decades with the advent of genetic manipulation methods, electron microscopy 
as well as improved histochemical techniques. Although observations of cell 
death were recorded as early as the mid-nineteenth century, it was only in 1972 
that John Kerr, Andrew Wyllie and Alastair. R. Currie highlighted the significance 
of cell death in the maintenance of tissue homeostasis in multicellular 
organisms. Together, they coined the term ‘apoptosis’ to define a controlled, 
programmed cell death mechanism and distinguish it from the uncontrolled cell 
death, necrosis (Kerr et al., 1972). In their seminal report, they described the 
distinct morphological features displayed by apoptotic cells including nuclear 
and cytoplasmic condensation and protrusions of plasma membrane to form 
blebs which eventually separated from the cell to form what they called 
‘apoptotic bodies’. The underlying signalling pathways that governed this mode 
of cellular demise transpired from numerous investigations of programmed cell 
death in nematode Caenorhabditis elegans (Horvitz, 1999). 
Much effort has gone into elucidating different inducers of apoptosis and their 
downstream targets, in particular the caspases that were identified as central 
components of the apoptotic program. Beyond the cell intrinsic mechanisms 
associated with apoptosis, another integral part of the program is the efficient 
removal of apoptotic cells, termed as efferocytosis. For many years, the 
significance of efferocytosis and its biological purpose was underestimated 
However, the efficient cell clearance capacity seen in tissues with high cellular 
turnover, as well as evidence linking failed apoptotic cell clearance to 
pathological consequences, spurred a great deal of research that improved our 
understanding of this complex and evolutionarily conserved process. To date, a 
plethora of apoptotic cell derived ligands, phagocytic receptors and ligand-
receptor bridging molecules involved in apoptotic corpse removal have been 
identified, which hints at an apparent redundancy in clearance mechanisms. 
Yet, the importance of apoptotic morphological features and how they might 
assist efferocytosis to expedite the removal of cellular corpses has only been 
deliberated, predominantly by means of in vitro studies. Hence, an in vivo 
genetic model system was long overdue. 
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10.1 ROCK1nc Mouse Model 
Our lab had previously showed that during apoptosis, caspase cleavage and 
consequent activation of ROCK1 drives the actomyosin contractile force 
generation that is responsible for the observed morphological features (Coleman 
et al., 2001) and for nuclear disintegration (Croft et al., 2005). Identification of 
the caspase cleavage site of ROCK1 enabled the generation of a mouse model 
that expressed a non-cleavable form of ROCK1 (ROCK1nc) by mutating the 
cleavage site (D1113A). This is the first genetic model system that would help to 
define the biological significance of the dramatic morphological changes that 
occur during apoptosis in vivo. Given the importance of cell death and efficient 
removal of cellular debris in multicellular organisms, I sought to understand 
whether ROCK1-dependant apoptotic morphological features played a role in 
tissue homeostasis and tumour development. 
Apoptotic cells from ROCK1nc mice showed distinct morphological defects which 
validated our genetic model and confirmed the role of caspase cleavage of 
ROCK1 in mediating membrane blebbing and cell contraction. Membrane 
blebbing and apoptotic body formation has mainly been studied in cell culture 
environment, leading many to speculate whether these features are an in vitro 
artefact. Our studies using GFP-expressing melanoblasts on ex vivo embryonic 
skin explants have established that membrane blebbing is a bona fide biological 
phenomenon in living tissue. In addition, we confirmed that knock in mutation in 
ROCK1 inhibited the typical morphological features seen during apoptosis. 
Defects in apoptotic cell clearance mechanisms have been linked to the 
development of several pathologies including autoimmunity. How these 
apoptotic morphological responses cooperate with the different steps of 
efferocytosis has never been delved into. Using SILAC-based approach on NIH 3T3 
cells, we showed that apoptotic cells release damage associated molecular 
patterns like histones, and this was influenced by actomyosin contractility that 
drives membrane blebbing and apoptotic body formation. These ‘suicide notes’ 
dispatched by apoptotic cells prior to secondary necrosis are taken up by 
macrophages, which may influence their response to dying cells. We also showed 
that actomyosin contractility contributed to the translocation of histones into 
blebs and apoptotic bodies (Wickman et al., 2013). Hence, limited membrane 
permeability during early apoptosis may help in alerting the immune system 
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before secondary necrosis can occur. For these studies, we utilized the ROCK 
inhibitor Y-27632 and the myosin ATPase inhibitor Blebbistatin to inhibit the 
classical apoptotic morphological features. Considering the off-target effects of 
inhibitors, cells from ROCK1nc mice would be an impressive option in addressing 
the role of these dramatic morphological responses in the release of potential 
‘suicide notes’ for alerting the neighbouring cells as well as the immune system. 
Since complete incorporation of labelled amino acids for SILAC experiments is 
usually achieved only by 5 or 6 passages, this might prove to be challenging for 
primary cells like MEFs which start senescing in 3 to 4 passages. A way forward 
would be to SILAC-label immortalized MEFs from these mice or use a label-free 
proteomics approach for primary MEFs. 
Given the evidence of obvious morphological defects during apoptosis in 
ROCK1nc model, we also questioned whether this might lead to an autoimmune 
phenotype. Surprisingly, mice were born in expected Mendelian ratios, were 
viable and fertile, and did not display any overt autoimmune phenotype, 
suggesting that these morphological defects did not have significant implications 
at basal level, even in tissues with high cellular turnover. Histologically, 
ROCK1nc mice did not reveal an autoimmune phenotype even though the kidney 
showed minor indications of the same. A number of ‘eat me’ signals have been 
found to adorn the surface of apoptotic cells that not only set them apart from 
health viable cells in the vicinity but also aids in establishing a physical contact 
between the phagocyte and the apoptotic cell. A role for apoptotic blebs to 
serve as focal points for the aggregation of ‘eat me’ signals was anticipated. 
Nonetheless, we did not observe a difference in externalization of 
phosphatidylserine, a key ‘eat me’ signal, in ROCK1nc MEFs. This might partly 
explain the apparent lack of a pathological phenotype in ROCK1nc mice. 
On the other hand, focal concentration of C1q, a complement protein that binds 
to apoptotic cells and expedites phagocytic engulfment by engaging with their 
C1q receptors (Korb and Ahearn, 1997, Navratil et al., 2001), was compromised 
in ROCK1nc MEFs due to the obvious lack of discernible membrane blebs. 
Although C1q-deficient mice developed glomerulonephritis and displayed 
increased mortality due to impaired clearance of apoptotic cells (Botto et al., 
1998), we did not observe the same in our model. This could be because, in an 
in vivo setting, the lack of membrane blebs may not be a limiting factor for C1q 
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to bind to apoptotic cells. Moreover, the phenotype associated with C1q 
deficiency was not observed on a different genetic background (Botto et al., 
1998), thus suggesting a role for genetic modifiers in the development of 
autoimmunity. 
Genetic predisposition is an important contributor to susceptibility to 
autoimmune diseases. Several strains of mice spontaneously develop an 
autoimmune phenotype including NZB/WF1, MRL/Mp-lpr/lpr and BXSB.YaaB6 
(Theofilopoulos and Dixon, 1985). The ROCK1nc mouse model can be 
backcrossed to any of these strains to check for the contribution of apoptotic 
morphological defects in the development of autoimmunity. Hybrid strains 
between 129 and C57Bl/6 are commonly used in the generation of gene-targeted 
mice. Studies showed that F2 generation of 129 and C57Bl/6 cross demonstrates 
the expression of a powerful autoimmune phenotype (Bygrave et al., 2004). To 
test whether ROCK1nc mutation would exacerbate the autoimmune phenotype in 
this strain which is spontaneously predisposed, we backcrossed the mice to a 129 
background for eight generations and then crossed with C57Bl/6 mice. The F2 
generation is currently underway and will be analysed for the development of 
autoimmunity. 
10.2 Apoptotic Morphological Responses Maintain 
Homeostasis in Liver 
An intricate balance between two competing processes; cell proliferation versus 
cell death, regulates tissue homeostasis in multicellular organisms. Maintenance 
of homeostasis relies heavily on the rapid clearance of apoptotic debris before 
they cause havoc by undergoing secondary necrosis. While apoptotic 
morphological responses do not appear to be critical at basal level, this may not 
be the case when challenged with a strong apoptotic stimulus. Tissues are often 
exposed to several stresses which can result in cell death. In such cases, the 
number of cells dying at a given time increases and hence the need for highly 
efficient clearance mechanisms becomes of paramount importance. Whether 
these morphological features contribute to efferocytosis in physiologically 
relevant in vivo contexts was definitely intriguing, and the ROCK1nc model was 
ideal to address this question. 
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Owing to its central role in detoxifying drugs and other harmful substances in the 
blood, the liver is quite vulnerable to cell death, thus making it an excellent 
system to study responses to defective apoptotic morphological features. To 
induce damage, I used the liver-selective genotoxic carcinogen, 
diethylnitrosamine (DEN) that forms DNA adducts by ethylation (Williams et al., 
1996). Liver function tests combined with histological analysis provided clear 
indications of higher degrees of hepatocellular damage in ROCK1nc mice. 
Evidence of increased accumulation of apoptotic debris in ROCK1nc livers 
suggested the possibility of these corpses releasing toxic intracellular contents 
thereby causing tissue damage. Furthermore, the increased assembly of immune 
cells including neutrophils in ROCK1nc livers, possibly in response to the 
accumulating debris, may also have contributed in aggravating hepatocellular 
damage by releasing reactive oxygen intermediates and serine proteases 
(Jaeschke and Hasegawa, 2006). 
Increased recruitment of immune cells like neutrophils to sites of damage may 
be influenced by DAMPs like HMGB1 released by accumulating apoptotic debris in 
ROCK1nc livers. Increased cytoplasmic translocation of HMGB1 in ROCK1nc 
hepatocytes gave strong indication of an impending extracellular release (Zhou 
et al., 2011). This however has to be confirmed in the sera of mice treated with 
DEN and we are currently collaborating with Professor Marco Bianchi, a leading 
scientist in the HMGB1 field at San Raffaele University, Italy, to achieve this. A 
recent study showed that hepatocyte-specific deletion of HMGB1 reduced 
neutrophil recruitment to the liver in response to acetaminophen overdose or 
ischemia/reperfusion injury (Huebener et al., 2015). Consistent with this 
finding, inhibiting the cytokine activity of HMGB1 with Glycyrrhizin reduced 
neutrophil infiltration to the liver as well as DEN-induced hepatocellular damage 
in ROCK1nc mice. Together, these results showed that defective apoptotic 
morphological responses may result in the inadvertent release of HMGB1 which 
may have contributed to the pathological response via neutrophil mediated 
amplification of liver injury. Certainly, the link between neutrophil infiltration 
and amplification of hepatocellular damage is purely hypothetical at this 
juncture and needs experimental validation. By introducing the ROCK1nc 
mutation into Elane-/- mice deficient for neutrophil elastase that is essential for 
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neutrophil effector functions (Belaaouaj et al., 1998), it would be possible to 
confirm the contribution of neutrophils to liver damage. 
Glycyrrhizin, the HMGB1 inhibitor used for my studies, is a natural triterpene 
found in the roots and rhizomes of licorice (Glycyrrhiza glabra) that can bind 
directly to HMGB1 and inhibit its chemoattractant and mitogenic activities 
(Mollica et al., 2007). The effects of HMGB1 in ROCK1nc model can be further 
confirmed by using another functional inhibitor BoxA, which is a truncated form 
of the protein that acts as a competitive antagonist by inhibiting HMGB1 binding 
to its receptor RAGE (Kokkola et al., 2003) and also by using anti-HMGB1 
antibodies. Once secreted, HMGB1 induces inflammatory responses by binding to 
TLRs and RAGE receptors on immune cells. By combining DEN treatment with 
TLR4 inhibitor (CLI-095) and/or neutralizing RAGE antibody, it would be possible 
to delineate the exact mechanism of action of HMGB1 in mediating liver injury 
during defective apoptotic blebbing. 
The effect of defective apoptotic morphological responses in increasing liver 
damage can be extended to other models of liver injury, especially those which 
are physiologically relevant such as acetaminophen-induced injury and 
ischemia/reperfusion injury. Moreover, the consequence of defective ROCK1 
cleavage on liver regeneration and fibrosis was not addressed in this study 
mostly due to the toxic dose of DEN used that made it difficult to maintain the 
mice for longer periods to study liver regeneration. Moreover, treatment with 
DEN is not commonly associated with fibrosis (Verna et al., 1996, Zhang et al., 
2010). A suitable model would be carbon tetrachloride-induced liver damage 
that is associated with a very strong fibrotic response (Liedtke et al., 2013). The 
successful portrayal of the role of apoptotic morphological features in liver 
homeostasis provides enough confidence in further extending these studies to 
determine whether the observed phenotype echoes in models of acute apoptosis 
in other tissues as well. It is highly likely that the consequence of defective 
apoptotic morphological features may be different in other tissues, probably 
depending on the presence or absence of tissue-resident professional 
phagocytes. 
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10.3 Effect of Apoptotic Morphological Responses on 
Tumour Development 
Having established that ROCK1 cleavage dependent morphological features 
during apoptosis maintained tissue homeostasis by influencing the immunological 
microenvironment, I then went on to explore the role of these features in 
tumour development. Decades of research on the immune system has revealed 
that the link between inflammation and cancer is complex. While there is 
considerable evidence pointing towards a causal link between inflammation and 
cancer, a protective effect of inflammation against tumour development is also 
appreciated. Considering the fact that defective apoptotic morphologic features 
modulated the inflammatory microenvironment in tissues, it was intriguing to 
figure out whether the balance would be tipped to favour tumour development 
or curb it. 
To address this, the ROCK1nc mutation was introduced into two different cancer 
models, namely hepatocellular carcinoma (HCC) and Eµ-myc lymphoma. In DEN-
induced HCC model, ROCK1nc mutation reduced tumour numbers. Similarly, in 
Eµ-myc lymphoma model, mice with the ROCK1nc mutation survived longer. 
These data clearly suggested that impairment of ROCK1-mediated apoptotic 
morphologies had a protective effect against tumour development. It was 
hypothesized that the reduced tumour growth seen in ROCK1nc mice was 
associated with immune responses to defective apoptotic morphologies and 
consequent debris accumulation. Indeed, ROCK1nc liver tumours harboured 
significantly more tumour suppressive CD8+ T cells. It is possible that defective 
apoptotic morphological responses in ROCK1nc mice stimulated cancer 
immunosurveillance wherein immune cells destroyed cancer cells and thus 
limited tumour formation. This was supported by reduced tumour numbers in 
preneoplastic ROCK1nc livers. The immune sentinels triggered by defective 
apoptotic features were successful in curbing tumour development even 9 
months after DEN treatment. However, some tumour cells were successful in 
surviving the ‘elimination’ and ‘equilibrium’ phases and entered the ‘escape’ 
phase, where their growth was no longer blocked by the immune system. This 
was evidenced by the presence of large tumours in ROCK1nc mice that was 
comparable to DEN-induced tumours in wild-type mice, despite the significant 
reduction in tumour numbers in ROCK1nc mice. 
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This raises many questions as to what exactly triggered increased infiltration of 
these cytotoxic T lymphocytes into ROCK1nc liver tumours. Although 
immunohistochemical analysis did not reveal a difference in HMGB1 staining in 
ROCK1nc liver tumours when compared to wild-type, this is not conclusive and 
has to be confirmed in sera of preneoplastic mice. Provided there is substantial 
evidence supporting the role of HMGB1 in suppressing tumour growth in liver, it 
would be interesting to study whether introducing ROCK1nc mutation in mice 
with hepatocyte specific deletion of HMGB1(Huebener et al., 2014, Huebener et 
al., 2015) will impede the tumour suppressive property of defective apoptotic 
morphologies. Apart from HMGB1, there are several other DAMPs that could be 
involved in recruiting tumour-suppressive immune cells, which needs to be 
investigated as well. 
Since the early 1900s, prospective ways to harness the inherent protective 
features of the immune system to curb tumour growth have been extensively 
researched. Currently, several immunotherapy strategies have made their way 
into phase III clinical trials. This includes the administration of synthetic 
cytokines that can boost immune response in patients, monoclonal antibodies 
that can specifically target and kill tumour cells, and vaccines that are made 
from cancer cells (Elert, 2013). Given the finding that defective ROCK1 
activation due to non-cleavage by caspases during apoptosis had a tumour 
suppressive effect and increased infiltration of CD8+ T cells, future strategy 
would be to use ROCK inhibitors in DEN-induced HCC, and see if they induce a 
similar tumour suppressive effect by modulating the immune response. If 
successful, this might prove to be an attractive treatment option that can be 
used in combination with standard chemotherapy. 
10.4  Conclusion 
Despite impressive advances to date in the field of cell death and efferocytosis, 
much remains to be learned about the apoptotic morphological features and 
their biological significance. Here, I presented data on a novel genetic mouse 
model that would go a long way in defining the role of membrane blebbing, cell 
contraction and apoptotic body formation when cells die. Using this model I 
showed that apoptotic morphologies are crucial for the maintenance of tissue 
homeostasis during acute damage but enables tumourigenesis in the long run. 
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